000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|31549|43177|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche Registration GmbH|Epóetín||31549||31549|43177||2|0|S|0|||0 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|7813|12252|lyfalmen|V0457|8760|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7813||7813|12252||2|0|E|0|||0 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|23989|33615|lyfalmen|V0475|9452|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23989||23989|33615||2|0|E|0|||0 000193|N05AH0302|Zyprexa Velotab|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|30986|42465|lyfalmen|V0540|20624|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30986||30986|42465||2|0||0|||0 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|1|FER|0|0|0|100|DKK|4895|8235|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4895||4895|8235||1|H|S|0|||0 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|4677|9044|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||4677||4677|9044||1|0||0|||0 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|1|FER|0|0|0|100|DKK|13016|19413|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||13016||13016|19413||1|H|S|0|||0 000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|2984|5605|lyfalmen|V0942|5147|1|6|0|6,0000|Icepharma hf|Merck AB|Prógesterón||2984||2984|5605||2|0|G|0|||0 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4142|7199|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4142||4142|7199|30.9.2020|1|0||0|||0 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|G|0|JAS|0|0|0|100|SEK|3051|5697|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3051||3051|5697||1|0|G|0|||0 000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|8261|12868|lyfalmen|V0942|12868|1|15|0|15,0000|Icepharma hf|Merck AB|Prógesterón||8261||8261|12868||2|0|G|0|||0 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|1|FKA|0|0|0|100|DKK|37961|51287|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||37961||37961|51287||1|H|S|0|||0 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3445|6240|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3445||3445|6240||1|0||0|||0 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|1|0|1|MRP|0|0|0|100|SEK|93508|121543|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||93508||93508|121543||2|0|S|0|||0 000985|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|AZD|0|0|0|100|SEK|10352|15746|lyfalmen|V0095|10428|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||10352||10352|15746||1|0|E|0|||0 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|PLS|0|0|0|100|DKK|16205|23802|lyfalmen|V0115|8242|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||16205||16205|23802||1|0|E|0|||0 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1870|4072|lyfalmen|V0050|2530|1|100|0|15,8333|Vistor hf|Recordati Ireland Limited|Metóprólól||1870||1870|4072||1|0|G|0|||0 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5746|9407|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5746||5746|9407||1|0|G|0|||0 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2874|5454|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2874||2874|5454||1|0|G|0|||0 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|1|FKA|0|0|0|100|DKK|19640|28530|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||19640||19640|28530||1|0|S|0|||0 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|G|0|VIF|0|0|1|100|CHF|13633|20262|lyfalmen|V0637|20260|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||13633||13633|20262||1|0|G|0|||0 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|1|FKA|0|0|0|100|DKK|26774|37137|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||26774||26774|37137||1|0|S|0|||0 001870|QP54AA0601|Slice vet.|forbl|0,2|% w/w|2,5|kg|1|þpakki|duft|QP54AA06|01.02.2019||R|0|0|0|0|0|IBV|0|0|0|100|DKK|141456|228027|veteldis|||0|2,5|0||Vistor hf|Intervet International BV|emamektín||141456||141456|228027||1|0||0|||0 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|1|HES|0|0|0|100|DKK|2527|4976|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2527||2527|4976||1|H|S|0|||0 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|4719|7993|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||4719||4719|7993||1|0|G|0|||0 001905|N03AX0901|Lamictal|dreifit.|2|mg|30|stk|1|glas||N03AX09|01.08.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|530|2227|lyfalmen|||1|30|0|0,2000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||530||530|2227||1|0|G|0|||0 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1810|2639|lyfalmen|V0291|2048|2|60|0|12,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||829||829|2639||1|0|G|0|||0 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|BIG|0|0|1|100|SEK|3453|6251|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3453||3453|6251||2|0|E|0|||0 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3160|3947|lyfalmen|V0292|3494|2|60|0|24,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||1779||1779|3947||1|0|G|0|||0 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|1681|3812|lyfalmen|V0004|2839|1|28|0|18,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||1681||1681|3812||1|0|E|0|||0 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|3423|6209|lyfalmen|V0005|3012|1|28|0|37,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3423||3423|6209||1|0|E|0|||0 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|1|FKA|0|0|0|100|DKK|22805|32117|lyfsjukr|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||22805||22805|32117||2|0|S|0|||0 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3014|5646|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3014||3014|5646||1|0|G|0|||0 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|12898|19251|lyfalmen|V0492|14111|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||12898||12898|19251||1|0|G|0|||0 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|G|0|ATE|0|0|1|100|IKR|||lyfalmen|V0362|2728|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||2728||1|0|G|0|||0 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|1|0|1|LPT|0|0|0|100|XEU|25811|35919|lyfsjukr|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||25811||25811|35919||1|0|ES|0|||0 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|G|0|MSD|0|0|0|100|DKK|12274|16179|lyfalmen|V0089|3631|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||10666||10666|16179||1|0|G|0|||0 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|8364|13010|lyfalmen|V0515|4251|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||8364||8364|13010||1|0|G|0|||0 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|11612|17481|lyfalmen|V0253|4190|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||11612||11612|17481||1|0|G|0|||0 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|22537|31778|lyfalmen|V0516|5902|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||22537||22537|31778||1|0|G|0|||0 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|SEK|8578|13305|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8578||8578|13305||1|0|G|0|||0 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|SEK|12667|18933|lyfalmen|V0992|16319|1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||12667||12667|18933||1|0|G|0|||0 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|6112|9910|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6112||6112|9910||1|0|G|0|||0 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|G|0|AZD|0|0|0|100|SEK|7275|11511|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||7275||7275|11511||1|0|G|0|||0 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3161|5849|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3161||3161|5849||1|0|G|0|||0 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|1|SGB|0|0|0|100|XEU|34656|47107|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||34656||34656|47107||1|H|S|0|||0 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|2087|3041|lyfalmen|||2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1121||1121|3041||1|0|G|0|||0 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|G|0|ATE|0|0|0|100|XEU|25812|29015|lyfalmen|||2|500|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||20352||20352|29015||1|0|G|0|||0 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1102|2761|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||918||918|2761||1|0|E|0|||0 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2338|3470|lyfalmen|V0322|2858|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||1433||1433|3470||1|0|G|0|||0 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|1|HES|0|0|0|100|DKK|19305|28069|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||19305||19305|28069||1|H|S|0|||0 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|G|0|HES|0|0|0|100|DKK|8072|12608|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8072||8072|12608||1|0|G|0|||0 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4397|7550|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4397||4397|7550||1|0|G|0|||0 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5909|9631|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5909||5909|9631||1|0|G|0|||0 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|1|PEU|0|0|0|100|DKK|17698|25857|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||17698||17698|25857||1|H|ES|0|||0 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|BOI|0|0|0|100|DKK|7848|15060|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Fenetamathýdrójoðíð í blöndum með öðrum sýklalyfjum||7848||7848|15060||1|0||0|||0 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2560|5022|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2560||2560|5022||1|0||0|||0 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2912|2836|lyfalmen|V0494|2836|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||972||972|2836||1|0|G|0|||0 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2914|4406|lyfalmen|V0318|4406|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||2113||2113|4406||1|0|G|0|||0 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3113|5783|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||3113||3113|5783||1|0||0|||0 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4231|4570|lyfalmen|V0320|3975|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||2232||2232|4570||1|0|G|0|||0 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2045|3663|lyfalmen|V0317|3663|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||1573||1573|3663||1|0|G|0|||0 004676|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.03.2018||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1023|3180|0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0||0|||0 004687|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1022|2299|0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0||0|||0 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|G|0|SDH|0|0|0|100|XEU|8396|13054|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8396||8396|13054||1|0|G|0|||0 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|857|2677|lyfalmen|||2|24|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||857||857|2677||1|0||0|||0 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|1|PLS|0|0|1|100|DKK|4295|7410|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4295||4295|7410||1|0|ES|0|||0 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|ATE|0|0|1|100|DKK|367|2003|lyfalmen|||2|8|0|2,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||367||367|2003||1|0||0|||0 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|942|2794|lyfalmen|||2|14|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||942||942|2794||1|0||0|||0 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1611|3715|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||1611||1611|3715||1|0||0|||0 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2627|5114|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2627||2627|5114||1|0||0|||0 005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|8939|7763|lyfalmen|V0148|4063|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4552||4552|7763||1|0|G|0|||0 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2603|5081|lyfalmen|||2|20|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díkloxacillín||2603||2603|5081||1|0|E|0|||0 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2668|4448|lyfalmen|V0337|4211|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díkloxacillín||2143||2143|4448||1|0|E|0|||0 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|18334|26733|lyfalmen|V0356|26731|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18334||18334|26733||1|0|G|0|||0 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|1|G|0|AZA|0|0|0|100|SEK|51448|66880|lyfalmen|V0451|56656|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||50290||50290|66880||1|0|G|0|||0 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|G|0|BOI|0|0|0|100|DKK|1825|4010|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1825||1825|4010||1|0|G|0|||0 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4970|8339|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4970||4970|8339||1|0|G|0|||0 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|5013|8398|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5013||5013|8398||1|0|G|0|||0 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1909|4125|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1909||1909|4125||2|0|G|0|||0 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|5997|9752|lyfalmen|V0020|7004|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5997||5997|9752||2|0|G|0|||0 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|4381|7528|lyfalmen|V0020|3502|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4381||4381|7528||2|0|G|0|||0 005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4650|7898|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Europe B.V.|Cetrorelix||4650||4650|7898||2|0|G|0|||0 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|5550|9137|lyfalmen|V0324|4230|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5550||5550|9137||1|0|G|0|||0 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8908|13759|lyfalmen|V0325|5315|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8908||8908|13759||1|0|E|0|||0 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|G|0|NED|0|0|0|100|XEU|2799|5350|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2799||2799|5350||2|0|G|0|||0 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|14965|21983|lyfalmen|V0326|6651|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14883||14883|21983||1|0|E|0|||0 005963|J01CR0204|Amoxin comp|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RHA|0|0|1|100|IKR|1834|2532|lyfalmen|V0169|2530|2|14|0|8,1667|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||751||751|2532||2|0|E|0|||0 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5619|9232|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5619||5619|9232||1|0|G|0|||0 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|1|MSD|0|0|0|100|DKK|102281|133720|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||102281||102281|133720||1|H|ES|0|||0 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5366|8884|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5366||5366|8884||1|0|G|0|||0 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|1|MSD|0|0|0|100|DKK|78140|102105|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||78140||78140|102105||1|H|ES|0|||0 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|1|0|0|100|DKK|3634|7065|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||3634|7065||1|0||0|||0 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|1|GEB|0|1|0|100|XEU|456274|573988|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||456274||456274|573988||1|H|L|0|||0 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|13889|20615|lyfalmen|V0099|10279|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||13889||13889|20615||1|0|G|0|||0 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|11829|17779|lyfalmen|V0117|5177|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11829||11829|17779||1|0|E|0|||0 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|16939|24813|lyfalmen|V0118|8414|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16939||16939|24813||1|0|E|0|||0 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|20141|28748|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20141||20141|28748||1|0|E|0|||0 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|1|0|1|PLS|0|1|0|100|DKK|85722|111695|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||85722||85722|111695||1|0|L|0|||0 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|1|0|1|PLS|0|1|0|100|DKK|219161|279086|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||219161||219161|279086||1|0|L|0|||0 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|G|0|PLS|0|0|0|100|DKK|2330|4705|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2330||2330|4705||1|0|G|0|||0 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|1|BAM|0|0|0|100|SEK|7436|11733|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||7436||7436|11733||2|0|S|0|||0 007449|V03AB3402|Fomepizol EUSA Pharma|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|1|SER|0|0|0|100|XEU|99245|128799|lyfsjukr|||1|100|0||SERB SA|SERB SA|Fómepízól||99245||99245|128799||3|H|S|0|||0 007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|1|ABV|0|0|0|100|DKK|23532|33037|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||23532||23532|33037||1|H|S|0|||0 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|6174|9996|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||6174||6174|9996||1|0|G|0|||0 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|1|SHG|0|1|0|100|XEU|252259|320251|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||252259|320251||1|H|L|0|||0 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5015|8401|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||5015||5015|8401||1|0|G|0|||0 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|15827|23282|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||15827||15827|23282||1|0|G|0|||0 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1731|2817|lyfalmen|V0290|2461|2|60|0|6,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||958||958|2817||1|0|G|0|||0 007852|G02BB0101|NuvaRing|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst.|G02BB01|01.11.2002||R|0|0|0|0|0|DSM|0|0|0|100|DKK|4080|6368|lyfalm11|V0983|5613|1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||4080||4080|6368||1|0||0|||0 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|NEL|0|0|0|100|DKK|1405|3432|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1405||1405|3432||1|0||0|||0 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|G|0|MCK|0|0|0|100|SEK|344|1971|lyfalmen|V0502|1065|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||344||344|1971||2|0|G|0|||0 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|912|2328|lyfalmen|V0226|2255|2|20|0|6,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||603||603|2328||1|0|G|1|30|dagar|0 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1071|2972|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||1071||1071|2972||1|0|G|0|||0 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2910|4816|lyfalmen|V0227|4526|2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2411||2411|4816||1|0|G|1|30|dagar|0 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4140|5721|lyfalmen|V0228|5352|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||3068||3068|5721||1|0|G|1|30|dagar|0 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4852|7229|lyfalmen|V0224|6728|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||4164||4164|7229||1|0|G|1|30|dagar|0 008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|1|GEB|0|0|0|100|XEU|129007|166960|lyfsjukr|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||129007||129007|166960||1|H|S|0|||0 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|CHP|0|0|0|100|XEU|8072|13913|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |Fenbendazolum||8072||8072|13913||2|0||0|||0 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|CHP|1|0|0|100|XEU|12098|23123|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||12098||12098|23123||2|0||0|||0 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2775||2|0|G|0|||0 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2856|5429|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2856||2856|5429||1|0|G|0|||0 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|88850|115651|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||88850||88850|115651||2|0|S|0|||0 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|109372|142539|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||109372||109372|142539||2|0|S|0|||0 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|7200|11408|lyfalmen|V0145|2105|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||7200|11408||2|0|E|0|||0 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|14276|21147|lyfalmen|V0145|4210|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||14276|21147||2|0|E|0|||0 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4383|7531|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4383||4383|7531||2|0|G|0|||0 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|1|FMC|0|0|0|100|XEU|7987|12491|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7987||7987|12491||2|0|S|0|||0 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|4915|8263|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4915||4915|8263||2|0|G|0|||0 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|1|FMC|0|0|0|100|XEU|7987|12491|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7987||7987|12491||2|0|S|0|||0 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|PEU|0|0|1|100|DKK|11205|16920|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Europe MA EEIG|Parekoxíb||11205||11205|16920||1|0||0|||0 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|1|FMC|0|0|0|100|XEU|6995|11126|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6995||6995|11126||2|0|S|0|||0 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|1|PEU|0|0|1|100|DKK|22290|31466|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||22290||22290|31466||1|0|ES|0|||0 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1163|3099|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1163||1163|3099||1|0|G|0|||0 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1283|3264|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1283||1283|3264||1|0|G|0|||0 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1489|3547|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1489||1489|3547|31.10.2020|1|0|G|0|||0 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1858|4055|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1858||1858|4055||1|0|G|0|||0 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|NOK|6351|10239|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6351||6351|10239||2|0|S|0|||0 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|7706|12104|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7706||7706|12104||2|0|S|0|||0 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|NOK|6351|10239|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6351||6351|10239||2|0|S|0|||0 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|1|0|1|GII|0|0|0|100|DKK|57619|76150|lyfsjukr|||1|30|0|30,0000|Gilead Sciences International Ltd|Gilead Sciences Ireland UC|Tenófóvír dísóproxíl||57619||57619|76150||2|0|S|0|||0 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9569|14669|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9569||9569|14669||1|0||0|||0 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|10937|16552|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10937||10937|16552||1|0||0|||0 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8662|13420|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8662||8662|13420||1|0||0|||0 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|10937|16552|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10937||10937|16552||1|0||0|||0 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8782|13585|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8782||8782|13585||1|0||0|||0 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9569|14669|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9569||9569|14669||1|0||0|||0 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002|30.09.2020|R|1|0|0|0|1|ROA|0|0|1|100|DKK|211775|269900|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||211775||211775|269900||2|0|S|||| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|1|0|1|MSD|0|0|0|100|DKK|6051|9827|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||6051||6051|9827||1|H|ES|0|||0 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|G|0|LUN|0|0|0|100|DKK|16277|23902|lyfalmen|V0605|2793|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||16277||16277|23902||1|0|G|0|||0 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|8206|12793|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||8206||8206|12793||1|0|E|0|||0 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|1|FKA|0|0|0|100|DKK|10051|15332|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||10051||10051|15332||1|H|S|0|||0 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|SAO|0|0|1|100|XEU|1418|3450|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1418||1418|3450||2|0||0|||0 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|1|0|1|JCI|0|1|0|100|SEK|263126|333766|lyfsjukr|||1|56|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||263126||263126|333766||3|0|L|0|||0 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|1|0|1|JCI|0|1|0|100|SEK|263807|334613|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||263807||263807|334613||3|0|L|0|||0 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|1|0|1|PEU|0|0|0|100|DKK|722300|904850|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||722300||722300|904850||1|0|ES|0|||0 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|1|BAM|0|0|0|100|SEK|42251|56713|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||42251||42251|56713||2|H|S|0|||0 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2824|2807|lyfalmen|V0058|2807|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||951||951|2807||2|0|G|0|||0 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|20625|29360|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||20625||20625|29360||1|0|E|0|||0 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|13896|20624|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||13896||13896|20624||1|0||0|||0 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3882|3262|lyfalmen|V0059|3262|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1282||1282|3262||2|0|G|0|||0 010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1677||2|0|G|0|||0 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|31684|43348|lyfalmen|V0683|3050|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||31684||31684|43348||1|0|E|0|||0 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|25600|35652|lyfalmen|V0684|3050|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||25600||25600|35652||1|0|G|0|||0 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3683|6567|lyfalmen|V0825|2811|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3683||3683|6567||1|0|G|0|||0 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3811|6743|lyfalmen|V0826|2870|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3811||3811|6743||1|0|G|0|||0 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|16331|23976|lyfalmen|V0327|8216|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||16331||16331|23976||1|0|E|0|||0 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|1199|3148|lyfalmen|V0827|2159|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1199||1199|3148||1|0|G|0|||0 011397|J01CA0102|Doktacillin|stl/irs|||1|g|10|hgl||J01CA01|01.03.2020||R|0|0|0|0|1|MEA|0|0|1|100|SEK|14773|21831|lyfsjukr|||1|10|0|1,6666|Icepharma hf|Meda AB|Ampicillín||14773||14773|21831||2|0|0|0|||0 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|G|0|AZD|0|0|0|100|SEK|6030|9798|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6030||6030|9798||1|0|G|0|||0 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|5432|8975|lyfalmen|V0691|6025|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5432||5432|8975||1|0|E|1|30|dagar|0 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|6948|8413|lyfalmen|V0624|5788|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5024||5024|8413||1|0|E|1|30|dagar|0 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|CHP|1|0|0|100|XEU|1970|3872|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||1970||1970|3872||2|0||0|||0 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|0|0|1|PLS|0|0|0|100|DKK|3882|6841|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3882||3882|6841||1|H|S|1|30|dagar|0 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|OCO|0|0|0|100|DKK|4566|8833|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||4566||4566|8833||2|0||0|||0 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3723|5275|lyfalmen|V0323|4166|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||2744||2744|5275||1|0|G|0|||0 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|1|MAR|0|0|0|100|DKK|3948|6932|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3948||3948|6932||2|H|S|0|||0 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|1|MAR|0|0|0|100|DKK|2080|4361|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||2080||2080|4361||2|H|S|0|||0 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|1|0|1|MSD|0|0|0|100|DKK|28822|39728|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||28822||28822|39728||1|0|S|0|||0 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3794|6720|lyfalmen|V0909|3144|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3794||3794|6720||1|0|G|0|||0 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6928|11034|lyfalmen|V0924|6005|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||6928||6928|11034||2|0|E|0|||0 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|0|0|0|JAS|0|0|0|100|SEK|9093|10801|lyfalmen|V0622|6647|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6759||6759|10801||1|0|E|1|30|dagar|0 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|GPH|0|0|1|100|DKK|973|2837|lyfalmen|||1|80|0|2,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||973||973|2837||1|0|E|0|||0 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|JCI|0|0|0|100|SEK|4425|6793|lyfalm11|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4425||4425|6793||1|0||0|||0 012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|G|0|LBI|0|0|0|100|DKK|6103|9898|lyfalmen|||1|30|0|30,0000|Vistor hf|Laboratoires Besins International|Testósterón||6103||6103|9898||1|0|G|0|||0 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1974|2723|lyfalmen|V0250|2723|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||890||890|2723||2|0|G|0|||0 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2941|3356|lyfalmen|V0251|3150|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||1350||1350|3356||2|0|G|0|||0 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|6763|9141|lyfalmen|V0959|4858|1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5553||5553|9141||1|0|E|1|30|dagar|0 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|9741|13528|lyfalmen|V0996|7873|1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8740||8740|13528||1|0|E|1|30|dagar|0 013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|1|CSB|0|0|0|100|SEK|7727|12133|lyfsjukr|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||7727||7727|12133||2|H|S|0|||0 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3067|5719|lyfalmen|V0042|4460|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxazósín||3067||3067|5719||1|0|G|0|||0 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|1|0|1|AZE|0|1|0|100|SEK|313279|396143|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Gefitiníb||313279||313279|396143||1|0|L|0|||0 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1302|3290|lyfalmen|||1|5|0|1,6700|Icepharma hf|Mundipharma A/S|Oxýcódon||1302||1302|3290||2|0|E|1|30|dagar|0 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|846|2501|lyfalmen|V0562|2349|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Íbúprófen||729||729|2501||2|0|G|0|||0 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2501|4940|lyfalmen|||1|10|0|3,3300|Icepharma hf|Mundipharma A/S|Oxýcódon||2501||2501|4940||2|0|E|1|30|dagar|0 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|382|2024|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Lídókaín||382||382|2024||2|0||0|||0 013872|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|G|0|AZD|0|0|0|100|SEK|10341|15731|lyfalmen|V0215|9994|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10341||10341|15731||1|0|G|0|||0 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|6297|10165|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6297||6297|10165||1|0|G|0|||0 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2323|4695|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2323||2323|4695||1|0|G|0|||0 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4846|8168|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4846||4846|8168||1|0|G|0|||0 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|1|0|1|NEL|0|1|0|100|DKK|103441|135163|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||103441||103441|135163||1|0|L|0|||0 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|1|0|1|NEL|0|1|0|100|DKK|205936|262638|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||205936||205936|262638||1|0|L|0|||0 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2507|4949|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2507||2507|4949||1|0|G|0|||0 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|1|GRH|0|0|1|100|DKK|6642|10640|lyfsjukr|||1|50|0|13,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||6642||6642|10640||1|0|ES|0|||0 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|G|0|UCB|0|0|0|100|DKK|16612|24363|lyfalmen|V1000|16638|1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16612||16612|24363||1|0|G|0|||0 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|52865|70137|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||52865||52865|70137||2|0|E|0|||0 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1388|3408|lyfalmen|V0479|3090|2|60|0|4,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1388||1388|3408||1|0|E|0|||0 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1799|3974|lyfalmen|||2|100|0|6,6667|Artasan ehf|Sandoz A/S|Amoxicillín||1799||1799|3974||1|0|E|0|||0 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|G|0|AZD|0|0|0|100|SEK|18092|26400|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18092||18092|26400||1|0|G|0|||0 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|406|1857|lyfalmen|V0563|1759|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Íbúprófen||261||261|1857||2|0|G|0|||0 014435|QM01AE0303|Dolovet vet.|duft|160|mg/g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|VET|0|0|0|100|XEU|2588|5080|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||2588||2588|5080||2|0||0|||0 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|1|0|1|GEI|0|0|0|100|DKK|78680|102788|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||78680|102788||2|0|S|0|||0 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1102|2346|lyfalmen|V0564|2113|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Íbúprófen||616||616|2346||2|0|G|0|||0 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|963|2823|lyfalmen|||1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||963||963|2823||2|0|G|1|30|dagar|0 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|24410|34147|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||24410||24410|34147||1|0|G|0|||0 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|67631|88813|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||67631||67631|88813||1|0|G|0|||0 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|45084|60296|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||45084||45084|60296||1|0|G|0|||0 014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OEU|0|0|0|100|XEU|739230|925906|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||739230||739230|925906||3|0|E|0|||0 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2689|4205|lyfalmen|V0673|4030|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1967||1967|4205||1|0|G|0|||0 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|G|0|NAS|0|0|0|100|DKK|7773|12197|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7773||7773|12197||1|0|G|0|||0 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1115|3033|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1115||1115|3033||1|0|G|0|||0 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1859|2947|lyfalmen|V0234|1823|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1053||1053|2947||1|0|G|0|||0 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2654|2947|lyfalmen|V0233|2325|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1053||1053|2947||1|0|G|0|||0 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|G|0|NAS|0|0|0|100|DKK|9043|13945|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9043||9043|13945||1|0|G|0|||0 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|1|PAM|0|0|0|100|DKK|304505|385230|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||304505||304505|385230||3|H|S|0|||0 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|1|PAM|0|0|0|100|DKK|81155|105918|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||81155|105918||3|H|S|0|||0 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|12325|18462|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12325||12325|18462||1|0|G|0|||0 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|12254|18364|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12254||12254|18364||1|0|G|0|||0 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|10706|16234|lyfalmen|V0829|13781|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10706||10706|16234||1|0|G|0|||0 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|18753|27310|lyfalmen|V0470|23497|1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||18753||18753|27310||1|0|G|0|||0 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|37461|50654|lyfalmen|V1008|44166|1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||37461||37461|50654||1|0|G|0|||0 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4043|6969|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||4043||4043|6969||2|0||0|||0 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6214|10710|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||6214||6214|10710||2|0||0|||0 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3361|5793|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3361||3361|5793||2|0||0|||0 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3411|5879|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3411||3411|5879||2|0||0|||0 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5965|10281|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5965||5965|10281||2|0||0|||0 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|100|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2|0||0|||0 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|0|0|0|ETH|0|0|1|100|GBP|1464|3513|lyfalmen|||2|10|0|3,3300|Icepharma hf|Ethypharm|Morfín||1464||1464|3513||2|0|E|1|30|dagar|0 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3279|5652|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3279||3279|5652||2|0||0|||0 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|60|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2|0||0|||0 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|1661|3784|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1661||1661|3784||1|0|E|0|||0 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2546|5002|lyfalmen|||1|14|0|7,0000|Icepharma hf|Upjohn EESV|Pregabalín||2546||2546|5002||1|0|E|0|||0 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|5406|8939|lyfalmen|V0686|2033|1|56|0|14,0000|Icepharma hf|Upjohn EESV|Pregabalín||5406||5406|8939||1|0|E|0|||0 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|9533|14619|lyfalmen|V0687|2766|1|56|0|28,0000|Icepharma hf|Upjohn EESV|Pregabalín||9533||9533|14619||1|0|E|0|||0 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|G|0|ATE|0|0|0|100|XEU|5261|8739|lyfalmen|||2|1000|0|1000,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||5261||5261|8739|31.10.2020|1|0|G|0|||0 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1674|3802|lyfalmen|||1|14|0|3,5000|Icepharma hf|Upjohn EESV|Pregabalín||1674||1674|3802||1|0|E|0|||0 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|12009|18027|lyfalmen|V0689|3445|1|56|0|56,0000|Icepharma hf|Upjohn EESV|Pregabalín||12009||12009|18027||1|0|E|0|||0 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|1|PEU|0|0|1|100|DKK|95975|124663|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||95975||95975|124663||1|0|ES|0|||0 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|1|PLS|0|0|0|100|DKK|3346|6103|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3346||3346|6103||1|H|S|0|||0 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2450|4870|lyfalmen|V0685|2190|1|56|0|4,6667|Icepharma hf|Upjohn EESV|Pregabalín||2450||2450|4870||1|0|E|0|||0 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|16906|24767|lyfalmen|V0690|6125|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||16906||16906|24767||1|0|E|0|||0 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||8519||1|0|E|0|||0 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|27917|38583|lyfalmen|V0682|3050|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||27917||27917|38583||1|0|E|0|||0 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|8051|10846|lyfalmen|V0960|6024|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6792||6792|10846||1|0|E|1|30|dagar|0 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|G|0|LVR|0|0|0|100|DKK|3048|5693|lyfalmen|V0240|5693|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3048||3048|5693||3|0|G|0|||0 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|G|0|LVR|0|0|0|100|DKK|5797|9477|lyfalmen|V0433|9477|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5797||5797|9477||3|0|G|0|||0 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|52685|69910|lyfalmen|V0721|8409|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||52685||52685|69910||1|0||0|||0 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|77618|101445|lyfalmen|V0722|34144|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||77618||77618|101445||1|0||0|||0 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|28857|39772|lyfalmen|V0720|6829|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||28857||28857|39772||1|0||0|||0 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|1|GEB|0|1|0|100|XEU|66456|87327|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||66456||66456|87327||1|H|L|0|||0 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1606|3708|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1606|3708||1|0|E|0|||0 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|1|0|1|GEI|0|0|0|100|DKK|32878|44858|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||32878||32878|44858||2|0|S|0|||0 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|2117|4412|lyfalmen|V0943|2957|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||2117||2117|4412||2|0|G|1|30|dagar|0 017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1065|2653|lyfalm11|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1065||1065|2653||1|0|G|0|||0 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|ATE|0|0|0|100|XEU|6642|10640|lyfalmen|||2|500|0|333,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||6642||6642|10640||1|0||2|225|mg|0 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|ATE|0|0|0|100|SEK|7183|11385|lyfalmen|||2|500|0|500,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||7183||7183|11385||1|0||2|225|mg|0 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|1|0|1|BNB|0|0|0|100|XEU|92696|120516|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||92696||92696|120516||2|0|S|0|||0 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|3796|6723|lyfalmen|V0944|3501|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||3796||3796|6723||2|0|G|1|30|dagar|0 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|6763|10807|lyfalmen|V0945|6262|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||6763||6763|10807||2|0|G|1|30|dagar|0 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|1|MSD|0|0|1|100|DKK|7860|12316|lyfsjukr|||1|3|0|1,7273|Vistor hf|M.S.D.|Aprepitant||7860||7860|12316||1|0|S|0|||0 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|G|0|MEA|0|0|1|100|DKK|2783|5328|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2783||2783|5328||2|0|G|0|||0 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6884|13231|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||6884||6884|13231||1|0||0|||0 017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1500|2186|lyfalmen|V0556|2186|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2186||2|0||0|||0 017679|J02AC0107|Fluconazol Krka|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.12.2018||L|1|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól|||||||2|0||0|||0 017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2300|3563|lyfalmen|V0556|3279|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1500||1500|3563||2|0||0|||0 017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1271|2117|lyfalmen|V0551|2007|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2117||2|0||0|||0 017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|3500|2599|lyfalmen|V0552|2555|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||800||800|2599||2|0||0|||0 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|PLS|0|0|0|100|DKK|9120|14051|lyfalmen|V0107|2461|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9120||9120|14051||1|0|0|0|||0 018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1544|2461|lyfalmen|V0946|2461|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||700||700|2461||2|0|G|0|||0 018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2107|3287|lyfalmen|V0947|3287|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1300||1300|3287||2|0|G|0|||0 018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2975|3563|lyfalmen|V0948|3563|2|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G|0|||0 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|G|0|GPH|0|0|0|100|DKK|895|2355|lyfalmen|V0243|2150|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||623||623|2355||1|0|G|0|||0 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|6788|10841|lyfalmen|V0985|5792|1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6788||6788|10841||1|0|G|0|||0 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|18973|27612|lyfalmen|V0441|12202|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||18973||18973|27612||1|0|G|0|||0 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|G|0|MEC|0|0|1|100|SEK|1150|3081|lyfalmen|V0414|3081|1|100|0|50,0000|Icepharma hf|Merck AB|Prednisólón||1150||1150|3081||2|0|G|0|||0 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|5659|9287|lyfalmen|V0438|3824|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5659||5659|9287||1|0|G|0|||0 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|4937|8293|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||4937||4937|8293||1|0|E|0|||0 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|14313|21198|lyfalmen|V0440|9648|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14313||14313|21198||1|0|G|0|||0 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|PLS|0|0|0|100|DKK|32885|44867|lyfalmen|V0111|6040|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||32885||32885|44867||1|0|E|0|||0 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|1|WIL|0|0|0|100|XEU|60025|79193|lyfsjukr|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||60025||60025|79193||2|H|S|0|||0 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|795|2592|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||795||795|2592||1|0|E|0|||0 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|1|0|1|TGM|0|0|0|100|NOK|79444|103754|lyfsjukr|||1|28|0|28,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||79444||79444|103754||1|0|ES|0|||0 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|KEL|1|0|0|100|NOK|936|1840|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|Lídókaín í blöndum||936||936|1840||2|0||0|||0 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|1|GEH|0|0|0|100|NOK|5656|9283|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||5656||5656|9283||2|H|S|0|||0 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|183742|225401|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||175996||175996|225401||2|H|L|0|||0 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|17194|25164|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||17194||17194|25164||2|H|S|0|||0 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|20565|29284|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||20565||20565|29284||2|H|S|0|||0 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|18491|26949|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||18491||18491|26949||2|H|S|0|||0 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|24884|34747|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||24884||24884|34747||2|H|S|0|||0 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|91871|114573|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||87998||87998|114573||2|H|L|0|||0 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|45935|58924|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||43999||43999|58924||2|H|L|0|||0 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|22968|31098|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||21999||21999|31098||2|H|L|0|||0 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|6497|12497|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||6497||6497|12497||1|0||0|||0 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|491|2009|lyfalmen|V0633|2009|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||371||371|2009||1|0|G|0|||0 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|CAR|0|0|0|100|DKK|33510|63746|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||33510||33510|63746||1|0||0|||0 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|6774|10822|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6774||6774|10822||2|0|E|0|||0 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|1|RRG|0|1|0|100|DKK|50431|67059|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||50431||50431|67059||2|H|L|0|||0 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|6327|10206|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6327||6327|10206||2|0|E|0|||0 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|1|RRG|0|1|0|100|DKK|190947|243996|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||190947||190947|243996||2|H|L|0|||0 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|MYL|0|0|1|100|SEK|965|2490|lyfalmen|V0159|2369|2|20|0|6,6667|Icepharma hf|Mylan AB|Amoxicillín||721||721|2490||2|0|E|0|||0 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|1|NED|0|1|0|100|XEU|169248|217008|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||169248||169248|217008||2|H|L|0|||0 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|13229|19706|lyfalmen|V0812|3903|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13229||13229|19706||2|0|E|0|||0 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|13229|19706|lyfalmen|V0813|3903|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13229||13229|19706||2|0|E|0|||0 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12495|18696|lyfalmen|V0814|3903|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12495||12495|18696||2|0|E|0|||0 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12495|18696|lyfalmen|V0815|3903|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12495||12495|18696||2|0|E|0|||0 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12495|18696|lyfalmen|V0816|4224|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12495||12495|18696||2|0|E|0|||0 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|0|1|0|1|VIC|0|0|0|100|DKK|62972|82921|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín og abacavír||62972||62972|82921||1|0|S|0|||0 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1199|2914|lyfalmen|V0160|2914|2|30|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1029||1029|2914||2|0|E|0|||0 019969|N06AB0405|Citalopram PCD|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|G|0|PDA|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|4406|2|100|0|100,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||2600||2600|5077||2|0|G|0|||0 020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|G|0|PDA|0|0|0|100|IKR|4500|3975|lyfalmen|V0320|3975|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1800||1800|3975||2|0|G|0|||0 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1|0||0|||0 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|32499|44378|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||32499||32499|44378||1|0||0|||0 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|LVR|0|0|0|100|NOK|2813|5370|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2813||2813|5370|31.10.2020|3|0|E|0|||0 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|1|0|1|RPR|0|0|0|100|XEU|99750|129437|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|HRA Pharma Rare Diseases|Mitotanum||99750||99750|129437||0|0|S|0|||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|ASP|0|0|0|100|XEU|49905|66393|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||49905||49905|66393||1|0|G|0|||0 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|ASP|0|0|0|100|XEU|23124|32521|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||23124||23124|32521||1|0|G|0|||0 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6740|4794|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||2395||2395|4794||2|0|G|0|||0 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|BOA|0|0|0|100|XEU|2278|3926|vetorma|||0|7,74|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum í blöndum||2278||2278|3926||1|0||0|||0 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|0|0|UCC|0|0|0|100|DKK|51098|67902|lyfalmen|||1|180|0||Vistor hf|UCB Pharma S.A.|sodium oxybate||||51098|67902||1|0|E|3|||0 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|VEB|0|0|0|100|XEU|2664|4592|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Pyrantelum||2664||2664|4592||2|0||0|||0 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|LLS|0|0|0|100|DKK|2667|5169|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2667||2667|5169||2|0||0|||0 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|GAN|0|0|0|100|XEU|2081|4362|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2081||2081|4362||2|0||0|||0 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|IKR|633|2369|lyfalmen|V0188|2048|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||633||633|2369||1|0|G|0|||0 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1448|2876|lyfalmen|V0189|2461|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||1001||1001|2876||1|0|G|0|||0 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|G|0|MSD|0|0|0|100|DKK|13120|19556|lyfalmen|V0490|9481|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||13120||13120|19556||1|0|G|0|||0 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1|0||0|||0 021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|33799|46023|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||33799||33799|46023||3|0|G|0|||0 021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|61928|81600|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||61928||61928|81600||3|0|G|0|||0 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|4105|7148|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4105||4105|7148||1|0|G|0|||0 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|13704|20360|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13704||13704|20360||1|0|G|0|||0 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|AZD|0|0|0|100|SEK|12543|18762|lyfalmen|V0214|4543|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12543||12543|18762||1|0|E|0|||0 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|6843|10917|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6843||6843|10917||1|0|G|0|||0 021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|G|0|FER|0|0|0|100|DKK|15052|22215|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15052||15052|22215||1|0|G|0|||0 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|1|FKA|0|0|0|100|DKK|16204|23801|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||16204||16204|23801||1|H|S|0|||0 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|19227|27962|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||19227||19227|27962||1|0|G|0|||0 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005|31.08.2020|R|0|0|0|0|1|FKA|0|0|0|100|DKK|15129|22321|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||15129||15129|22321||1|H|S|||| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|24942|34820|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24942||24942|34820||1|0|G|0|||0 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|1|FKA|0|0|0|100|DKK|9317|14322|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||9317||9317|14322||1|H|S|0|||0 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|1|PLS|0|0|1|100|DKK|4459|7635|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4459||4459|7635||1|0|S|0|||0 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|19968|28982|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19968||19968|28982||1|0|G|0|||0 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|3478|6285|lyfalmen|V0692|2334|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3478||3478|6285||2|0|E|0|||0 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|4888|8226|lyfalmen|V0693|3453|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4888||4888|8226||2|0|E|0|||0 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|12766|19069|lyfalmen|V0694|4119|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||12766||12766|19069||2|0|E|0|||0 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|1|0|1|SCL|0|0|0|100|DKK|26440|36715|lyfsjukr|||1|100|0||Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Anagrelidum||26440||26440|36715||1|0|ES|0|||0 022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|1|VIN|0|0|1|100|XEU|2833|5397|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2833||2833|5397||2|0|ES|0|||0 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|1|AXA|0|0|0|100|SEK|107250|139900|lyfsjukr|||1|1200|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||107250||107250|139900||2|H|S|0|||0 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4566|7783|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4566||4566|7783||1|0|G|0|||0 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|1|0|0|LPT|0|0|0|100|XEU|16007|23530|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||16007||16007|23530||1|0||0|||0 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2327|4011|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||2327||2327|4011||2|0||0|||0 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|3897|3290|lyfalmen|V0056|2312|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1302||1302|3290||1|0|G|0|||0 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|6909|4328|lyfalmen|V0057|2312|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2056||2056|4328||1|0|G|0|||0 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2204|3799|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||2204||2204|3799||2|0||0|||0 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|1427|2460|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||1427||1427|2460||2|0||0|||0 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2053|4160|lyfalmen|V0321|4160|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paroxetín||1934||1934|4160||1|0|G|0|||0 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4346||2|0|G|0|||0 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|2235|4574|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2235||2235|4574||1|0|G|0|||0 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|3457|5198|lyfalmen|V0125|3467|2|30|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2688||2688|5198||1|0|G|0|||0 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|1|0|1|GEI|0|0|0|100|DKK|68535|89957|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||68535||68535|89957||2|0|S|0|||0 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|24592|34378|lyfalmen|||1|90|0|20,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||24592||24592|34378||1|0||0|||0 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|37731|50996|lyfalmen|||1|90|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||37731||37731|50996||1|0||0|||0 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|3000|3907|lyfalmen|V0125|3467|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||1750||1750|3907||2|0|G|0|||0 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|LUX|0|0|0|100|DKK|13891|20617|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||13891||13891|20617||1|0|G|0|||0 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|5231|6935|lyfalmen|V0125|6935|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||3950||3950|6935||2|0|G|0|||0 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|LUX|0|0|0|100|DKK|16450|24140|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||16450||16450|24140||1|0|G|0|||0 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2360|3106|lyfalmen|V0250|2723|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1168||1168|3106||2|0|G|0|||0 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|3046|3642|lyfalmen|V0251|3150|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1558||1558|3642||2|0|G|0|||0 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|G|0|SGB|0|0|0|100|XEU|17654|25797|lyfalmen|V0029|6106|1|100|0|100,0000|Vistor hf|Sanofi-aventis groupe|Klópídógrel||17654||17654|25797||1|0|G|0|||0 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2102|4391|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2102||2102|4391||2|0|G|0|||0 023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|1|BAM|0|0|0|100|SEK|124818|161750|lyfsjukr|||2|1500|0||Icepharma hf|Baxter Medical AB|Sevóflúran||124818||124818|161750||2|H|S|0|||0 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|900|2737|lyfalmen|V0066|2737|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2737||2|0|G|0|||0 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1050|2943|lyfalmen|V0449|2943|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2943||2|0|G|0|||0 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|750|2530|lyfalmen|V0448|2375|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||750||750|2530||2|0|G|0|||0 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|6144|9955|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6144||6144|9955||2|0|G|0|||0 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2327|4030|lyfalmen|V0673|4030|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1840||1840|4030||2|0|G|0|||0 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|1|0|1|UPJ|0|0|0|100|DKK|28193|38932|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Upjohn EESV|Síldenafíl||28193||28193|38932||1|0|ES|0|||0 023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3500|4251|lyfalmen|V0007|4251|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||2000||2000|4251||2|0|G|0|||0 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2493|4929|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2493||2493|4929||1|0|G|0|||0 024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OEU|0|0|0|100|XEU|63853|84035|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||63853||63853|84035||3|0|E|0|||0 024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3264|4251|lyfalmen|V0323|4251|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||2000||2000|4251||2|0|G|0|||0 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|24942|34820|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24942||24942|34820||1|0|G|0|||0 024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1926|3012|lyfalmen|V0322|2916|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1100||1100|3012||2|0|G|0|||0 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|7852|12305|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7852||7852|12305||1|0||0|||0 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|7852|12305|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7852||7852|12305||1|0||0|||0 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|5661|9290|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5661||5661|9290||1|0||0|||0 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|1612|3717|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1612||1612|3717||1|0||0|||0 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|5684|9321|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5684||5684|9321|31.10.2020|1|0||0|||0 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|30.09.2020|R|0|0|0|0|0|ALK|0|0|0|100|DKK|7596|11953|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7596||7596|11953||1|0||||| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|7852|12305|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7852||7852|12305||1|0||0|||0 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|1612|3717|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1612||1612|3717||1|0||0|||0 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1820|4003|lyfalmen|||2|100|0|66,6667|Alvogen|ratiopharm GmbH|Metóprólól||1820||1820|4003||2|0|G|0|||0 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|19968|28982|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19968||19968|28982||1|0|G|0|||0 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1547|3627|lyfalmen|||2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||1547||1547|3627||2|0|G|0|||0 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|1|0|1|BSP|0|1|0|100|DKK|58341|77063|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||58341||58341|77063||1|0|L|0|||0 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|BOI|1|0|0|100|DKK|9895|18943|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||9895||9895|18943||1|0||0|||0 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|15514|22851|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||15514||15514|22851||1|0|E|0|||0 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|5418|8955|lyfalmen|V0205|1279|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||5418||5418|8955||2|0|E|0|||0 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|14521|21485|lyfalmen|V0205|3838|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||14521||14521|21485||2|0|E|0|||0 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|45007|60198|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||45007||45007|60198||1|0|E|0|||0 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|1|MAR|0|0|0|100|DKK|6406|10315|lyfsjukr|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||6406||6406|10315||2|H|S|0|||0 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|24942|34820|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24942||24942|34820||1|0|G|0|||0 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1038|2836|lyfalmen|V0597|2836|2|28|0|3,7300|Alvogen|ratiopharm GmbH|Oxýcódon||972||972|2836||2|0|G|1|30|dagar|0 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3476|5652|lyfalmen|V0598|5625|2|98|0|13,0700|Alvogen|ratiopharm GmbH|Oxýcódon||3018||3018|5652||2|0|G|1|30|dagar|0 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|1|0|1|CPV|0|1|0|100|XEU|53266|70644|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Thalidómíde||||53266|70644||2|0|L|0|||0 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|29449|40521|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||29449||29449|40521||1|0||0|||0 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|4009|6910|vetorma|||0|1|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||4009||4009|6910||1|0||0|||0 025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|1|0|1|IPC|0|0|0|100|XEU|94921|100074|lyfsjukr|||2|28|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||76534||76534|100074||2|0|S|0|||0 025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2|0||0|||0 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|2258|4438|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2258||2258|4438||1|0||0|||0 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|9566|16488|vetorma|||0|2,5|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||9566||9566|16488||1|0||0|||0 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|44468|59517|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||44468||44468|59517||1|0|G|0|||0 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010|31.08.2020|R|0|0|0|0|1|PFM|0|0|0|100|DKK|36138|48981|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||36138||36138|48981||1|H|S|||| 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010|31.08.2020|R|0|0|0|0|1|PFM|0|0|0|100|DKK|180692|231241|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||180692||180692|231241||1|H|S|||| 026490|L04AD0204|Dailiport|forðahlk|2|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|17214|25191|lyfalmen|||2|50|0|20,0000|Artasan ehf|Sandoz A/S|Tacrolimus||17214||17214|25191||1|0|G|0|||0 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|1877|4081|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1877|4081||1|0|G|0|||0 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|7408|11694|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||7408|11694||1|0|G|0|||0 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|3707|6600|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3707|6600||1|0|G|0|||0 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|14466|21409|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||14466|21409||1|0|G|0|||0 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|21595|30587|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||21595|30587||1|0|G|0|||0 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|28665|39529|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||28665|39529||1|0|G|0|||0 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|6532|10489|lyfalmen|V0099|10489|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||6532||6532|10489||2|0|G|0|||0 027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7860|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7860||2|0|E|1|30|dagar|0 027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|18350|26755|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||18350||18350|26755||1|0|G|0|||0 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2043|3563|lyfalmen|V0823|3563|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1500||1500|3563||2|0|G|0|||0 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|952|2808|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||952||952|2808||2|0||0|||0 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2218|4551|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2218||2218|4551||1|0|G|0|||0 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|13636|11824|lyfalmen|||2|100|0|66,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||7502||7502|11824||1|0|G|0|||0 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|13130|11824|lyfalmen|V0342|11824|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||7502||7502|11824||1|0|G|0|||0 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|1|BAM|0|0|1|100|SEK|2484|4917|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2484||2484|4917||2|0|S|0|||0 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|G|0|EIG|0|0|0|100|SEK|6386|10288|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai GmbH|Zonisamíð||6386||6386|10288||1|0|G|0|||0 027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|0|G|0|MYL|0|0|0|100|SEK|4197|6262|lyfalmen|V0945|6262|2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||3461||3461|6262||2|0|G|1|30|dagar|0 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|G|0|TDA|0|0|0|100|DKK|623|2355|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||623||623|2355||1|0|G|0|||0 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|G|0|TDA|0|0|0|100|DKK|717|2485|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||717||717|2485||1|0|G|0|||0 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|21176|30057|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||21176||21176|30057||1|0|E|0|||0 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|1|NED|0|0|0|100|XEU|24340|34059|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||24340|34059||2|H|S|0|||0 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|24014|33647|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||24014||24014|33647||1|0|E|0|||0 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|1|NED|0|0|0|100|XEU|29912|41106|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||29912||29912|41106||2|H|S|0|||0 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|1|NED|0|0|0|100|XEU|41224|55414|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||41224|55414||2|H|S|0|||0 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|BAB|0|0|0|100|DKK|4435|6805|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||4435||4435|6805||2|0||0|||0 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|18303|26690|lyfalmen|V0387|26690|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||18303||18303|26690||1|0|G|0|||0 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2943||2|0||0|||0 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|17799|25996|lyfalmen|V0386|25996|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||17799||17799|25996||1|0|G|0|||0 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|1|0|1|NEL|0|1|0|100|DKK|50957|67724|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||50957||50957|67724||1|0|L|0|||0 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2714|5233|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir mótefnavakar||2714||2714|5233||1|0||0|||0 028342|J07BL0101|Stamaril|sts|||0,5|ml|1|hgl|+1 áf.spr.með leysi+2 nálar|J07BL01|01.04.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|4361|7500|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Gulusótt, veikluð veira||4361||4361|7500||1|0||0|||0 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|43611|58433|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||43611|58433||1|0||0|||0 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|2498|4109|lyfalmen|V0202|4109|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1897||1897|4109||2|0|G|0|||0 028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|632|2368|lyfalmen|V0266|2368|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||632||632|2368||2|0|G|0|||0 028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2582|4251|lyfalmen|V0267|4251|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||2000||2000|4251||2|0|G|0|||0 028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|14853|21942|lyfalmen|||2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21942||2|0|G|0|||0 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|6286|5305|lyfalmen|V0245|4936|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2766||2766|5305||1|0|G|0|||0 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|11841|11869|lyfalmen|V0232|10426|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||7535||7535|11869||1|0|G|0|||0 028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|822|2620|lyfalmen|V0266|2368|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||815||815|2620||2|0|G|0|||0 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|OCO|1|0|0|100|DKK|8212|15750|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||8212||8212|15750||2|0||0|||0 028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|3080|4578|lyfalmen|V0267|4251|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||2238||2238|4578||2|0|G|0|||0 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|G|0|GCA|0|0|1|100|DKK|1248|3082|lyfalmen|V0625|2079|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Flútíkasón||1151||1151|3082||1|0|G|0|||0 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|6417|10330|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||6417||6417|10330||2|0||0|||0 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|17652|25794|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||17652||17652|25794||2|0||0|||0 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1|0|0|0|||0 029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36425|49344|lyfalmen|V0802|49344|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36425||36425|49344||2|0|E|1|30|dagar|0 029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36425|49344|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36425||36425|49344||2|0|E|1|30|dagar|0 029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36425|49344|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36425||36425|49344||2|0|E|1|30|dagar|0 029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|12122|18183|lyfalmen|V0801|16423|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||12122||12122|18183||2|0|E|1|30|dagar|0 029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|GOP|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1|0||0|||0 029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36365|49268|lyfalmen|V0801|49268|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36365||36365|49268||2|0|E|1|30|dagar|0 029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|12142|18210|lyfalmen|V0802|16448|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||12142||12142|18210||2|0|E|1|30|dagar|0 029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36425|49344|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36425||36425|49344||2|0|E|1|30|dagar|0 029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36425|49344|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36425||36425|49344||2|0|E|1|30|dagar|0 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|1|EIG|0|1|0|100|SEK|51034|67821|lyfsjukr|||1|2|0||Vistor hf|Eisai GmbH|Eribulin||51034||51034|67821||1|H|L|0|||0 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|0|1|ATE|0|0|0|100|XEU|11057|16717|lyfsjukr|||2|5|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Vínorelbín||||11057|16717||1|H|S|0|||0 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|GAN|0|0|1|100|XEU|5991|9744|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5991||5991|9744||2|0|E|0|||0 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2778|lyfalmen|V0168|2778|2|20|0|6,6667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||930||930|2778||2|0|E|0|||0 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|PEU|0|0|0|100|DKK|8480|13170|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||8480||8480|13170||1|0||0|||0 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|16992|29287|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||16992||16992|29287||2|0||0|||0 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|G|0|NED|0|0|0|100|XEU|2831|5395|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2831||2831|5395||2|0|G|0|||0 031140|N06AX2701|Spravato|nefúði|28|mg|28|mg|2|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|0|0|100|SEK|67735|88945|lyfalmen|||1|56|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||67735||67735|88945||1|H||0|||0 031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2564|5027|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2564||2564|5027||2|0|G|0|||0 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5927|9656|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5927||5927|9656||1|0|G|0|||0 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|1|FEL|0|0|0|100|DKK|19816|28773|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19816||19816|28773||1|H|S|0|||0 032257|C01CA1703|Hypotron|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|RET|0|0|0|100|IKR|8875|13713|lyfalmen|V0969|12927|2|50|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||8875||8875|13713||2|0||0|||0 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|G|0|OPC|0|0|0|100|DKK|21833|30888|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||21833||21833|30888||1|0|G|0|||0 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|BOA|1|0|0|100|XEU|15088|26006|vetorma|||0|200|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||15088||15088|26006||1|0||0|||0 032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2100|3170|lyfalmen|V0069|2806|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1215||1215|3170||2|0|G|0|||0 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|23051|32429|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||23051||23051|32429||1|0|G|0|||0 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|42086|56504|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||42086|56504||1|0|G|0|||0 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|1266|2182|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||1266||1266|2182||2|0||0|||0 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|3189|5887|lyfalmen|V1004|4877|1|28|0|3,7400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||3189||3189|5887||2|0|E|1|30|dagar|0 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|9481|18158|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||9481|18158||2|0||0|||0 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|10938|16553|lyfalmen|V1005|14367|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||10938||10938|16553||2|0|E|1|30|dagar|0 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|6382|10282|lyfalmen|V1006|8611|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||6382||6382|10282||2|0|E|1|30|dagar|0 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|20904|29713|lyfalmen|||1|98|0|26,1400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||20904||20904|29713||2|0|E|1|30|dagar|0 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|G|0|HES|0|0|1|100|DKK|1586|3681|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1586||1586|3681||1|0|G|0|||0 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|RHA|0|0|1|100|XEU|1542|2905|lyfalmen|V0189|2461|2|100|0|50,0000|Alvogen|ratiopharm Oy|Díklófenak||1022||1022|2905||2|0|G|0|||0 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|RHA|0|0|1|100|XEU|685|2441|lyfalmen|V0188|2048|2|30|0|15,0000|Alvogen|ratiopharm Oy|Díklófenak||685||685|2441||2|0|G|0|||0 033644|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|9055|13961|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||9055||9055|13961||2|0|G|1|30|dagar|0 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|16966|24850|lyfalmen|V0185|19013|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||16966||16966|24850||2|0|G|0|||0 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|1|0|1|JCI|0|0|0|100|SEK|81642|106534|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||81642||81642|106534||1|0|S|0|||0 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2567|5041|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2567|5041||2|0||0|||0 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|XEU|2181|3139|lyfalmen|V0098|2488|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||1192||1192|3139||2|0|G|0|||0 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|24602|34390|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||24602||24602|34390||2|H|L|0|||0 034613|N02AB0310|Fentanyl Alvogen|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|3724|6450|lyfalmen|V0220|6450|2|5|0|15,0000|Alvogen|Alvogen|Fentanýl||3598||3598|6450||2|0|G|1|30|dagar|0 034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|G|0|BFP|0|0|0|100|XEU|4304|4690|lyfalmen|V0323|4251|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||2319||2319|4690||1|0|G|0|||0 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|1115|3033|lyfalmen|||1|6|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||1115||1115|3033||1|0|G|0|||0 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|2606|5085|lyfalmen|||1|12|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||2606||2606|5085||1|0|G|0|||0 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|1|LEP|0|0|1|100|DKK|7323|11577|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7323||7323|11577||1|0|S|0|||0 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2100|4388|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||2100||2100|4388||1|H|S|0|||0 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|2585|5056|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2585|5056||1|0|G|0|||0 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|16147|23723|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16147||16147|23723||1|0|G|0|||0 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1137|2538|lyfalmen|V0050|2530|2|100|0|15,8333|Alvogen|ratiopharm GmbH|Metóprólól||756||756|2538||2|0|G|0|||0 035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|662|2409|lyfalmen|||2|20|0|6,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||662||662|2409||1|0|E|3|||0 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1386|2881|lyfalmen|||2|100|0|31,6667|Alvogen|ratiopharm GmbH|Metóprólól||1005||1005|2881|31.10.2020|2|0|G|0|||0 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2334|3012|lyfalmen|V0049|2943|2|100|0|63,3333|Alvogen|ratiopharm GmbH|Metóprólól||1100||1100|3012||2|0|G|0|||0 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4390|5571|lyfalmen|V0054|3975|2|100|0|126,6667|Alvogen|ratiopharm GmbH|Metóprólól||2959||2959|5571||2|0|G|0|||0 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|3066|3487|lyfalmen|V0233|3487|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1445||1445|3487||1|0|G|0|||0 035802|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|AZD|0|0|0|100|SEK|12516|18725|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||12516||12516|18725||1|0|E|0|||0 035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|GEB|0|0|0|100|XEU|25269|35234|lyfalmen|V0680|16753|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||25269||25269|35234||1|0||0|||0 036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|8598|13332|lyfalmen|V0806|9749|1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||8598|13332||2|0|G|0|||0 036339|N02BE5107|Paradorm|filmhtfl|525|mg|10|stk|1|þpakki|500+25 mg|N02BE51|01.09.2020||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6666|Acare ehf|Acare ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||2|0|0|0|||0 036353|R06AX2708|Dasergin|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|G|0|KAN|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||2979||2|0|G|0|||0 036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1553|3635|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1553|3635||1|0|G|0|||0 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|769|2556|lyfalmen|||1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||769||769|2556||2|0|E|0|||0 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|G|0|NEL|0|0|0|100|DKK|17488|25568|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17488||17488|25568||1|0|G|0|||0 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|BIV|0|0|0|100|DKK|1482|2554|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1482||1482|2554||1|0||0|||0 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1|0||0|||0 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2668|5170|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2668||2668|5170||2|0|E|0|||0 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|1013|2892|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1013||1013|2892||2|0|E|0|||0 036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|G|0|VAL|0|0|1|100|IKR|342|1969|lyfalmen|V0006|1312|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||342||342|1969||2|0|G|0|||0 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|6963|7922|lyfalmen|V0532|7345|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4667||4667|7922||1|0|G|0|||0 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|13022|11118|lyfalmen|||1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6989||6989|11118||1|0|G|0|||0 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|18001|20860|lyfalmen|||1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||14067||14067|20860||1|0|G|0|||0 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2569|5034|lyfalmen|V0434|4932|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2569||2569|5034||2|0|G|0|||0 037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3533|3975|lyfalmen|V0054|3975|2|100|0|133,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1800||1800|3975||2|0|G|0|||0 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||2825||2|0|G|0|||0 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||5008||2|0|G|0|||0 038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3615|4470|lyfalmen|V0321|4160|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||2159||2159|4470||1|0|G|0|||0 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1768|2878|lyfalmen|V0110|2694|2|100|0|133,3333|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||1003||1003|2878||1|0|G|0|||0 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|14879|21977|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||14879|21977||2|0|G|0|||0 039145|L01XC0303|Trazimera|st/irþ|420|mg|420|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|1|PEU|0|1|0|100|DKK|235597|299528|lyfsjukr|||1|420|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||235597||235597|299528||1|H|L|0|||0 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|1|0|1|PSS|0|0|0|100|SEK|29206|40213|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||29206||29206|40213||2|0|S|0|||0 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|12813|17945|lyfalmen|||2|50|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||11949||11949|17945||1|0|G|0|||0 039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|1652|3772|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1652||1652|3772||2|0|G|0|||0 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5929|9659|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5929||5929|9659||1|0||0|||0 039441|A09AA0217|Creon 10.000 (Lyfjaver)|sþ-hylki|||100|stk|1|tfílát||A09AA02|01.12.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|3867|6820|lyfalmen|V0706|6820|3|100|0|16,6700|Lyfjaver ehf|Lyfjaver ehf|Hvatablöndur (lípasi, próteasi o.s.frv.)||3867||3867|6820||3|0|G|0|||0 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|1|0|0|SGB|0|0|0|100|XEU|19448|28266|lyfalmen|V1027|19253|1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||19448||19448|28266||1|0|E|0|||0 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4526|6914|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3935||3935|6914||2|0|G|0|||0 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1121|3041|lyfalmen|||2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||1121||1121|3041||2|0|G|0|||0 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1123|2847|lyfalmen|V0542|2276|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||980||980|2847||2|0|G|0|||0 039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|PLS|0|0|1|100|DKK|760|2544|lyfalmen|V0821|2186|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||760||760|2544||1|0|E|0|||0 039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1599|3699|lyfalmen|V0822|2874|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1599||1599|3699||1|0|E|0|||0 039829|L04AX0402|Lenalidomid Alvogen|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|777926|974033|lyfsjukr|||2|21|0|52,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||777926||777926|974033||2|0|L|0|||0 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2173|2694|lyfalmen|V0110|2640|2|98|0|130,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||869||869|2694||1|0|G|0|||0 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|G|0|ATE|0|0|1|100|XEU|6861|4481|lyfalmen|V0182|4394|2|42|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír||2167||2167|4481||1|0|G|0|||0 040092|N02AX0213|Tramadol Krka|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2200|4526|lyfalmen|V0227|4526|2|100|0|33,3300|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2200||2200|4526||2|0|G|1|30|dagar|0 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2932|5534|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2932||2932|5534||2|0|G|0|||0 040771|N06AX2701|Spravato|nefúði|28|mg|28|mg|3|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|0|0|100|SEK|101602|132876|lyfalmen|||1|84|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||101602||101602|132876||1|H||0|||0 040823|A06AD6503|Movicol Junior Neutral|mixtduft|6,9|g|30|pokar|1|pakki|lausn|A06AD65|01.11.2018||L|0|0|0|0|0|NOG|0|0|0|100|IKR|||lyfalmen|||0|30|0||Vistor hf|Norgine BV|Makrógól 3350|||||3874||1|0|E|0|||0 040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|241205|306503|lyfsjukr|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||241205||241205|306503||2|0|ES|0|||0 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|8617|13358|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8617||8617|13358||2|0|E|0|||0 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|8617|13358|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8617||8617|13358||2|0|E|0|||0 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|IBV|0|0|0|100|DKK|4187|7217|vetbolu|||0|100|0||Vistor hf|Intervet International BV|Clostridíum bóluefni||4187||4187|7217||1|0||0|||0 041816|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|5243|3050|lyfalmen|V0682|3050|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1128||1128|3050||2|0|G|0|||0 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1381|3399|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||1381||1381|3399||2|0|G|0|||0 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|7000|11133|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7000||7000|11133||2|0|G|0|||0 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|7161|11354|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7161||7161|11354||2|0|G|0|||0 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1|0||0|||0 042157|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1270|3246|lyfalmen|V0449|2943|2|100|0|200,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||1270||1270|3246||1|0|G|0|||0 042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|IKR|6000|9619|lyfalmen|||2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5900||5900|9619||2|0|E|0|||0 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2483|4916|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2483||2483|4916||1|0|S|0|||0 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3670|6549|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3670||3670|6549||1|0|S|0|||0 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2216|4548|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2216||2216|4548||1|0|S|0|||0 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2139|4442|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2139||2139|4442||1|0|S|0|||0 042500|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|1 innöndunartæk+3 rörlykjur|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|13727|20136|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||13541||13541|20136||1|0|G|0|||0 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2359|4745|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||2359||2359|4745||1|0||0|||0 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2081|4362|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2081||2081|4362||1|0|S|0|||0 042628|N06AX2108|Aritavi|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.07.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|7131|5670|lyfalmen|V0811|5670|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||3031||3031|5670||1|0|E|0|||0 042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|XEU|1453|3498|lyfalmen|V0560|3498|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1453||1453|3498||2|0||0|||0 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|PLS|0|0|1|100|DKK|544|2247|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||544||544|2247||1|0||2|60|töflur|0 043965|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|5527|5975|lyfalmen|V0624|5788|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3253||3253|5975||1|0|E|1|30|dagar|0 044065|H02AB0804|Kenacort-T|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2019||R|0|0|0|0|0|BBB|0|0|1|100|DKK|756|2538|lyfalmen|||0|1|0|5,3330|Vistor hf|Bristol-Myers Squibb AB|Tríamcínólón||756||756|2538||1|0||0|||0 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|G|0|LVR|0|0|1|100|CHF|13631|20260|lyfalmen|V0637|20260|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||13631||13631|20260||3|0|G|0|||0 044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|0|1|ZAA|0|0|0|100|DKK|14430|21359|lyfsjukr|||1|8|0|1,0000|Azanta Danmark A/S|Azanta Danmark A/S|Misóprostól||14430||14430|21359||2|H|S|0|||0 044532|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8866|8380|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||5000||5000|8380||2|0||0|||0 044560|J05AB0105|Zovirax|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|5395|8924|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||5395||5395|8924||1|0|G|0|||0 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|1|0|1|NEL|0|1|0|100|DKK|353877|446635|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||353877||353877|446635||1|0|L|0|||0 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|1|0|1|NEL|0|1|0|100|DKK|495557|622845|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||495557||495557|622845||1|0|L|0|||0 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|G|0|BAM|0|0|0|100|SEK|5417|8954|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5417||5417|8954||2|0|G|0|||0 045332|V03AN0502|Airapy|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|7605|11965|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||7605||7605|11965||1|0|G|0|||0 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1400|2472|lyfalmen|V0109|2371|2|98|0|65,3400|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||708||708|2472||1|0|G|0|||0 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1157|2398|lyfalmen|V0108|2225|2|98|0|32,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||654||654|2398||1|0|G|0|||0 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|1812|3992|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1812|3992||2|0|ES|0|||0 045634|N02AJ0603|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AJ06|01.01.2011|31.08.2020|R|0|0|0|0|0|ATE|0|0|1|100|XEU|384|2026|lyfalmen|||2|10|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||384||384|2026||1|0|E|0|||0 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|G|0|ATE|0|0|0|100|SEK|3961|6950|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||3961||3961|6950||1|0|G|0|||0 046155|L01AD0105|Carmustine Obvius|sts|100|mg|1|hgl|1|pakki|1 lykja m. 3 ml leysi|L01AD01|01.03.2019||R|0|0|0|0|1|OBV|0|0|0|100|NOK|177973|227860|lyfsjukr|||2|1|0||Oresund Pharma ApS|Obvius Investment B.V.|Carmustine ||177973||177973|227860||2|H|S|0|||0 046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|2075|4354|lyfalmen|V0429|4354|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||2075||2075|4354||2|0|G|0|||0 046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|14206|10582|lyfalmen|V0419|10582|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||6600||6600|10582||2|0||0|||0 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|1442|3483|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1442|3483||1|0|G|0|||0 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|930|2778|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||930||930|2778||1|0|G|0|||0 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|536|2154|lyfalmen|V0021|2046|2|90|0|45,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||477||477|2154||1|0|G|0|||0 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|826|2489|lyfalmen|V0022|2368|2|90|0|90,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||720||720|2489||1|0|G|0|||0 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1058|2766|lyfalmen|V0023|2628|2|90|0|135,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||921||921|2766||1|0|G|0|||0 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|G|0|TSA|0|0|1|100|IKR|1563|2599|lyfalmen|V0625|2599|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||800||800|2599||2|0|G|0|||0 046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|G|0|POF|0|0|0|100|IKR|6568|3838|lyfalmen|V0205|3838|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1700||1700|3838||2|0|G|0|||0 047108|QA14AB0101|Myodine vet|stl|25|mg/ml|10|ml|1|hgl|lausn|QA14AB01|01.04.2019||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3385|6593|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Nandrolone||3385||3385|6593||2|0|0|0|||0 047154|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|3252|4832|lyfalmen|V1010|3662|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||2422||2422|4832||2|0|G|0|||0 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|G|0|MYL|0|0|0|100|SEK|905|2744|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||905||905|2744|31.10.2020|2|0|G|0|||0 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19925|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19925||5|H|S|0|||0 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|63421|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|63421||5|H|S|0|||0 047709|J05AB1403|Valganciclovir Medical Valley|filmhtfl|450|mg|60|stk|1|glas||J05AB14|01.06.2020||R|1|0|0|0|1|VAL|0|0|1|100|XEU|40599|54623|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Valgancíklóvír||40599||40599|54623||2|0|S|0|||0 047840|C02CA0408|Doxazosin Krka|töflur|4|mg|120|stk|1|þpakki|með br.losunarhraða|C02CA04|01.10.2020||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3622|5352|lyfalmen|V0042|5352|2|120|0|120,0000|Krka Sverige AB|Krka d.d. Novo mesto|Doxazósín||2800||2800|5352||2|0|G|0|||0 048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|1|AXA|0|0|0|100|SEK|4517|7715|lyfsjukr|||1|250|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||4517||4517|7715||2|H|S|0|||0 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|1|FKA|0|0|1|100|DKK|8310|12936|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||8310||8310|12936||1|0|S|0|||0 048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|1|AXA|0|0|0|100|SEK|7327|11583|lyfsjukr|||1|100|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||7327||7327|11583||2|H|S|0|||0 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1985|4230|lyfalmen|V0324|4230|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1985||1985|4230||1|0|G|0|||0 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1167|3104|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1167||1167|3104||1|0|E|0|||0 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2773|5315|lyfalmen|V0325|5315|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||2773||2773|5315||1|0|G|0|||0 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3744|6651|lyfalmen|V0326|6651|2|100|0|150,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||3744||3744|6651||1|0|G|0|||0 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5812|8216|lyfalmen|V0327|8216|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||4881||4881|8216||1|0|G|0|||0 048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5720|8087|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4787||4787|8087||2|0|G|0|||0 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|G|0|MEA|0|0|0|100|DKK|2197|3521|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||1470||1470|3521||2|0|G|2|100|töflur|0 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1852|3623|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1852||1852|3623||1|0||0|||0 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|1|GEB|0|1|0|100|XEU|888055|1111003|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||888055||888055|1111003||1|H|L|0|||0 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|GCA|0|0|1|100|DKK|423|2080|lyfalmen|V0230|2080|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||423||423|2080||1|0|E|0|||0 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|1|GAA|0|0|0|100|SEK|3959|6947|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3959||3959|6947||2|H|S|0|||0 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|39192|52844|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||39192||39192|52844||3|0|L|0|||0 048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4659|4211|lyfalmen|V0148|4063|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1971||1971|4211||2|0|G|0|||0 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|4650|4310|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||2043||2043|4310||1|0|G|0|||0 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|G|0|PLS|0|0|0|100|DKK|5473|9031|lyfalmen|V0376|5345|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5473|9031||1|0|G|0|||0 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|1|RRD|0|0|0|100|DKK|299724|379284|lyfsjukr|||1|1|0|16,6700|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||299724||299724|379284||1|0|ES|0|||0 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|944|2797|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||944||944|2797||1|0|G|0|||0 049536|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|G|0|AZD|0|0|0|100|SEK|8063|12596|lyfalmen|V0080|6569|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8063||8063|12596||1|0|G|0|||0 049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|5401|8932|lyfalmen|||1|7|0|1,7500|Eisai AB|Eisai GmbH|Perampanel||5401||5401|8932||1|0|G|0|||0 049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2511|2371|lyfalmen|V0109|2371|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||634||634|2371||2|0|G|0|||0 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|962|2822|lyfalmen|||2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||962||962|2822||1|0|G|0|||0 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1879|4084|lyfalmen|||2|100|0|400,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1879||1879|4084||1|0|G|0|||0 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||1938||1|0|E|0|||0 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|0|0|WPA|0|0|0|100|DKK|77766|101632|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma (International) B.V|Cannabinoids||77766||77766|101632||1|0|E|1|30|dagar|0 049906|N02CC0106|Sumatriptan Apofri|filmhtfl|50|mg|2|stk|1|þpakki||N02CC01|01.06.2020||L|1|0|0|0|0|APO|0|0|0|100|IKR|||lyflausa|||0|2|0||LYFIS ehf|Apofri AB|Súmatriptan|||||||2|0||0|||0 049942|B03BB0108|Folsyra Evolan|töflur|5|mg|100|stk|1|þpakki||B03BB01|01.10.2018||R|1|0|0|G|0|EVO|0|0|1|100|IKR|2000|4251|lyfalmen|||2|100|0|1250,0000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2000||2000|4251|31.8.2020|2|0|G|||| 049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|1|0|1|MBV|0|1|0|100|DKK|1159795|1448971|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1159795||1159795|1448971||1|0|L|0|||0 050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|6728|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6728||2|0|E|0|||0 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4263||1|0|G|0|||0 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|7734|12143|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||7734||7734|12143||2|0|G|0|||0 050323|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9201|14162|lyfalmen|V0925|14162|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||||9201|14162||2|0|E|0|||0 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|1|NEL|0|1|0|100|DKK|68332|89700|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||68332|89700||1|0|L|0|||0 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0 050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2750|5283|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||2750||2750|5283||2|0|G|0|||0 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|11708|17613|lyfalmen|V0688|12655|1|56|0|42,0000|Icepharma hf|Upjohn EESV|Pregabalín||11708||11708|17613||1|0|E|0|||0 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5683|5839|lyfalmen|V0042|4460|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3154||3154|5839|||0|G|0|||0 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|0|ATE|0|0|1|100|IKR|4615|6816|lyfalmen|V0002|6816|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||3864||3864|6816||1|0|0|0|||0 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|4360|2324|lyfalmen|V0006|2186|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||600||600|2324||1|0|G|0|||0 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|6304|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||1000||1000|2874||1|0|G|0|||0 051109|V03AN0502|Airapy|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1106|2792|lyfalmen|V0363|2792|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||940||940|2792||2|0|G|0|||0 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3401|5177|lyfalmen|V0365|5177|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2673||2673|5177||2|0|G|0|||0 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|1|UCB|0|0|0|100|DKK|17734|25907|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||17734||17734|25907||1|H|S|0|||0 052210|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5526|4142|lyfalmen|V0144|4142|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1921||1921|4142||2|0|E|0|||0 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|187|1755|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||187||187|1755||2|0||2|120|töflur|0 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|725|2366|lyfalmen|V0305|1284|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||631||631|2366||2|0||2|120|töflur|0 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|280|1883|lyfalmen|V0439|1883|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||280||280|1883||2|0|0|2|60|töflur|0 052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|645|2386|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||645||645|2386||2|0||2|60|töflur|0 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|892|2567|lyfalmen|V0305|2567|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||777||777|2567||2|0||2|120|töflur|0 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|1|0|1|BMS|0|1|0|100|DKK|598961|751451|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||598961||598961|751451||1|0|L|0|||0 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|G|0|AGC|0|0|0|100|XEU|3485|6295|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Tímólól í blöndum||3485||3485|6295||1|0|G|0|||0 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|G|0|TIC|0|0|0|100|XEU|8395|13053|lyfalmen|||1|9|0|180,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||8395||8395|13053||1|0|G|0|||0 052467|N06AX1615|Venlafaxine Alvogen|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2018||R|1|0|0|G|0|POF|0|0|0|100|IKR|7035|2874|lyfalmen|V0335|2601|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|31707|43377|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||31707||31707|43377||1|0|S|0|||0 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|25777|35876|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||25777||25777|35876||1|0|S|0|||0 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|26501|36792|lyfsjukr|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||26501||26501|36792||2|0|S|0|||0 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|23236|32662|lyfsjukr|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||23236||23236|32662||2|0|S|0|||0 052677|N02AB0310|Fentanyl Alvogen|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.09.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|1854|4050|lyfalmen|V0222|4050|2|5|0|3,6000|Alvogen|Alvogen|Fentanýl||1854||1854|4050||2|0|G|1|30|dagar|0 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|G|0|KRK|0|0|0|100|IKR|4448|3934|lyfalmen|V0682|3050|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0 052790|N06BA0904|Atomoxetine Sandoz|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|SHS|0|0|0|100|DKK|11899|5595|lyfalmen|V0815|3903|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Atomoxetín||2977||2977|5595||1|0|0|0|||0 052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|NAS|0|0|0|100|DKK|15489|22817|lyfalmen|||1|6|0|24,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||15489||15489|22817||1|0|E|0|||0 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983|31.08.2020|R|1|0|0|G|0|SNP|0|0|0|100|XEU|4900|8242|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4900||4900|8242||1|0|G|||| 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|43332|58080|lyfalmen|V1007|44819|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||43332||43332|58080||2|0|E|1|30|dagar|0 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|6251|10102|lyfalmen|V1003|8886|1|98|0|6,5400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||6251||6251|10102||2|0|E|1|30|dagar|0 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|1833|4010|lyfalmen|V1002|3367|1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||1825||1825|4010||2|0|E|1|30|dagar|0 053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|6489|8242|lyfalmen|V0115|8242|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4900||4900|8242||2|0|E|0|||0 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|1|G|0|SDH|0|0|0|100|XEU|27379|37903|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||27379||27379|37903||1|0|G|0|||0 053846|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.11.2019||R|0|1|0|0|0|ATP|0|0|0|100|DKK|14644|21654|lyfalmen|V0957|16820|1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||14644||14644|21654||2|0|E|0|||0 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|0|0|0|ETH|0|0|0|100|GBP|10978|16608|lyfalmen|||2|10|0|50,0000|Icepharma hf|Ethypharm|Hýdrómorphón||10978||10978|16608||2|0||1|30|dagar|0 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|OPC|0|0|0|100|DKK|1545|3624|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||1545||1545|3624||1|0|E|0|||0 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|2074|4353|lyfalmen|||1|15|0|10,0000|Alvogen|Karo Pharma AB|Pívmecillínam||2074||2074|4353||2|0|E|0|||0 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|2923|5521|lyfalmen|||1|20|0|13,3300|Alvogen|Karo Pharma AB|Pívmecillínam||2923||2923|5521||2|0|E|0|||0 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|UCN|0|0|1|100|SEK|1161|3096|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1161||1161|3096||1|0||0|||0 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|UCN|0|0|1|100|SEK|1247|3214|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1247||1247|3214||1|0||0|||0 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1580|3673|lyfalmen|V0061|3673|2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||1580||1580|3673||1|0|E|0|||0 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|0|0|0|CES|1|0|0|100|DKK|5832|11235|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||5832||5832|11235||2|0||1|30|dagar|0 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|11562|17412|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||11562||11562|17412||2|0|G|0|||0 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|7174|5957|lyfalmen|V0187|5957|2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||3240||3240|5957||2|0|G|0|||0 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|HES|0|0|1|100|DKK|2138|4441|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||2138|4441||1|0||0|||0 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|PLS|0|0|0|100|DKK|9645|14773|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9645||9645|14773||1|0|G|1|30|dagar|0 055372|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2861|lyfalmen|V0334|2861|2|110|0|82,5000|Acare ehf|Medical Valley Invest AB|Venlafaxín||990||990|2861||2|0|G|0|||0 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|1959|3773|lyfalmen|V0467|2772|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1653||1653|3773||1|0|E|0|||0 055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|10082|15375|lyfalmen|V0965|15375|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10082||10082|15375||2|0|G|0|||0 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|3211|5918|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3211||3211|5918||1|0|G|0|||0 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2729|3070|lyfalmen|V0112|2806|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1142||1142|3070||1|0|G|0|||0 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4149|3351|lyfalmen|V0113|2806|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1346||1346|3351||1|0|G|0|||0 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6028|3351|lyfalmen|V0114|2806|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1346||1346|3351||1|0|G|0|||0 056196|L01XC0501|Mylotarg|st/irþ|5|mg|1|hgl|1|pakki|lausn|L01XC05|01.06.2019||R|0|0|0|0|1|PEU|0|0|0|100|DKK|1136947|1420555|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Gemtuzumab ozogamicin||1136947||1136947|1420555||2|H|0|0|||0 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|24766|34598|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||24766||24766|34598||2|0|E|0|||0 056339|C09BA0203|Enalapril-Hydrochlorthiazid Krka|töflur|32,5|mg|110|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2737|lyfalmen|V0098|2737|2|110|0|110,0000|LYFIS ehf|Krka Sverige AB|Enalapríl og þvagræsilyf||900||900|2737||2|0|G|0|||0 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|CES|1|0|0|100|XEU|28208|48619|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28208||28208|48619||2|0||0|||0 056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|3524|6348|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||3524||3524|6348||1|0|G|0|||0 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|MEA|0|0|1|100|DKK|2078|3901|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1746||1746|3901||2|0|E|0|||0 056858|L04AD0204|Dailiport|forðahlk|5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|49456|65826|lyfalmen|||2|50|0|50,0000|Artasan ehf|Sandoz A/S|Tacrolimus||49456||49456|65826||1|0|G|0|||0 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|1|BNB|0|1|0|100|XEU|224906|286231|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Netherlands B.V.|Natalizumab||224906||224906|286231||2|H|L|0|||0 057304|V03AN0502|Airapy|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|3499|6314|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3499||3499|6314||2|0|S|0|||0 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|1|HES|0|0|0|100|DKK|3708|6602|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3708||3708|6602||1|0|S|0|||0 057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2859|2874|lyfalmen|V0334|2601|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0 057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3700|2874|lyfalmen|V0335|2601|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|1|HES|0|0|0|100|DKK|2583|5053|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2583||2583|5053||1|0|S|0|||0 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|10949|2862|lyfalmen|V0607|2737|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||991||991|2862||2|0|G|0|||0 057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|96832|125747|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||96832|125747||2|0|L|0|||0 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|21100|29961|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||21100|29961||1|0||0|||0 058199|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5090|8427|lyfalmen|V0585|8427|2|100|0|26,6666|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||5034||5034|8427||1|0|G|1|30|dagar|0 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|1|RRD|0|0|0|100|DKK|382976|482826|lyfsjukr|||1|1|0|33,3300|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||382976||382976|482826||1|0|ES|0|||0 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|169474|292105|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||169474|292105||2|0||0|||0 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|257447|443736|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||257447|443736||2|0||0|||0 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2240|4581|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||2240||2240|4581||2|0|E|0|||0 058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|38083|51441|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||38083||38083|51441||1|0|E|0|||0 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|5143|8577|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5143||5143|8577||2|0|S|0|||0 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1251|3220|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1251||1251|3220||1|0|G|0|||0 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1801|3977|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1801||1801|3977||1|0|G|0|||0 059012|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki|stakskammtaþynna|A06AH03|01.10.2018||R|1|0|0|0|0|KWA|0|0|0|100|XEU|12624|18874|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||12624||12624|18874||2|0|0|0|||0 059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|14895|21999|lyfalmen|||2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||14895||14895|21999||2|0|G|0|||0 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|G|0|ATE|0|0|1|100|IKR|2374|2737|lyfalmen|V0006|1224|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||900||900|2737||1|0|G|0|||0 059211|L01XC2801|Imfinzi|irþ|50|mg/ml|10|ml|1|hgl|500 mg/10 ml|L01XC28|01.06.2019||R|0|0|0|0|1|AZE|0|1|0|100|SEK|464818|584615|lyfsjukr|||1|10|0||Vistor hf|AstraZeneca AB|Durvalumab||||464818|584615||1|H|L|0|||0 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|1|HBP|0|0|0|100|DKK|11829|17779|lyfsjukr|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11829||11829|17779||3|H||0|||0 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|1|G|0|ASP|0|0|0|100|XEU|98410|127743|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||98410||98410|127743||1|0|G|0|||0 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|1|PEU|0|0|0|100|DKK|61725|81343|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Europe MA EEIG|Anidulafungin||61725||61725|81343||1|H|ES|0|||0 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|G|0|BPC|0|0|0|100|SEK|25593|35644|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||25593||25593|35644||1|0|G|0|||0 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|G|0|BAB|0|0|0|100|DKK|4831|8147|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4831|8147||2|0|G|0|||0 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|9345|14360|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||9345||9345|14360||1|0|E|0|||0 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|46725|62371|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||46725||46725|62371||1|0|E|0|||0 059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|3393|6168|lyfsjukr|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||3393||3393|6168||2|0|ES|0|||0 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|2131|4431|lyfalmen|V0219|4048|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||2131||2131|4431||2|0|G|1|30|dagar|0 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|3724|6450|lyfalmen|V0220|6450|2|5|0|15,0000|Alvogen|ratiopharm GmbH|Fentanýl||3598||3598|6450||2|0|G|1|30|dagar|0 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5505|8831|lyfalmen|V0221|8830|2|5|0|22,5000|Alvogen|ratiopharm GmbH|Fentanýl||5328||5328|8831||2|0|G|1|30|dagar|0 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5894|9445|lyfalmen|V0223|8754|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||5774||5774|9445||2|0|G|1|30|dagar|0 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|22780|32086|lyfalmen|V0713|32086|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||22780||22780|32086||1|0|G|0|||0 060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|EQL|0|0|1|100|IKR|5000|8380|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||5000||5000|8380||2|0|E|0|||0 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|1|0|1|SGB|0|1|0|100|XEU|106917|139486|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||106917||106917|139486||1|0|L|0|||0 061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1994|2806|lyfalmen|V0112|2806|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|G|0|MBV|0|0|0|100|DKK|5330|8834|lyfalmen|V0133|7487|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||5330||5330|8834||1|0|G|0|||0 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|1|HES|0|0|0|100|DKK|4011|7019|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||4011||4011|7019||1|H|S|0|||0 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|1|MLD|0|0|0|100|DKK|14746|21794|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||14746||14746|21794||1|0|ES|0|||0 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|1|MLD|0|0|0|100|DKK|18028|26312|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||18028||18028|26312||1|0|ES|0|||0 062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|15000|18015|lyfalmen|V0924|18015|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||12000||12000|18015||2|0|E|0|||0 062544|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.11.2019||R|1|0|0|G|0|PIX|0|0|1|100|DKK|5982|9732|lyfalmen|||1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||5982||5982|9732||2|0|G|0|||0 062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|1|0|1|GSE|0|1|0|100|XEU|2148926|2679173|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||2148926|2679173||1|0|L|0|||0 062662|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|úðaílá|HFA 134a|R03AC12|01.09.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|3952|6937|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3952||3952|6937||1|0|G|0|||0 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|PLS|0|0|0|100|DKK|968|2830|lyfalmen|V0308|2806|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||968||968|2830||1|0||2|60|mg|0 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|BAN|0|0|0|100|DKK|18824|32445|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Phoximum||18824||18824|32445||2|0||0|||0 062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|1|ALO|0|0|0|100|XEU|81451|71981|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||54323||54323|71981||2|0|S|0|||0 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|GBI|0|0|0|100|DKK|12331|16439|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||10855||10855|16439||1|0||0|||0 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|GBI|0|0|0|100|DKK|124405|161236|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||124405||124405|161236||1|0||0|||0 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995|31.10.2020|R|1|0|0|G|0|PIX|0|0|1|100|DKK|6006|9765|lyfalmen|||1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||6006||6006|9765||1|0|G|0|||0 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1912|3041|lyfalmen|V0276|3041|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1121||1121|3041||1|0|G|0|||0 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5901|6859|lyfalmen|V0277|6859|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||3895||3895|6859||1|0|G|0|||0 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3568||2|0|E|0|||0 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2272|3765|lyfalmen|V0123|3765|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||1647||1647|3765||1|0|E|0|||0 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|1|0|1|RRG|0|1|0|100|DKK|150602|193818|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||150602||150602|193818||2|0|L|0|||0 063940|N05CD0806|Buccolam|munnh.l|2,5|mg|0,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13722|20385|lyfalmen|||2|2|0|0,6667|Shire Services BVBA|Shire Services BVBA|Mídazólam||13722||13722|20385||1|0|E|2|450|mg|0 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1009|2887|lyfalmen|V0310|2855|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1009||1009|2887||1|0||2|60|mg|0 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|979176|1224332|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||979176|1224332||2|H|S|0|||0 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|388246|489381|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||388246|489381||2|H|S|0|||0 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|3356384|4180913|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3356384|4180913||2|H|S|0|||0 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|1739324|2169743|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1739324|2169743||2|H|S|0|||0 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2138|4441|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||2138||2138|4441||2|0|G|0|||0 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|6820|6106|lyfalmen|V0029|6106|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3348||3348|6106||2|0|G|0|||0 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1237|2431|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Oxytetracyclinum||1237||1237|2431||1|0||0|||0 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|7060|12169|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||7060|12169||1|0||0|||0 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|1|OCT|0|0|0|100|DKK|33950|46214|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||33950||33950|46214||1|H|S|0|||0 064809|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.03.2020||R|1|0|0|G|0|ATE|0|0|0|100|IKR|4118|3904|lyfalmen|V0679|3904|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1748||1748|3904||1|0|G|0|||0 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|G|0|ASS|0|0|1|100|DKK|868|2693|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||868||868|2693||1|0|G|0|||0 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|G|0|ASS|0|0|1|100|DKK|1167|3104|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||1167||1167|3104||1|0|G|0|||0 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5208|10051|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||5208||5208|10051||2|0||0|||0 065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|581|2298|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||581||581|2298||2|0|ES|0|||0 065276|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|G|0|AZD|0|0|0|100|SEK|7166|11361|lyfalmen|V0081|6781|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7166||7166|11361||1|0|G|0|||0 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|G|0|FEL|0|0|0|100|DKK|16422|24101|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||16422||16422|24101||1|0|G|0|||0 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|1|GEH|0|0|0|100|NOK|9954|15199|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9954||9954|15199||2|H|S|0|||0 065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5183|7140|lyfalmen|V0830|6864|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4099||4099|7140||2|0|G|0|||0 065583|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|112|stk|1|þpakki||C10AX09|01.07.2019||R|0|0|0|0|0|VAL|0|0|0|100|DKK|9631|8747|lyfalmen|V0954|7813|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||5267||5267|8747||2|0|0|0|||0 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|1|G|0|LVR|0|0|0|100|SEK|51408|66880|lyfalmen|V0451|56656|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||50290||50290|66880||3|0|G|0|||0 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065751|J01CR0204|Amoxin comp|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RTH|0|0|1|100|DKK|2130|4430|lyfalmen|||2|70|0|3,7333|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||2130||2130|4430||2|0|E|0|||0 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|2959|5571|lyfalmen|||2|200|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||2959||2959|5571||1|0|E|3|||0 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|1|GEH|0|0|0|100|NOK|3145|5827|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Iohexol||3145||3145|5827||2|H|S|0|||0 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|1626|3736|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||1626||1626|3736||1|0|G|0|||0 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|2975|5593|lyfalmen|||2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||2975||2975|5593||1|0|G|0|||0 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|5114|8103|lyfalmen|||2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||4799||4799|8103||1|0|G|0|||0 066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|URE|0|0|0|100|XEU|11262|16999|lyfalmen|||1|20|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||11262||11262|16999||3|0|E|0|||0 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|DOR|1|0|0|100|DKK|4696|9080|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||4696||4696|9080||2|0||0|||0 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|GOG|0|0|1|100|DKK|916|2759|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||916||916|2759||2|0||0|||0 066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|7500|8930|lyfalmen|V0272|8917|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5400||5400|8930||2|0|G|0|||0 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|1|ATE|0|0|0|100|XEU|13237|19717|lyfsjukr|||2|50|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paklítaxel||||13237|19717||1|H|S|0|||0 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|8561|13281|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||8561||8561|13281||1|0|S|0|||0 067215|C01BC0402|Flecainid STADA|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.01.2018|31.08.2020|R|1|0|1|G|0|ASR|0|0|0|100|IKR|3320|4939|lyfalmen|||2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Flekaíníð||2500||2500|4939|31.5.2020|2|0|G|||| 067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|1|0|1|GSU|0|0|0|100|DKK|113601|147799|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland UC|Emtricitabine, tenofovir alafenamide og rilpivirine||||113601|147799||2|0|S|0|||0 067394|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.05.2019||R|1|0|0|0|0|LVR|0|0|1|100|DKK|11954|16966|lyfalmen|V0012|5851|3|100|0|133,3300|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||11238||11238|16966||3|0|0|0|||0 067829|QA04AD9002|Prevomax|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|8701|16678|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|maropitant||||8701|16678||2|0||0|||0 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|2460|4884|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2460|4884||2|0|S|0|||0 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|1|G|0|MEA|0|0|0|100|DKK|4823|8136|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||4823||4823|8136||2|0|G|0|||0 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3123||2|0|G|0|||0 068555|J05AB1106|Valablis|filmhtfl|500|mg|40|stk|1|þpakki||J05AB11|01.06.2017||R|1|0|0|G|0|POF|0|0|1|100|GBP|6895|4185|lyfalmen|V0182|4185|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1952||1952|4185||2|0|G|0|||0 068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|1|0|G|0|GRP|0|0|0|100|XEU|8915|13769|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8915||8915|13769||1|0|G|0|||0 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0 068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3178|5872|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3178||3178|5872||2|0|G|0|||0 068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2|0||0|||0 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|2458|4881|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2458||2458|4881||2|H|S|0|||0 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|2453|4874|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||2453||2453|4874||2|H|S|0|||0 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3622||2|0||0|||0 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3805||2|0||0|||0 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3576||2|0||0|||0 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3755||2|0||0|||0 069030|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.08.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|16481|24182|lyfalmen|V0651|24182|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||16481||16481|24182||3|0|G|0|||0 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|13646|20280|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13646||13646|20280||1|0|G|0|||0 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|39488|53218|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||39488||39488|53218||1|0|G|0|||0 069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10169|lyfalmen|V0195|10169|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|405199|510465|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||405199||405199|510465||1|0|L|0|||0 069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 069536|L04AA0607|Mycofenolsýra Accord|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|15983|23497|lyfalmen|V0470|23497|2|120|0|10,8000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||15983||15983|23497||1|0|G|0|||0 069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|G|0|KRK|0|0|1|100|IKR|||lyfalmen|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||3284||2|0|G|0|||0 069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|1|0|1|GEI|0|0|0|100|DKK|69943|91738|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||69943|91738||2|0|S|0|||0 070203|N05CF0107|Imomed|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2020||R|1|0|0|0|0|DIC|0|0|0|100|IKR|450|2117|lyfalmen|V0312|1798|2|30|0|30,0000|LYFIS ehf|Medical ehf|Zópíklón||450||450|2117||2|0||2|30|töflur|0 070512|L01XE3501|Tagrisso|filmhtfl|40|mg|30|stk|1|stsk.þ||L01XE35|01.07.2020||R|0|0|1|0|1|AZE|0|1|0|100|SEK|932967|1166861|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||932967||932967|1166861||1|0|L|0|||0 070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|22170|31314|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||22170||22170|31314||2|0|L|0|||0 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|G|0|JAS|0|0|0|100|SEK|10071|15360|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10071||10071|15360||1|0|G|0|||0 070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|CZV|1|0|0|100|XEU|7306|12593|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||7306||7306|12593||1|0||0|||0 071450|J01FA1008|Azitromicina Normon|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.03.2019||R|1|0|0|0|0|WEH|0|0|1|100|IKR|1100|2640|lyfalmen|V0174|2461|2|3|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Azitrómýcín||830||830|2640||2|0||0|||0 071784|A10BD2401|Steglujan|filmhtfl|105|mg|98|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|38244|51426|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||38071||38071|51426||1|0|G|0|||0 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|1|0|1|GEB|0|0|0|100|XEU|79355|103642|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||79355|103642||1|0|S|0|||0 072103|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7862|12319|lyfalmen|V0609|12319|2|56|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||7862||7862|12319||1|0|E|0|||0 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|ORF|1|0|0|100|DKK|7337|14090|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|Detomidinum||7337||7337|14090||1|0||0|||0 072374|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|300|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|5732|9387|lyfalmen|V1029|9387|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||5732||5732|9387||3|0|E|0|||0 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|G|0|PSA|0|0|0|100|XEU|6820|6160|lyfalmen|V0029|6106|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3387||3387|6160||2|0|G|0|||0 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184956|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184956||5|H|S|0|||0 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184956|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184956||5|H|S|0|||0 072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|6000|9756|lyfalmen|||2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||6000||6000|9756||2|0|G|0|||0 072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3169|5860|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3169||3169|5860||2|0|G|0|||0 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|0|0|1|PBV|0|0|0|100|SEK|540|2241|lyfsjukr|||1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Súfentaníl||540||540|2241||1|0|S|1|30|dagar|0 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|1|0|1|JCI|0|0|0|100|SEK|56953|75308|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||56953||56953|75308||1|0|S|0|||0 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9258|6917|lyfalmen|V0286|5627|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||3937||3937|6917||1|0|G|0|||0 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|G|0|SHS|0|0|0|100|DKK|484|2164|lyfalmen|V0500|2082|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||484||484|2164||1|0|G|0|||0 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|1|0|1|JCI|0|1|0|100|SEK|357665|451346|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Macitentan||||357665|451346||1|0|L|0|||0 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|1|0|1|PEU|0|1|0|100|DKK|539364|677329|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotiníb||539364||539364|677329||1|0|L|0|||0 073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2980|5136|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2980||2980|5136||1|0||0|||0 073520|N02AE0101|Bupremyl|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|0|G|0|MYL|0|0|0|100|SEK|2246|3560|lyfalmen|V0944|3501|2|4|0|5,6000|Icepharma hf|Mylan AB|Búprenorfín||1498||1498|3560||2|0|G|1|30|dagar|0 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3264|5990|lyfalmen|V1010|3662|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||3264||3264|5990||1|0|G|0|||0 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|16966|19013|lyfalmen|V0185|19013|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Letrózól||12725||12725|19013||1|0|G|0|||0 073728|L01CB0105|Etópósíð Accord|irþ|20|mg/ml|25|ml|1|hgl||L01CB01|01.06.2020||R|0|0|0|0|1|AEE|0|0|0|100|XEU|9660|14794|lyfsjukr|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Etoposíð||9660||9660|14794||1|H|S|0|||0 073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|7967|lyfalmen|V0924|6005|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4700||4700|7967||2|0|E|0|||0 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1001|2876|lyfalmen|V0305|2567|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||1001||1001|2876||1|0||2|120|töflur|0 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|PLS|0|0|1|100|DKK|539|2240|lyfalmen|V0439|1883|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||539||539|2240||1|0||2|60|töflur|0 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1464|3513|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1464||1464|3513||1|0||2|60|töflur|0 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1342|3345|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1342||1342|3345||2|0|G|0|||0 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|3666|6319|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||3666||3666|6319||2|0||0|||0 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|963|2823|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||963||963|2823||2|0|G|0|||0 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|NEL|0|0|0|100|DKK|3112|5781|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3112||3112|5781||1|0|E|0|||0 074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|21601|30595|lyfalmen|||1|28|0|28,0000|Eisai AB|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 074364|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|40|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|917|2760|lyfalmen|||2|40|0|20,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||917||917|2760||2|0|E|0|||0 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1123|3044|lyfalmen|||2|25|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1123||1123|3044||1|0||2|50|töflur|0 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2|0||0|||0 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|ATE|0|0|0|100|DKK|956|2814|lyfalmen|||2|50|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||956||956|2814||1|0||2|50|töflur|0 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1429|3465|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1429||1429|3465||1|0||2|50|töflur|0 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|713|2479|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||713||713|2479||2|0|G|0|||0 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|G|0|AEP|0|0|0|100|DKK|401|2050|lyfalmen|V1025|2050|1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||401||401|2050||2|0|G|0|||0 074927|C02AC0201|Intuniv|forðatfl|2|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|11217|16937|lyfalmen|||1|28|0|18,6666|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||11217||11217|16937||1|0|E|0|||0 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|G|0|AEP|0|0|0|100|DKK|2330|4705|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||2330||2330|4705||2|0|G|0|||0 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5485|9047|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5485||5485|9047||1|0|G|0|||0 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|16079|23629|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||16079||16079|23629||1|0|G|0|||0 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5782|9456|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5782||5782|9456||1|0|G|0|||0 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1195|3143|lyfalmen|V0363|2792|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1195||1195|3143||1|0|G|0|||0 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|16926|24795|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||16926||16926|24795||1|0|G|0|||0 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|NBV|0|0|0|100|DKK|||lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun|||||5053||1|0|E|0|||0 075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|G|0|POF|0|0|0|100|IKR|5987|2984|lyfalmen|V0445|2984|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1080||1080|2984||2|0|G|0|||0 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|DEC|0|0|0|100|DKK|1273|2502|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1273||1273|2502||1|0||0|||0 075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|13335|11372|lyfalmen|V0440|9648|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||7174||7174|11372||2|0|G|0|||0 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|6007|9766|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6007||6007|9766||2|0|S|0|||0 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|6007|9766|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6007||6007|9766||2|0|S|0|||0 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|6323|10201|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6323||6323|10201||2|0|S|0|||0 075921|N02AA0507|OxyContin Depot|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|4284|7394|lyfalmen|V0598|5625|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||4284||4284|7394||2|0|G|1|30|dagar|0 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|5149|8585|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||5149||5149|8585||1|0|G|0|||0 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|G|0|MBV|0|0|0|100|DKK|17897|26131|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||||17897|26131||1|0|G|0|||0 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|15900|23383|lyfalmen|||1|98|0|24,5000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||15900||15900|23383||1|0|G|0|||0 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16053|23593|lyfalmen|V0982|23592|1|98|0|49,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||16053||16053|23593||1|0|G|0|||0 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1605|2461|lyfalmen|V0143|1194|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2461||2|0|E|0|||0 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2971|3571|lyfalmen|V0143|2388|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3571||2|0|E|0|||0 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3742|3604|lyfalmen|V0143|3582|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3604||2|0|E|0|||0 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1667|2613|lyfalmen|V0144|1381|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2613||2|0|E|0|||0 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3208|3897|lyfalmen|V0144|2761|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3897||2|0|E|0|||0 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|7023|4182|lyfalmen|V0144|4142|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4182||2|0|E|0|||0 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1944|2048|lyfalmen|V0291|2048|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||400||400|2048||2|0|G|0|||0 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||3549||1|0|G|0|||0 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0290|2461|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G|0|||0 076657|N05AH0416|Quetiapin Medical Valley|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|6400|6990|lyfalmen|V0273|5077|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||3990||3990|6990||2|0|0|0|||0 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|252369|320388|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||252369||252369|320388||1|0|L|0|||0 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|146301|188469|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||146301||146301|188469||1|0|L|0|||0 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|73151|95795|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||73151||73151|95795||1|0|L|0|||0 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|42062|56474|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||42062||42062|56474||1|0|L|0|||0 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3020|5655|lyfalmen|V0598|5625|2|98|0|13,0700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||3020||3020|5655||1|0|G|1|30|dagar|0 076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|85744|111723|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||85744||85744|111723||2|0|L|0|||0 076995|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|IKR|4503|2668|lyfalmen|V0145|2105|2|4|0|8,0000|Alvogen|ratiopharm GmbH|Tadalafíl||850||850|2668||2|0|E|0|||0 077085|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|105|stk|1|glas||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|7330|11587|lyfalmen|||2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||7330||7330|11587||2|0|E|0|||0 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|0|1|SPP|0|0|0|100|XEU|55669|73684|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||55669||55669|73684||2|H|S|0|||0 077555|N07BC0102|Buvidal|stl|8|mg|0,16|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14465|21408|lyfsjukr|||1|0,16|0|1,0000|Vistor hf|Camurus AB|Búprenorfín||14465||14465|21408||1|H|L|1|30|dagar|0 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2625|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2625||2|0|E|1|30|dagar|0 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2701|lyfalmen|V0671|2701|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2701||2|0|E|1|30|dagar|0 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4697|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4697||2|0|E|1|30|dagar|0 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|6040|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8380|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8380||2|0|E|1|30|dagar|0 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10169|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12674|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12674||2|0|E|1|30|dagar|0 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987|31.08.2020|R|0|0|0|G|0|GPH|0|0|1|100|DKK|720|2489|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||720||720|2489||1|0|G|||| 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|G|0|TVA|0|0|0|100|IKR|5017|5352|lyfalmen|V0275|4788|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||2800||2800|5352||2|0|G|0|||0 078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|10572|16049|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||10572||10572|16049||1|0|G|0|||0 078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|41148|78236|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||41148||41148|78236||2|0||0|||0 078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|14141|20962|lyfalmen|||1|30|0|50,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||14141||14141|20962||1|0|E|1|30|dagar|0 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|G|0|MSD|0|0|0|100|DKK|8820|6856|lyfalmen|V0069|2750|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3893||3893|6856||1|0|G|0|||0 079195|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5526|4142|lyfalmen|V0144|4142|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1921||1921|4142||2|0|E|0|||0 079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2071|3975|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3975||2|0|G|0|||0 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4202|7282|lyfalmen|V0315|7282|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||4202||4202|7282||1|0|G|0|||0 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|G|0|TSA|0|0|0|100|XEU|11182|14016|lyfalmen|V0184|14016|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||9095||9095|14016||2|0|G|0|||0 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1|0||0|||0 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|524|2219|lyfalmen|||2|10|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||524||524|2219||1|0|E|0|||0 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|850|2532|lyfalmen|V0418|2532|2|20|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||751||751|2532||1|0|E|0|||0 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|862|2545|lyfalmen|V0177|2545|2|10|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||761||761|2545||1|0|E|0|||0 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1502|3384|lyfalmen|V0411|3384|2|20|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||1370||1370|3384||1|0|E|0|||0 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Cloprostenolum||4985||4985|9628||2|0||0|||0 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|ANI|1|0|0|100|XEU|4172|8086|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4172|8086||2|0||2|||0 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|2874|lyfalmen|V0422|2874|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1000||1000|2874||2|0|G|0|||0 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|BAN|0|0|0|100|DKK|13598|23438|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||13598||13598|23438||2|0||0|||0 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|G|0|BFP|0|0|0|100|XEU|7236|7426|lyfalmen|||2|30|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Letrózól||4307||4307|7426||1|0|G|0|||0 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|G|0|LBK|0|0|0|100|DKK|2381|4775|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2381||2381|4775||1|0|G|0|||0 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5734|9390|lyfalmen|V1029|9387|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5734||5734|9390||1|0|E|0|||0 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2719|5240|lyfalmen|V1028|5239|1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2719||2719|5240||1|0|E|0|||0 080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|35241|47846|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||35241||35241|47846||1|0|G|0|||0 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|0|1|AMR|0|0|0|100|XEU|3265|5992|lyfsjukr|||1|1|0|1,0000|Alvogen|Amring|Mifepriston||3265||3265|5992||2|H|S|0|||0 081038|QI01AN0101|Evalon|innúðal|||1000|skammtar|1|hgl|+50ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|22950|39557|vetorma|||0|1000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||22950||22950|39557||2|0|0|0|||0 081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0815|3903|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|1|0|1|PEU|0|1|0|100|DKK|674205|845033|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotiníb||674205||674205|845033||1|0|L|0|||0 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081626|N06AX2108|Aritavi|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2041|2501|lyfalmen|V0692|2501|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||729||729|2501||1|0|E|0|||0 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|4679|7938|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4679||4679|7938||1|0|G|0|||0 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|6070|9853|lyfalmen|||2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9853||2|0|G|0|||0 081821|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|lykjur|innr.lyf, fleyti|N01AX10|01.11.2019||R|0|0|0|0|1|FKA|0|0|0|100|DKK|1621|3729|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1621||1621|3729||1|H|S|0|||0 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|5188|8639|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||5188||5188|8639||1|0|G|0|||0 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|6989|11118|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6989||6989|11118||1|0|G|0|||0 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|28418|39217|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||28418||28418|39217||2|H|S|0|||0 082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|14255|24570|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||14255||14255|24570||1|0||0|||0 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|59857|103170|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||59857||59857|103170||1|0||0|||0 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|543|2245|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||543||543|2245||1|0|G|0|||0 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|3101|5766|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3101||3101|5766||1|0|G|0|||0 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2792|5341|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2792||2792|5341||1|0|G|0|||0 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4020|7031|lyfalmen|V0080|6703|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||4020||4020|7031||1|0|G|0|||0 083019|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.04.2018||R|1|1|1|0|1|ALO|0|1|0|100|XEU|287934|326083|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||256948||256948|326083||2|0|L|0|||0 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|G|0|MYL|0|0|0|100|DKK|3868|6822|lyfalmen|V0706|6820|1|100|0|16,6700|Icepharma hf|Mylan AB|Hvatablöndur (lípasi, próteasi o.s.frv.)||3868||3868|6822||2|0|G|0|||0 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|3523|6347|lyfalmen|V0701|5558|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3523||3523|6347||1|0|G|0|||0 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5348|3702|lyfalmen|V0686|3631|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1601||1601|3702||1|0|E|0|||0 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|6408|12328|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||6408||6408|12328||2|0||0|||0 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|GCA|0|0|1|100|DKK|925|2669|lyfalmen|V0231|2669|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||851||851|2669||1|0|E|0|||0 083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|5341|5788|lyfalmen|V0624|5788|2|30|0|36,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3117||3117|5788||1|0|E|1|30|dagar|0 084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|175903|225285|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||175903||175903|225285||1|0||0|||0 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2430|4843|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4843||2|0||2|60|mg|0 084252|C03EA0115|Amiloride/HCT Alvogen|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|1345|3349|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||1345||1345|3349||2|0|G|0|||0 084454|G04CA5203|Dutasteride/Tamsulosin Teva|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.05.2020||R|0|0|0|G|0|TVI|0|0|0|100|XEU|3071|4832|lyfalmen|V1010|3662|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Dútasteríð og tamsúlósínhýdroklóríð||2422||2422|4832||1|0|G|0|||0 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|64135|84392|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||64135||64135|84392||1|0|L|0|||0 084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|6173|9994|lyfalmen|V0215|9994|2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||6173||6173|9994||2|0|G|0|||0 084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1309|3300|lyfalmen|||2|40|0|13,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1309||1309|3300||1|0|E|3|||0 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|1|0|1|MSD|0|0|0|100|DKK|39317|53002|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||39317||39317|53002||1|0|S|0|||0 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|0|G|0|PLS|0|0|0|100|DKK|13190|19653|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||13190||13190|19653||1|0|G|1|30|dagar|0 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|1|G|0|GAN|0|0|0|100|XEU|37881|51185|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||37881||37881|51185||2|0|G|0|||0 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,3|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|SAO|0|0|1|100|XEU|2701|5216|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Levófloxacín||2701||2701|5216||2|0||0|||0 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|G|0|GPH|0|0|1|100|DKK|851|2669|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||851||851|2669||1|0|G|0|||0 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|1|PLS|0|0|0|100|DKK|12755|19054|lyfsjukr|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||12755||12755|19054||1|H|S|0|||0 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|4438|7606|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4438||4438|7606||2|0|S|0|||0 085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4051|3563|lyfalmen|V0445|3045|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1500||1500|3563||2|0|G|0|||0 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ 5x1ml lykja m.leysi|G03GA02|01.03.2001||R|0|0|1|G|0|FEL|0|0|0|100|DKK|21413|30357|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||21413||21413|30357||1|0|G|0|||0 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|18013|24961|lyfalmen|V0652|24733|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||17047||17047|24961||1|0|G|0|||0 085584|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|75|pokar|lausn|B05BB01|01.01.2019||R|0|0|0|0|1|BAM|0|0|1|100|SEK|9081|13997|lyfsjukr|||1|3750|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9081||9081|13997||2|0|S|0|||0 085627|G03AA0708|Melleva|filmhtfl|||63|stk|1|þpakki|150mcg/30mcg|G03AA07|01.04.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|951|1924|lyfalm11|V0545|1924|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Levónorgestrel og ethinylestradíól||473||473|1924||2|0||0|||0 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|1|0|1|NED|0|0|0|100|XEU|79718|104101|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||79718||79718|104101||2|0|ES|0|||0 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|1|G|0|ATE|0|0|0|100|SEK|22032|31140|lyfalmen|V0579|31140|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rílúzól||22032||22032|31140||1|0|G|0|||0 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|AEB|0|0|0|100|DKK|32174|43967|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||32174||32174|43967||1|0|E|0|||0 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|1|ATE|0|0|0|100|XEU|8814|13630|lyfsjukr|||2|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Karbóplatín||8814||8814|13630||1|H|S|0|||0 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|2782|5327|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||2782||2782|5327||1|0|G|0|||0 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|6761|10804|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||6761||6761|10804||1|0|G|0|||0 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|SNP|0|0|1|100|XEU|394|2040|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||394||394|2040||1|0||2|45|töflur|0 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1999|4249|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1999||1999|4249||1|0|G|0|||0 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|3259|5984|lyfalmen|V0365|5177|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3259||3259|5984||1|0|G|0|||0 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|43001|57661|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||43001||43001|57661||2|0|E|0|||0 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|1|GPH|0|0|1|100|DKK|8030|12550|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||8030||8030|12550||1|0|ES|0|||0 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|1|GPH|0|0|1|100|DKK|8716|13495|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||8716||8716|13495||1|0|ES|0|||0 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|11238|16966|lyfalmen|V0012|5851|1|100|0|133,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||11238||11238|16966||1|0|E|0|||0 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|29514|40603|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||29514|40603||1|0|G|0|||0 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|51589|68523|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||51589|68523||1|0|G|0|||0 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|1|BSP|0|1|0|100|DKK|53255|70631|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||53255||53255|70631||1|H|L|0|||0 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|17435|22823|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||17435|22823||2|0|E|0|||0 086649|L01XX5001|Ninlaro|hylki|3|mg|1|stk|3|þpakki|Hver hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|1|0|1|TPA|0|0|0|100|DKK|868925|1087211|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||868925||868925|1087211||1|0|S|0|||0 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|1|ROA|0|0|1|100|DKK|46710|62352|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||46710||46710|62352||2|0|S|0|||0 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1|0||0|||0 087094|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|30|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|680|2434|lyfalmen|V0931|2434|2|30|0|15,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||680||680|2434||2|0|E|0|||0 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1|0||0|||0 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|SNP|0|0|1|100|XEU|366|2002|lyfalmen|V0060|1940|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||366||366|2002||1|0||2|30|töflur|0 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|247|1838|lyfalmen|V0312|599|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||247||247|1838||1|0||2|30|töflur|0 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|218|1798|lyfalmen|V0312|1798|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||218||218|1798||1|0||2|30|töflur|0 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1834|4022|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1834||1834|4022||1|0||2|30|töflur|0 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|16187|23778|lyfalmen|||2|250|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||16187||16187|23778||1|0|G|0|||0 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|16187|23778|lyfalmen|||2|250|0|333,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||16187||16187|23778||1|0|G|0|||0 087572|G04BD0801|Vesicare|mixtúra|1|mg/ml|150|ml|1|glas||G04BD08|01.08.2019||R|0|0|0|G|0|ASP|0|0|0|100|XEU|5920|9646|lyfalmen|||1|150|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5920||5920|9646||1|0|G|0|||0 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1680|3810|lyfalmen|V0952|3378|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1680||1680|3810||1|0|G|0|||0 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|CHP|0|0|0|100|XEU|35837|61769|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||35837||35837|61769||2|0||0|||0 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1|0||0|||0 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|5109|9863|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||5109||5109|9863||1|0||0|||0 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|CES|1|0|0|100|SEK|24545|42306|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||24545||24545|42306||2|0||0|||0 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|3237|5329|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||3237||3237|5329||2|0||0|||0 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|G|0|RGP|0|0|1|100|DKK|1104|3017|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Flútíkasón fúróat||1104||1104|3017||1|0|G|0|||0 088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3338|6092|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3338||3338|6092||2|0|G|0|||0 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|G|0|KRK|0|0|0|100|IKR|7196|3934|lyfalmen|V0684|3050|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|8490|13184|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||8490||8490|13184||1|0||0|||0 088677|N07BC0102|Buvidal|stl|24|mg|0,48|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14465|21408|lyfsjukr|||1|0,48|0|3,0000|Vistor hf|Camurus AB|Búprenorfín||14465||14465|21408||1|H|L|1|30|dagar|0 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|4896|8237|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4896||4896|8237||1|0|G|0|||0 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|G|0|LEP|0|0|0|100|DKK|8460|13142|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8460||8460|13142||1|0|G|0|||0 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|13876|20597|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13876||13876|20597||1|0|G|0|||0 088817|A10BD2301|Segluromet|filmhtfl|1002,5|mg|56|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|6343|10228|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||6343||6343|10228||1|0|G|0|||0 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|454242|571461|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||454242||454242|571461||1|H|S|0|||0 088961|N02AA0507|OxyContin Depot|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|22771|32074|lyfalmen|V0588|26180|1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||22771||22771|32074||2|0|G|1|30|dagar|0 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1528|3224|lyfalm11|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||||1528|3224||1|0||0|||0 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|MPS|0|0|0|100|DKK|24178|33854|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||24178||24178|33854||1|0|0|0|||0 089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|1|0|1|NEL|0|1|0|100|DKK|141670|182709|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||141670||141670|182709||1|0|L|0|||0 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|NDR|0|0|1|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6222||1|0||0|||0 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|1|PLS|0|1|0|100|DKK|20175|28791|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20175||20175|28791||1|0|L|0|||0 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|1|PLS|0|1|0|100|DKK|43881|58774|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||43881||43881|58774||1|0|L|0|||0 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012|31.08.2020|L|1|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2|0||||| 089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|1419|3012|lyfalmen|V0048|3012|2|100|0|33,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1100||1100|3012||2|0|G|0|||0 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|24567|34346|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24567||24567|34346||1|0|G|0|||0 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|98270|127565|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||98270||98270|127565||1|0|G|0|||0 090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|G|0|SSA|0|0|0|100|DKK|16553|19131|lyfalmen|V0261|11408|2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||12811||12811|19131||1|0|G|0|||0 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|2556|5016|lyfalmen|||1|20|0|5,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||2556||2556|5016||2|0|E|0|||0 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|5113|8535|lyfalmen|||1|40|0|10,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||5113||5113|8535||2|0|E|0|||0 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|STA|0|0|1|100|DKK|774|2563|lyfalmen|||1|100|0|2,5000|Icepharma hf|STADA Nordic ApS.|Cefalexín||774||774|2563||2|0|E|0|||0 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|1|STA|0|0|1|100|DKK|4569|7787|lyfsjukr|||1|10|0|3,3333|Icepharma hf|STADA Nordic ApS.|Cefazólín||4569||4569|7787||2|0|ES|0|||0 090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1956|4190|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1956||1956|4190||1|0|G|0|||0 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|825|2633|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai GmbH|Rúfínamíð||825||825|2633||1|0|G|0|||0 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|1|AAS|0|0|0|100|XEU|14037|20818|lyfsjukr|||1|60|0||Alcon Danmark A/S|Alcon Nordic A/S|Flúorescein||14037||14037|20818||1|H|S|0|||0 091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1084|2990|lyfalmen|V0333|2990|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1084||1084|2990||2|0|E|0|||0 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|1|PLS|0|0|0|100|DKK|2700|5214|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2700||2700|5214||1|H|S|0|||0 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|1|PLS|0|0|0|100|DKK|4671|7927|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4671||4671|7927||1|H|S|0|||0 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|1|PLS|0|0|0|100|DKK|13710|20368|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||13710||13710|20368||1|H|S|0|||0 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.03.2011||R|1|1|0|0|0|HES|0|0|0|100|DKK|3667|6337|lyfalmen|V0958|6152|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3516||3516|6337||1|0|E|1|30|dagar|0 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|6435|10355|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6435||6435|10355||1|0|G|0|||0 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|G|0|TAE|0|0|1|100|SEK|3730|6632|lyfalmen|||1|30|0||Alvogen|Trimb Healthcare AB|Dexametasón||3730||3730|6632||2|0|G|0|||0 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1069|2046|lyfalmen|V0021|2046|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||398||398|2046||1|0|G|0|||0 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1849|2368|lyfalmen|V0022|2368|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||632||632|2368||1|0|G|0|||0 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1201|3151|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||1201||1201|3151||1|0|G|0|||0 092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9455|18109|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||9455||9455|18109||2|0||0|||0 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2|0||0|||0 092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|KRK|0|0|1|100|IKR|||lyfalmen|V0004|2839|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2839||2|0|E|0|||0 092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2060|4251|lyfalmen|V0011|2822|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0 092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3453|4939|lyfalmen|V0011|4939|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2500||2500|4939||2|0|G|0|||0 092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1510|3012|lyfalmen|V0005|3012|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1100||1100|3012||2|0|E|0|||0 092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2400|4251|lyfalmen|V0012|3277|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0 092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|4794|5765|lyfalmen|V0012|5734|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||3100||3100|5765||2|0|G|0|||0 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2342|4721|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2342||2342|4721||1|0|G|0|||0 092694|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|án rotvarnar|H02AB04|01.01.2019||R|0|0|0|G|0|PLS|0|0|1|100|DKK|505|2193|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer Aps|Metýlprednisólón||505||505|2193||1|0|G|0|||0 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|G|0|WEH|0|0|0|100|IKR|1863|4026|lyfalmen|V0203|4026|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1837||1837|4026||2|0|G|0|||0 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1182|3125|lyfalmen|||1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxýcódon||1182||1182|3125||2|0|E|1|30|dagar|0 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2358|4743|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||2358||2358|4743||2|0|E|1|30|dagar|0 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|4585|7809|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||4585||4585|7809||2|0|E|1|30|dagar|0 093072|L01XE1101|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01XE11|01.01.2017||R|1|0|1|0|1|NEL|0|1|0|100|DKK|348268|439659|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||348268||348268|439659||1|0|L|0|||0 093083|L01XE1101|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01XE11|01.01.2017||R|1|0|1|0|1|NEL|0|1|0|100|DKK|464577|584315|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||464577||464577|584315||1|0|L|0|||0 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5076|8485|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||5076||5076|8485||1|0|G|0|||0 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5623|9237|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5623||5623|9237||1|0|G|0|||0 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|1|0|1|ERZ|0|0|0|100|XEU|25387|33051|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||23543||23543|33051||2|0|ES|0|||0 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|G|0|HES|0|0|0|100|DKK|1991|4238|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1991||1991|4238||1|0|G|0|||0 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|5649|9273|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5649||5649|9273||2|0|G|0|||0 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|4183|7255|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4183||4183|7255||2|0|G|0|||0 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2518|4964|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||2518||2518|4964||2|0||0|||0 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|G|0|ABC|0|0|0|100|SEK|34240|46580|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||34240||34240|46580||2|0|G|0|||0 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|22860|32187|lyfalmen|||1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||22860||22860|32187||2|0|G|1|30|dagar|0 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|0|1|0|1|JCI|0|1|0|100|SEK|421830|531150|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||421830||421830|531150||1|0|L|0|||0 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|0|1|0|1|JCI|0|1|0|100|SEK|421830|531150|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||421830||421830|531150||1|0|L|0|||0 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|G|0|AAC|0|0|0|100|DKK|5250|8724|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||5250||5250|8724||2|0|G|0|||0 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|1835|3607|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1835||1835|3607||1|0||0|||0 094146|L04AA2901|Xeljanz|forðatfl|11|mg|28|stk|1|þpakki||L04AA29|01.06.2020||R|0|1|1|0|1|PEU|0|1|0|100|DKK|125153|162167|lyfsjukr|||1|28|0|30,8000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||125153||125153|162167||1|0|L|0|||0 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1886|4094|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||1886||1886|4094||2|0|G|0|||0 094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|G|0|BFP|0|0|0|100|IKR|1955|4189|lyfalmen|V0324|4145|2|98|0|49,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||1955||1955|4189||1|0|0|0|||0 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|1|0|1|VIC|0|0|0|100|DKK|78280|102282|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín, lamívúdín og abacavír||78280||78280|102282||1|0|S|0|||0 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|HAL|0|0|1|100|DKK|46988|62704|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||46988|62704||1|0|E|0|||0 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6651|11464|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6651||6651|11464||2|0||0|||0 094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1|0||0|||0 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|1|TAG|0|0|0|100|DKK|44505|59564|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||44505||44505|59564||1|H|S|0|||0 095314|N04BA0211|Duodopa|hlaup|||100|ml|7|askja||N04BA02|01.10.2018||R|0|1|0|0|1|AIS|0|1|0|100|DKK|104549|136541|lyfsjukr|||1|700|0||Vistor hf|AbbVie A/S|Levódópa og dópadekarboxýl­asa­hemill||104549||104549|136541||1|0|L|0|||0 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|G|0|ATE|0|0|0|100|DKK|9010|13899|lyfalmen|||1|50|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dísúlfíram||9010||9010|13899||1|0|G|0|||0 095621|L04AX0306|Metojectpen|stl|20|mg|0,4|ml|6|áfpen||L04AX03|01.11.2019||R|0|0|0|G|0|WIL|0|0|0|100|XEU|15818|23270|lyfalmen|||1|2,4|0|48,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||15818||15818|23270||2|0|G|0|||0 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|15893|23373|lyfalmen|V0963|14969|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15893||15893|23373||1|0|E|0|||0 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|16131|23701|lyfalmen|V0964|16808|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16131||16131|23701||1|0|E|0|||0 095682|N06BA0408|Methylphenidate Teva|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|5407|4858|lyfalmen|V0959|4858|2|30|0|20,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||2441||2441|4858||1|0|E|1|30|dagar|0 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|18779|27345|lyfalmen|V0965|15375|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18779||18779|27345||1|0|G|0|||0 095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|1|GOV|0|0|0|100|XEU|1987|4233|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1987|4233||2|H|ES|0|||0 095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|1|GOV|0|0|0|100|XEU|3455|6253|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3455|6253||2|H|ES|0|||0 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|5558|lyfalmen|V0701|5558|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||2950||2950|5558||2|0|G|0|||0 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|4969|8467|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||4373||4373|8467||2|0|0|0|||0 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6855|11817|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||6139||6139|11817||2|0|0|0|||0 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|11400|20258|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||10588||10588|20258||2|0|0|0|||0 096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|1|RRG|0|1|0|100|DKK|754691|945136|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||754691||754691|945136||2|H|L|0|||0 096223|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|830|2599|lyfalmen|V0685|2190|2|56|0|4,6667|Acare ehf|Medical Valley Invest AB|Pregabalín||800||800|2599||2|0|E|0|||0 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|G|0|NEL|0|0|0|100|DKK|9737|14900|lyfalmen|V0347|14897|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9737||9737|14900||1|0|G|0|||0 096473|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|470|2048|lyfalmen|V0930|2048|2|20|0|10,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||400||400|2048||2|0|E|0|||0 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|719561|901444|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||719561||719561|901444||2|0|L|0|||0 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|660470|827951|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||660470||660470|827951||2|0|L|0|||0 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|695218|871168|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||695218||695218|871168||2|0|L|0|||0 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|764716|957604|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||764716||764716|957604||2|0|L|0|||0 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|G|0|NEL|0|0|0|100|DKK|9115|14044|lyfalmen|V0349|13361|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9115||9115|14044||1|0|G|0|||0 096703|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.02.2019||R|0|0|0|0|1|ATE|0|0|0|100|GBP|9793|14977|lyfsjukr|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Epírúbicín||||9793|14977||1|H|S|0|||0 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012|30.09.2020|R|0|0|1|G|0|SNP|0|0|0|100|XEU|12331|18470|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||12331||12331|18470||1|0|G|||| 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|ELC|0|0|0|100|DKK|75486|130108|vetorma|||1|1000|0||Elanco Denmark ApS|Elanco GmbH|Óvirkar bakteríur í bóluefnum||75486||75486|130108||2|0||0|||0 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|VMD|1|0|0|100|XEU|8310|15936|vetalmen|||0|10|0||Icepharma hf|V.M.D. n.v.|Bútorfanóltartrat||||8310|15936||2|0||2|||0 097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|PLS|0|0|0|100|DKK|11416|17211|lyfalmen|V0334|2549|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11416||11416|17211||1|0|E|0|||0 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|PLS|0|0|0|100|DKK|21238|30135|lyfalmen|V0335|2549|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21238|30135||1|0|E|0|||0 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|35905|48686|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||35905||35905|48686||1|0|E|0|||0 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|6363|12242|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||6363||6363|12242||2|0||0|||0 097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|1|0|0|0|DSM|0|0|0|100|DKK|18195|23759|lyfalm11|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||18195||18195|23759||1|0||0|||0 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2654|2628|lyfalmen|V0023|2628|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||821||821|2628||1|0|G|0|||0 097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|3113|5783|lyfsjukr|||2|2000|0|5,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||3113|5783||2|0|ES|0|||0 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1648|3766|lyfalmen|||2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1648||1648|3766||1|0|E|0|||0 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|G|0|ATE|0|0|0|100|IKR|2976|3563|lyfalmen|V0678|3563|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1500||1500|3563|||0|G|0|||0 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|G|0|BIG|0|0|1|100|SEK|596|2318|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||596||596|2318||2|0|G|0|||0 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|G|0|BIG|0|0|1|100|SEK|596|2318|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||596||596|2318||2|0|G|0|||0 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2|0||0|||0 098363|L04AA4201|Mayzent|filmhtfl|0,25|mg|120|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|1|NEP|0|0|0|100|DKK|262931|333524|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Limited|Siponimod||262931||262931|333524||1|0|0|0|||0 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|994|2559|lyfalmen|V0243|2559|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||771||771|2559||2|0|G|0|||0 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|1723|3046|lyfalmen|V0244|2829|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1125||1125|3046||2|0|G|0|||0 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|4592|5037|lyfalmen|V0245|5037|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||2571||2571|5037||2|0|G|0|||0 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|7999|10639|lyfalmen|V0232|10639|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||6641||6641|10639||2|0|G|0|||0 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|2773|5093|lyfalmen|V0381|5093|2|10|0|2,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2612||2612|5093||1|0|G|0|||0 099100|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2991|2461|lyfalmen|V0107|2461|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||700||700|2461||2|0||0|||0 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|1|AZA|0|0|0|100|SEK|86368|112512|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||86368||86368|112512||1|0|S|0|||0 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2472|2482|lyfalmen|V0284|2365|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||715||715|2482||2|0|G|0|||0 099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|G|0|SSA|0|0|0|100|DKK|11367|13815|lyfalmen|V0272|8917|2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||8949||8949|13815||1|0|G|0|||0 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4620|4369|lyfalmen|V0285|3287|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2086||2086|4369||2|0|G|0|||0 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|8268|7478|lyfalmen|V0286|5627|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4345||4345|7478||2|0|G|0|||0 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|3001|4509|lyfalmen|V0685|3910|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||2188||2188|4509||1|0|E|0|||0 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1712|2309|lyfalmen|V0247|2309|2|60|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||589||589|2309||1|0|G|0|||0 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2835|3981|lyfalmen|V0248|3981|2|60|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||1804||1804|3981||1|0|G|0|||0 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5901|4549|lyfalmen|V0249|4549|2|60|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||2217||2217|4549||1|0|G|0|||0 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|1|0|1|PEU|0|1|0|100|DKK|173573|222387|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||173573||173573|222387||1|0|L|0|||0 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|346373|437302|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||346373||346373|437302||1|0|L|0|||0 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|692720|868061|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||692720||692720|868061||1|0|L|0|||0 099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|storn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|1|CLU|0|1|0|100|XEU|152385|196036|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||152385||152385|196036||1|H|L|0|||0 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|NED|0|0|0|100|XEU|11915|17898|lyfalmen|V0925|14162|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||11915|17898||2|0|E|0|||0 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2308|3572|lyfalmen|V0823|3563|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1507||1507|3572||1|0|G|0|||0 100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|322|1759|lyfalmen|V0563|1759|2|30|0|15,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||190||190|1759||2|0|G|0|||0 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1000|2874|lyfalmen|V0685|2190|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1000||1000|2874||2|0|E|0|||0 100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2186|lyfalmen|V0821|2186|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||500||500|2186||2|0|E|0|||0 100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2874|lyfalmen|V0822|2874|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2874||2|0|E|0|||0 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|ATE|0|0|1|100|XEU|3540|6370|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lymecycline||3540||3540|6370||1|0|E|0|||0 101021|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3449|5740|lyfalmen|V0598|5740|2|100|0|13,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||3082||3082|5740||1|0|G|1|30|dagar|0 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|PLS|0|0|0|100|DKK|10286|14237|lyfalmen|V0254|12570|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9255||9255|14237||1|0|G|0|||0 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|PLS|0|0|0|100|DKK|14682|21706|lyfalmen|V0256|18856|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||14682||14682|21706||1|0|G|0|||0 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|PHA|0|0|0|100|NOK|58682|87009|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||53976||53976|87009||1|0||0|||0 101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5189||5189|10015||2|0||0|||0 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1970|4209|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||1970|4209||1|0||0|||0 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3397|6174|lyfalmen|||2|96|0|96,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||3397|6174||1|0|G|0|||0 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|12789|24434|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||12789||12789|24434||1|0||0|||0 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|6339|10223|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6339||6339|10223||2|0|E|0|||0 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|18804|27380|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||18804||18804|27380||2|0|E|0|||0 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1102|3015|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1102||1102|3015||1|0|G|0|||0 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1662|3785|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1662||1662|3785||1|0|G|0|||0 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|1|BAM|0|0|0|100|SEK|5846|9544|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5846||5846|9544||2|H|S|0|||0 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|429|2088|lyfalmen|V0230|2080|2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||429||429|2088||1|0|E|0|||0 102249|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|2|glas|2 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|400|0|13,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8625|3050|lyfalmen|V0684|3050|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1128||1128|3050||2|0|G|0|||0 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|G|0|TOG|0|0|0|100|SEK|3253|5975|lyfalmen|V0041|3880|1|98|0|147,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||3253||3253|5975||1|0|G|0|||0 102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|16388|14760|lyfalmen|V0441|12202|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||9635||9635|14760||2|0|G|0|||0 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|WEH|0|0|1|100|IKR|321|1940|lyfalmen|V0060|1940|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1940||2|0||2|30|töflur|0 103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2709|5227|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2709||2709|5227||2|0|G|0|||0 103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|1|0|0|PMA|0|0|0|100|DKK|7683|9983|lyfalmen|V0657|7829|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||6165||6165|9983||1|0|E|2|||0 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|1|0|1|TBB|0|0|0|100|NOK|95040|123480|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Teva B.V.|Lipegfilgrastim||95040||95040|123480||1|0|S|0|||0 103444|L04AB0404|IDACIO|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.08.2020||R|0|1|1|0|1|FKA|0|0|0|100|DKK|37185|50305|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||37185||37185|50305||1|0|0|0|||0 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2030|3161|lyfalmen|V0088|3108|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3161||2|0|G|0|||0 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2590|3747|lyfalmen|V0089|3631|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3747||2|0|G|0|||0 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1845|3934|lyfalmen|V0069|2750|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3934||2|0|G|0|||0 103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|G|0|POF|0|0|0|100|IKR|5678|2874|lyfalmen|V0334|2601|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|1854|4050|lyfalmen|V0222|4050|2|5|0|3,6000|Alvogen|ratiopharm GmbH|Fentanýl||1854||1854|4050||2|0|G|1|30|dagar|0 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|300230|379913|lyfsjukr|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||300230||300230|379913||2|H|S|0|||0 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|1|0|1|PEU|0|1|0|100|DKK|108815|141847|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||108815||108815|141847||1|0|L|0|||0 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|DEC|0|0|0|100|DKK|4087|7924|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||4087||4087|7924||1|0||0|||0 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2460||1|0|E|0|||0 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|1|GEH|0|0|0|100|NOK|8506|13206|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8506||8506|13206||2|H|S|0|||0 104401|N06AB0607|Sertralin Krka|filmhtfl|50|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3689|6575|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Sertralín||3689||3689|6575||2|0|G|0|||0 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|G|0|FEL|0|0|0|100|DKK|2915|5510|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2915||2915|5510||1|0|G|0|||0 104482|L01CA0403|Vinorelbine Alvogen|hylki|30|mg|1|stk|1|þpakki|mjúkt|L01CA04|01.10.2019||R|0|0|1|G|0|ALE|0|0|0|100|SEK|12063|16319|lyfalmen|V0992|16319|2|1|0||Alvogen|Alvogen Pharma Trading Europe EOOD|Vínorelbín||10768||10768|16319||2|0|G|0|||0 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|G|0|FEL|0|0|0|100|DKK|6474|10409|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6474||6474|10409||1|0|G|0|||0 104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|10921|16530|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||10921||10921|16530||1|0|E|0|||0 104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|4500|4801|lyfalmen|V0275|4788|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2400||2400|4801||2|0|G|0|||0 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|G|0|FER|0|0|0|100|DKK|7370|11642|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7370||7370|11642||1|0|G|0|||0 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|G|0|FER|0|0|0|100|DKK|3849|6796|lyfalmen|V0017|5995|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3849||3849|6796||1|0|G|0|||0 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|6150|9963|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6150||6150|9963||1|0|G|0|||0 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|4679|7938|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4679||4679|7938||2|0|G|0|||0 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|105935|138265|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||105935|138265||1|0|S|0|||0 105331|N02AE0105|Buprenorphine Alvogen|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|IKR|1916|3501|lyfalmen|V0944|3501|2|4|0|5,6000|Alvogen|Alvogen|Búprenorfín||1455||1455|3501||2|0|G|1|30|dagar|0 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BFP|0|0|0|100|XEU|3441|3302|lyfalmen|V0107|2461|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||1311||1311|3302||1|0|E|0|||0 105669|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2111|4404|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2111||2111|4404||2|0|G|1|30|dagar|0 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3068|5721|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||3068||3068|5721||2|0||0|||0 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3680|6563|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||3680||3680|6563||2|0||0|||0 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|2019|4277|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||2019||2019|4277||2|0||0|||0 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|3291|4277|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||2019||2019|4277||2|0||0|||0 106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|1|0|1|NEL|0|1|0|100|DKK|469997|591056|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||469997||469997|591056||1|0|L|0|||0 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|1|GPH|0|0|0|100|DKK|18092|26400|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||18092||18092|26400||1|H|S|0|||0 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|3724|2654|lyfalmen|V0107|2461|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||840||840|2654||2|0|E|0|||0 107002|R07AA0201|Curosurf|innönddr|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|1|CHI|0|0|0|100|XEU|129065|167032|lyfsjukr|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||129065||129065|167032||1|H|S|0|||0 107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|3328|5736|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3328||3328|5736||1|0||0|||0 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1623|3732|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1623||1623|3732|31.10.2020|1|0|G|0|||0 107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|4787|5623|lyfalmen|V0438|3824|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||2997||2997|5623||2|0|G|0|||0 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|1|PBV|0|0|0|100|XEU|20622|28206|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||19404||19404|28206||2|H|S|0|||0 107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|13210|4172|lyfalmen|V0814|3903|2|28|0|8,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1943||1943|4172||1|0|E|0|||0 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|G|0|KRK|0|0|0|100|IKR|5625|3934|lyfalmen|V0683|3050|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0 107785|L01XE4201|Kisqali|filmhtfl|200|mg|42|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|308116|389721|lyfsjukr|||1|42|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||308116||308116|389721||1|0|L|0|||0 107918|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|6024|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2|0||1|30|dagar|0 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013|31.08.2020|R|0|0|0|G|0|MYL|0|0|0|100|SEK|2093|4379|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2093||2093|4379||2|0|G|||| 108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2|0||1|30|dagar|0 108413|C10AX1401|Praluent|stl|75|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|75364|98594|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||75364||75364|98594||1|0|E|0|||0 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|9536|14623|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9536||9536|14623||1|0|G|0|||0 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|1|0|0|OEU|0|0|0|100|XEU|76472|99995|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||76472||76472|99995||3|0|E|0|||0 109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|776|2159|lyfalmen|V0827|2159|2|7|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||480||480|2159||2|0|G|0|||0 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1737|3741|lyfalmen|V0584|3737|2|28|0|7,4700|Alvogen|ratiopharm GmbH|Oxýcódon||1630||1630|3741||2|0|G|1|30|dagar|0 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|5919|8286|lyfalmen|V0585|8258|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||4932||4932|8286||2|0|G|1|30|dagar|0 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3888|6849|lyfalmen|||2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||3888||3888|6849||2|0|G|1|30|dagar|0 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|10812|14784|lyfalmen|V0587|14090|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||9653||9653|14784||2|0|G|1|30|dagar|0 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|20876|26180|lyfalmen|V0588|26180|2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||17932||17932|26180||2|0|G|1|30|dagar|0 110001|N03AX1602|Lyrica (Lyfjaver)|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|9653|14784|lyfalmen|V0686|3631|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||9653||9653|14784||3|0|E|0|||0 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0 110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|1881|4087|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1881||1881|4087||1|0|G|0|||0 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0291|2048|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G|0|||0 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2608|3494|lyfalmen|V0292|3494|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1450||1450|3494||2|0|G|0|||0 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4870|8201|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4870||4870|8201||2|0|G|0|||0 110341|A10BJ0601|Ozempic|stl|0,25|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|20200|28823|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||20200||20200|28823||1|0||0|||0 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5000|8380|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8380||2|0|G|0|||0 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1582|3290|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1582||1582|3290||1|0||0|||0 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|G|0|COR|0|0|0|100|DKK|5720|9371|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||5720||5720|9371||1|0|G|0|||0 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|1|0|1|MBV|0|0|0|100|DKK|94763|123130|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||94763||94763|123130||1|0|S|0|||0 110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|1|CLU|0|1|0|100|XEU|8975|13851|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||8975||8975|13851||1|0|L|0|||0 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|GED|0|0|0|100|XEU|14971|18490|lyfalm11|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||13919||13919|18490||1|0|E|0|||0 111479|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|G|0|POF|0|0|0|100|XEU|4948|5162|lyfalmen|V0373|4975|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2662||2662|5162||2|0|G|0|||0 111775|G03AA1209|Asubtela|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.11.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|2735|4711|lyfalm11|V0993|4711|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Dróspírenón og ethinylestradíól||2735||2735|4711||2|0||0|||0 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|GCA|0|0|1|100|DKK|721|2490|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||721||721|2490||1|0|E|0|||0 112073|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|lausn|V03AB33|01.05.2019||R|0|0|0|0|1|SEB|0|0|0|100|XEU|139737|180305|lyfsjukr|||2|1|0||Swedish Orphan Biovitrum A/S|SERB S.A.|Hydroxocobalamin||139737||139737|180305||3|H|0|0|||0 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|202600|258489|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||202600||202600|258489||1|0|L|0|||0 112345|J01FF0104|Clindamycin EQL Pharma|hylki|150|mg|32|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|1500|3012|lyfalmen|||2|32|0|4,0000|LYFIS ehf|EQL Pharma AB|Klindamýcín||1100||1100|3012||2|0|E|0|||0 112704|N05AH0415|Quetiapin Krka|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|1800|2599|lyfalmen|V0284|2365|2|100|0|6,2500|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||800||800|2599||2|0|G|0|||0 112713|N05AH0415|Quetiapin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3800|3287|lyfalmen|V0285|3287|2|100|0|25,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||1300||1300|3287||2|0|G|0|||0 112732|N05AH0415|Quetiapin Krka|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|5000|5627|lyfalmen|V0286|5627|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||3000||3000|5627||2|0|G|0|||0 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3737|lyfalmen|||2|100|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3737||2|0|E|0|||0 113088|M05BA0802|Aclasta|irl|5|mg|100|ml|1|glas|lausn|M05BA08|01.04.2019||R|0|1|1|0|0|NEL|0|0|0|100|DKK|55723|73752|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||55723||55723|73752||1|0|E|0|||0 113179|S01LA0601|Beovu|stl|120|mg/ml|0,165|ml|1|áfspr|lausn|S01LA06|01.06.2020||R|0|1|0|0|1|NEP|0|0|0|100|DKK|122411|158756|lyfsjukr|||1|0,165|0||Vistor hf|Novartis Europharm Limited|Brolucizumab||122411||122411|158756||1|H|0|0|||0 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|V0655|4899|2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||5077||2|0|E|0|||0 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7097|11266|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||7097||7097|11266||1|0|G|0|||0 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|6222|10062|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6222||6222|10062||1|0|G|0|||0 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|2380|4774|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||2380||2380|4774||2|H|S|0|||0 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|3672|6552|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3672||3672|6552||1|0|G|0|||0 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|5108|8529|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5108||5108|8529||1|0|G|0|||0 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|1|0|1|NEL|0|1|0|100|DKK|524692|659081|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||524692||524692|659081||1|0|L|0|||0 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|623|2355|lyfalmen|V0930|2048|1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||623||623|2355||2|0|E|0|||0 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|906|2745|lyfalmen|V0931|2434|1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||906||906|2745||2|0|E|0|||0 114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5000|3590|lyfalmen|V0145|2105|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||1520||1520|3590||2|0|E|0|||0 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1|0||0|||0 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|1|WIL|0|1|0|100|XEU|36299|49185|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||36299|49185||2|0|L|0|||0 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3908|6877|lyfalmen|V0824|2876|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3908||3908|6877||1|0|G|0|||0 114461|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|IKR|16097|6315|lyfalmen|V0145|6315|2|12|0|24,0000|Alvogen|ratiopharm GmbH|Tadalafíl||3500||3500|6315||2|0|E|0|||0 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|G|0|AEP|0|0|0|100|DKK|11036|16688|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||11036||11036|16688||2|0|G|0|||0 114605|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|9151|12914|lyfalmen|V0973|12914|2|100|0|60,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||8294||8294|12914||2|0|G|0|||0 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|G|0|MED|0|0|0|100|IKR|14000|18015|lyfalmen|V0420|16638|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||12000||12000|18015||2|0|G|0|||0 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|6230|10738|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||6230||6230|10738||2|0||0|||0 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2160|3967|lyfalmen|V0278|3967|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1794||1794|3967||2|0|G|0|||0 114950|L01BC0702|Azacitidine Accord|sts|25|mg/ml|100|mg|1|hgl||L01BC07|01.05.2020||R|0|0|0|0|1|CLU|0|1|0|100|XEU|53600|71067|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Azasitidín||53600||53600|71067||1|H|L|0|||0 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2911|3897|lyfalmen|V0279|3897|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1743||1743|3897||2|0|G|0|||0 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|8662|7290|lyfalmen|V0280|7290|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4208||4208|7290||2|0|G|0|||0 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|11971|7290|lyfalmen|V0282|7290|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4208||4208|7290||2|0|G|0|||0 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|0|KNM|0|0|0|100|IKR|5276|8760|lyfalmen|V0457|8760|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8760||2|0|G|0|||0 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12539|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12539||2|0|G|0|||0 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9452|lyfalmen|V0475|9452|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9452||2|0|G|0|||0 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20624|lyfalmen|V0540|20624|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20624||2|0|G|0|||0 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|90848|118178|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||90848||90848|118178||1|H|S|0|||0 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|1|RAU|0|0|1|100|XEU|8010|12523|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||8010||8010|12523||2|0|S|0|||0 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1164|3024|lyfalmen|V0158|2829|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1109||1109|3024||2|0|E|0|||0 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|1741|3081|lyfalmen|V0276|3041|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1150||1150|3081||2|0|G|0|||0 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|11703|17606|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11703||11703|17606||1|0|G|0|||0 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|10077|15368|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10077||10077|15368||1|0|G|0|||0 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|46787|62450|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||46787||46787|62450||1|0|G|0|||0 115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|STE|0|0|0|100|DKK|3736|6640|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||3736||3736|6640||1|0|0|0|||0 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|1|GPH|0|0|1|100|DKK|3609|6465|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3609||3609|6465||1|0|ES|0|||0 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|1|GPH|0|0|1|100|DKK|1887|4095|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1887||1887|4095||1|0|ES|0|||0 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|877|2572|lyfalmen|V0562|2349|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||780||780|2572||1|0|G|0|||0 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|446|2031|lyfalmen|V0563|1759|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||387||387|2031||1|0|G|0|||0 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|933|2759|lyfalmen|V0564|2113|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||916||916|2759||1|0|G|0|||0 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|15290|22543|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||15290||15290|22543||1|0|G|0|||0 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4592|7189|lyfalmen|V0081|6919|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||4135||4135|7189||1|0|G|0|||0 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|5960|9701|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5960||5960|9701||1|0|G|0|||0 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|6489|10429|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||6489||6489|10429||1|0|G|0|||0 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|16654|24420|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||16654||16654|24420||1|0|G|0|||0 116907|N02AE0104|Buprenorphine ratiopharm|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1916|3501|lyfalmen|V0944|3501|2|4|0|5,6000|Alvogen|ratiopharm GmbH|Búprenorfín||1455||1455|3501||2|0|G|1|30|dagar|0 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|KEL|1|0|0|100|XEU|10042|19222|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||10042||10042|19222||2|0||0|||0 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1609|3713|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1609||1609|3713||1|0|G|0|||0 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|ASZ|0|0|0|100|SEK|11772|16926|lyfalmen|V0275|4788|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||11209||11209|16926||1|0|E|0|||0 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|21685|28777|lyfalmen|V0273|5077|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||19819||19819|28777||1|0|G|0|||0 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1520|3590|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||1520||1520|3590||2|0|G|0|||0 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|31123|42638|lyfalmen|V0272|8917|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||31123||31123|42638||1|0|G|0|||0 117676|L01DB0107|Caelyx pegylated liposomal|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|1|JCI|0|1|0|100|SEK|57478|75972|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||57478||57478|75972||1|H|L|0|||0 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|NOK|5295|10216|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5295||5295|10216||2|0||0|||0 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|XEU|14567|27807|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||14567||14567|27807||2|0||0|||0 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1878|4083|lyfalmen|V0278|3967|2|28|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1878||1878|4083||1|0|G|0|||0 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2825|4174|lyfalmen|V0279|3897|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1944||1944|4174||1|0|G|0|||0 118046|N07BC0102|Buvidal|stl|96|mg|0,27|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|61863|81518|lyfsjukr|||1|0,27|0|12,0000|Vistor hf|Camurus AB|Búprenorfín||61863||61863|81518||1|H|L|1|30|dagar|0 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8477|8160|lyfalmen|V0282|7290|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4840||4840|8160||1|0|G|0|||0 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1797|3971|lyfalmen|V0283|3971|2|28|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1797||1797|3971||1|0|G|0|||0 118153|L02BB0401|Xtandi|filmhtfl|40|mg|112|stk|1|þpakki||L02BB04|01.10.2019||R|1|0|0|0|1|APE|0|1|0|100|XEU|445858|561034|lyfsjukr|||1|112|0|28,0000|Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||445858||445858|561034||1|0|L|0|||0 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14590|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14590||5|H|S|0|||0 118421|C02AC0201|Intuniv|forðatfl|3|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|12347|18492|lyfalmen|||1|28|0|28,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||12347||12347|18492||1|0|E|0|||0 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8662|8834|lyfalmen|V0280|7290|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||5330||5330|8834||1|0|G|0|||0 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|5534|10670|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5534||5534|10670||2|0||0|||0 118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|G|0|FER|0|0|0|100|DKK|21499|30466|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||21499||21499|30466||1|0|G|0|||0 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|1|BAM|0|0|0|100|SEK|1278|3257|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1278||1278|3257||2|H|S|0|||0 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|G|0|AEP|0|0|0|100|DKK|502|2189|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||502||502|2189||2|0|G|0|||0 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|1480|3535|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1480||1480|3535||2|0|G|0|||0 119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2326|2993|lyfalmen|V0824|2876|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1086||1086|2993||2|0|G|0|||0 119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|GAN|0|0|0|100|XEU|3193|5893|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3193||3193|5893||2|0|E|0|||0 119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5500|9068|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5500||5500|9068||2|0|E|0|||0 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1297|3283|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3283||2|0||2|60|mg|0 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|1|RGP|0|1|0|100|DKK|347783|439056|lyfsjukr|||1|30|0|20,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||347783||347783|439056||1|0|L|0|||0 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|1|RGP|0|1|0|100|DKK|322878|408081|lyfsjukr|||1|30|0|40,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||322878||322878|408081||1|0|L|0|||0 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|1|NED|0|1|0|100|XEU|40135|54036|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||40135||40135|54036||2|H|L|0|||0 120278|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|56740|75038|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||56740||56740|75038||1|H|L|0|||0 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|7679|8586|lyfalmen|V0118|8586|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||5150||5150|8586||2|0|E|0|||0 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|1|RRG|0|1|0|100|DKK|434262|546612|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||434262||434262|546612||2|H|L|0|||0 121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8586|lyfalmen|V0118|8586|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||5150||5150|8586||2|0|E|0|||0 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|skpokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|GRH|0|0|1|100|DKK|4029|7043|lyfalmen|||1|28|0|9,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||4029||4029|7043||1|0|E|0|||0 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3320|6068|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3320||3320|6068||2|0|G|0|||0 122133|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018|31.10.2020|R|1|0|0|0|0|MBP|0|0|0|100|IKR|3416|6200|lyfalmen|||2|4|0|8,0000|BGP Products ApS|Mylan S.A.S|Tadalafíl||3416||3416|6200||2|0|E|0|||0 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2|0||0|||0 122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|2500|2861|lyfalmen|V0010|2193|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2861||2|0|G|0|||0 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9503|16379|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9503||9503|16379||1|0||0|||0 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|33821|58294|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||33821||33821|58294||2|0||0|||0 123487|L01BC0603|Ecansya|filmhtfl|500|mg|120|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|18000|26273|lyfsjukr|||2|120|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||18000||18000|26273||2|0|S|0|||0 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|679|2432|lyfalmen|||2|100|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||679||679|2432||1|0|G|0|||0 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|1|G|0|SMA|0|0|0|100|XEU|33495|45638|lyfalmen|V0579|31140|1|56|0|28,0000|Vistor hf|Sanofi Mature IP|Rílúzól||33495||33495|45638||1|0|G|0|||0 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|CHP|0|0|0|100|XEU|1871|3677|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1871|3677||2|0||0|||0 124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|URE|0|0|0|100|XEU|33408|45528|lyfalmen|||1|60|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||33408||33408|45528||3|0|E|0|||0 124347|R03AC0206|Ventoline|innönddu|200|mcg/sk|60|skammtar|1|stk||R03AC02|01.03.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|749|2529|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||749||749|2529||1|0|G|0|||0 124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|8517|13221|lyfalmen|V0995|5627|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||8517||8517|13221||1|0|G|0|||0 124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4529||1|0|G|0|||0 125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|DKK|12245|18352|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||12245||12245|18352||2|0|G|0|||0 125376|B03BA0105|Optovite B12|stl|1000|mcg|2|ml|5|lykjur||B03BA01|01.05.2020||R|0|0|0|G|0|LNA|0|0|1|100|XEU|6325|8449|lyfalmen|||2|10|0|250,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Cyanocobalamin||5050||5050|8449||2|0|G|0|||0 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|5524|3356|lyfalmen|V0285|3287|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1350||1350|3356||2|0|G|0|||0 125613|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|1739324|2169743|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||1739324||1739324|2169743||2|H|S|0|||0 126390|A10BK0101|Forxiga|filmhtfl|5|mg|28|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|6980|11105|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||6980||6980|11105||1|0|G|0|||0 126496|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2397|2695|lyfalmen|V0057|2312|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||870||870|2695||1|0|G|0|||0 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|49201|65503|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||49201||49201|65503||2|H|L|0|||0 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|98398|127727|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||98398||98398|127727||2|H|L|0|||0 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|196830|251313|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||196830||196830|251313||2|H|L|0|||0 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|1|FIN|0|1|0|100|DKK|131295|169805|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||131295||131295|169805||2|H|L|0|||0 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|33118|45161|lyfalmen|V0976|45161|1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||33118|45161||2|0|G|0|||0 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3635|6501|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3635|6501||1|0|G|0|||0 126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|7635|12007|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||7635||7635|12007||2|0|G|0|||0 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|XEU|3426|5067|lyfalmen|V0011|5040|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||2593||2593|5067||1|0|G|0|||0 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||2|0||0|||0 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|NED|0|0|0|100|XEU|6459|10388|lyfalmen|V0279|3897|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6459||6459|10388||2|0|E|0|||0 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|G|0|KPA|0|0|0|100|DKK|1513|3580|lyfalmen|||1|100|0|50,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||1513||1513|3580||2|0|G|0|||0 128750|L04AA2901|Xeljanz|filmhtfl|10|mg|56|stk|1|þpakki||L04AA29|01.01.2019||R|0|1|1|0|1|PEU|0|1|0|100|DKK|250306|317822|lyfsjukr|||1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||250306||250306|317822||1|0|L|0|||0 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|G|0|NED|0|0|0|100|XEU|24822|34668|lyfalmen|V0282|7290|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||24822||24822|34668||2|0|G|0|||0 129152|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|1 innöndunartæki og 1 rörlykja|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|5055|8456|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5055||5055|8456||1|0|G|0|||0 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|19390|16753|lyfalmen|V0680|16753|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||11083||11083|16753||2|0||0|||0 129289|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|10136|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0 129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3590||2|0||0|||0 129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|G|0|BOI|0|0|0|100|DKK|3862|6814|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3862||3862|6814||1|0|G|0|||0 129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0812|3903|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15164|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15164||2|0|E|1|30|dagar|0 130001|N06AB0608|Sertralin WH|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|3423|4332|lyfalmen|V0323|4251|2|100|0|200,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||2059||2059|4332||2|0|G|0|||0 130242|L04AA4001|Mavenclad|töflur|10|mg|1|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|1|MRP|0|1|0|100|SEK|328735|415366|lyfsjukr|||1|1|0|29,4118|Icepharma hf|Merck Europe B.V.|Cladribine||328735||328735|415366||2|0|L|0|||0 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|DKK|5703|5239|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2718||2718|5239||2|0||0|||0 130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|1|PFM|0|0|0|100|SEK|324484|410078|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||324484||324484|410078||1|H|S|0|||0 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|21188|40368|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||21188||21188|40368||1|0||0|||0 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1584|3678|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1584||1584|3678||2|0||0|||0 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|10578|16057|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||10578|16057||1|0||0|||0 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|PHA|0|0|0|100|NOK|41775|67341|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||41775|67341||1|0||0|||0 131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|RPG|1|0|0|100|XEU|7265|13954|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||7265||7265|13954||2|0||0|||0 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|MYL|0|0|0|100|SEK|4955|6295|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||3485||3485|6295||2|0||0|||0 131383|N03AA0207|Fenemal Meda|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|G|0|MEA|0|0|0|100|DKK|1713|3856|lyfalmen|||2|100|0|15,0000|Icepharma hf|Meda AB|Phenobarbital||1713||1713|3856||2|0|G|2|||0 131417|N03AA0207|Fenemal Meda|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|G|0|MEA|0|0|0|100|DKK|1941|4170|lyfalmen|||2|100|0|50,0000|Icepharma hf|Meda AB|Phenobarbital||1941||1941|4170||2|0|G|2|||0 131620|C08CA0107|Amlodipine Vitabalans|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|2461|lyfalmen|V0057|2312|2|100|0|200,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0 132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|VAL|0|0|1|100|XEU|1232|2288|lyfalmen|V0003|2234|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||574||574|2288||2|0||0|||0 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|5076|6597|lyfalmen|V0581|6597|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3705||3705|6597|||0|G|0|||0 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|3156|5159|lyfalmen|V0580|5159|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||2660||2660|5159|||0|G|0|||0 132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|1|TPA|0|1|0|100|DKK|428926|539975|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||428926||428926|539975||1|H|L|0|||0 132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016|31.08.2020|L|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2|0||||| 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|G|0|AGC|0|0|0|100|XEU|9539|14627|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||9539||9539|14627||1|0|G|0|||0 132633|D11AH0501|Dupixent|stl|300|mg|2|áf.spr|1|pakki|með nálarhlíf|D11AH05|01.08.2019||R|0|0|1|0|1|SGB|0|1|0|100|XEU|193393|247038|lyfsjukr|||1|2|0|28,0374|Vistor hf|Sanofi-aventis groupe|Dupilumab||193393||193393|247038||1|0|L|0|||0 132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2364|3631|lyfalmen|V0089|3631|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1550||1550|3631||2|0|G|0|||0 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|0|0|0|JAS|0|0|0|100|SEK|5074|8482|lyfalmen|V0681|7963|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5074||5074|8482||1|0|E|1|30|dagar|0 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|6775|13024|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||||6775|13024||2|0||0|||0 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|4858|4209|lyfalmen|V0335|2601|2|100|0|150,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1970||1970|4209||1|0|G|0|||0 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|464|2137|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Proxýmetakaín||464||464|2137||1|0||0|||0 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1|0||0|||0 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|1|SLP|0|0|0|100|SEK|23557|33068|lyfsjukr|||1|0,5|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||23557||23557|33068||1|H|S|0|||0 133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|1323|3319|lyfalmen|V0037|3312|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||1323||1323|3319||2|0|G|0|||0 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|1|SLP|0|0|0|100|SEK|31323|42891|lyfsjukr|||1|1|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||31323||31323|42891||1|H|S|0|||0 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|1|SLP|0|0|0|100|SEK|42592|57144|lyfsjukr|||1|2|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||||42592|57144||1|H|S|0|||0 133227|R03AK0605|Salmex|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GLZ|0|0|0|100|DKK|5493|7458|lyfalmen|V0981|7458|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||4330||4330|7458||2|0|G|0|||0 133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|1|GAA|0|0|0|100|SEK|4330|7458|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4330||4330|7458||2|H|S|0|||0 133856|N06BA0904|Atomoxetine Sandoz|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|SHS|0|0|0|100|DKK|11704|5528|lyfalmen|||2|28|0|8,7500|Artasan ehf|Sandoz A/S|Atomoxetín||2928||2928|5528|30.9.2020|1|0|E|0|||0 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|BFP|0|0|0|100|XEU|1423|3457|lyfalmen|V0333|3204|2|30|0|11,2500|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1423||1423|3457||1|0|E|0|||0 134067|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2019||R|0|0|1|G|0|AZA|0|0|0|100|SEK|51448|66880|lyfalmen|V0451|56656|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||50290||50290|66880||1|0|G|0|||0 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3064|5715|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3064||3064|5715||2|0|G|0|||0 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7787|12216|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7787||7787|12216||2|0|G|0|||0 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|1|0|1|BRS|0|0|0|100|DKK|61603|81189|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||61603||61603|81189||1|0|S|0|||0 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|1|0|1|GAD|0|0|0|100|DKK|112515|146448|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland UC|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||112515||112515|146448||2|0|S|0|||0 135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3912|3838|lyfalmen|V0678|3563|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||1700||1700|3838||2|0|G|0|||0 135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5538|4251|lyfalmen|V0679|3904|2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||2000||2000|4251||2|0|G|0|||0 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|10451|15883|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10451||10451|15883||1|0|G|0|||0 135253|A10BB0906|Gliclazíð Krka|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3500|5008|lyfalmen|V0020|3502|2|90|0|45,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||2550||2550|5008||2|0|G|0|||0 135264|A10BB0906|Gliclazíð Krka|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4800|7004|lyfalmen|V0020|7004|2|180|0|90,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||4000||4000|7004||2|0|G|0|||0 135384|R03BA0501|Flixotide|innönddu|500|mcg/sk|60|skammtar|1|sk-ílá|Fjölskammtaílát|R03BA05|01.09.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4621|7858|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4621||4621|7858||1|0|G|0|||0 135434|R03BA0501|Flixotide|innönddu|100|mcg/sk|60|skammtar|1|pakki|fjölskammtaílát|R03BA05|01.07.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1311|3302|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1311||1311|3302||1|0|G|0|||0 135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|G|0|VAL|0|0|0|100|DKK|2426|3144|lyfalmen|V0909|3144|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||1196||1196|3144||2|0|G|0|||0 135533|R03AC1201|Serevent|innönddu|50|mcg/sk|60|skammtar|1|innö.t||R03AC12|01.10.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|2999|5626|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2999||2999|5626||1|0|G|0|||0 136121|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|2 hgl m 5 ml leysi + 2 millist|B06AC01|01.03.2019||R|0|1|1|0|1|SSE|0|1|0|100|DKK|213870|272506|lyfsjukr|||1|2|0|0,7143|Shire Services BVBA|Shire Services BVBA|C1 hemill||213870||213870|272506||1|0|L|0|||0 136180|M05BA0306|Pamidronatdinatrium Pfizer|irþ|3|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|1|PLS|0|0|0|100|DKK|6442|10365|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||6442||6442|10365||1|H|S|0|||0 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|1|G|0|PEU|0|0|0|100|DKK|38502|51971|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||38502||38502|51971||1|0|G|0|||0 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|MEA|0|0|0|100|DKK|9300|11869|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||7535||7535|11869||2|0||0|||0 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|64135|84392|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||64135||64135|84392||1|0|L|0|||0 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|3006|5635|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||3006||3006|5635||1|0||0|||0 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|804|2605|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2605||2|0||2|60|mg|0 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól|||||||1|0||0|||0 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|16195|14574|lyfalmen|V0261|11408|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9500||9500|14574||2|0|G|0|||0 137665|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|30|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|1786|3607|lyfalmen|V1002|3607|2|30|0|2,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||1532||1532|3607||2|0|E|1|30|dagar|0 137690|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|668|2417|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck AB|Levótýroxínnatríum||668||668|2417||2|0|G|0|||0 137721|L04AA4001|Mavenclad|töflur|10|mg|6|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|1|MRP|0|1|0|100|SEK|1972413|2459641|lyfsjukr|||1|6|0|176,4706|Icepharma hf|Merck Europe B.V.|Cladribine||1972413||1972413|2459641||2|0|L|0|||0 137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6500|7004|lyfalmen|V0273|5077|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4000||4000|7004||2|0|G|0|||0 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4824|4939|lyfalmen|V0689|3445|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2500||2500|4939||2|0|E|0|||0 138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2817|5375|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2817||2817|5375||2|0|G|0|||0 138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|1|0|1|GSE|0|0|0|100|DKK|2540993|3166795|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2540993|3166795||2|0|ES|0|||0 138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2500|2806|lyfalmen|V0114|2806|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2806||2|0|G|0|||0 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|17599|25721|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||17599||17599|25721||1|0||0|||0 138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3730|6632|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3730||3730|6632||2|0|G|0|||0 138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|5281|6025|lyfalmen|V0691|6025|2|30|0|18,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3289||3289|6025||1|0|E|1|30|dagar|0 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|G|0|ATE|0|0|0|100|XEU|2850|4975|lyfalmen|V0373|4975|2|15|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tímólól í blöndum||2526||2526|4975||1|0|G|0|||0 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|1|0|1|AEB|0|1|0|100|XEU|112067|145891|lyfsjukr|||1|56|0|28,0000|Vistor hf|Amgen Europe B.V.|Apremilast||112067||112067|145891||1|0|L|0|||0 139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0 140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|565|2276|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||565||565|2276||1|0|G|0|||0 140132|C08CA0107|Amlodipine Vitabalans|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|1267|2461|lyfalmen|V0056|2312|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0 140191|R06AX2708|Dasergin|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|0|0|KAN|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||||2|0||0|||0 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|1069|2969|lyfalmen|V0266|2368|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||1069||1069|2969||1|0|G|0|||0 140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015|30.09.2020|R|1|0|0|G|0|ATE|0|0|0|100|XEU|15991|21307|lyfalmen|||2|98|0|104,5300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||14392||14392|21307||1|0|G|0|||0 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|1|LBK|0|0|0|100|DKK|9898|15122|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9898||9898|15122||1|0|S|0|||0 140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|0|0|0|ARO|0|0|0|100|DKK|7330|11587|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||7330||7330|11587||2|0|E|1|30|dagar|0 140611|N06BA0408|Methylphenidate Teva|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|3381|6152|lyfalmen|V0958|6152|2|30|0|10,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3381||3381|6152||1|0|E|1|30|dagar|0 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|SRR|0|0|0|100|NOK|73668|139933|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||73668||73668|139933||1|0||0|||0 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|1|0|1|JAS|0|0|0|100|SEK|66793|87753|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||66793||66793|87753||1|0|S|0|||0 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1243|3209|lyfalmen|V0413|2954|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1243||1243|3209||1|0|G|0|||0 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3258|5982|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||3258||3258|5982||1|0|G|0|||0 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1|0||0|||0 141238|N05CH0104|Melatonin Vitabalans|töflur|3|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|4000|3700|lyfalmen|||2|50|0|75,0000|LYFIS ehf|LYFIS ehf|Melatonin||1600||1600|3700||2|0|0|0|||0 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|1|FKA|0|0|1|100|DKK|3700|6591|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3700||3700|6591||1|0|S|0|||0 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|15069|22239|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||15069|22239||2|0|G|0|||0 141783|R02AX0101|Strefen|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0 141847|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|100|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|37341|45734|lyfalmen|V1007|45734|2|100|0|53,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||33571||33571|45734||2|0|E|1|30|dagar|0 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3781||1|0||0|||0 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|6484|10422|lyfalmen|V0267|4251|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||6484||6484|10422||1|0|G|0|||0 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1708|3849|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1708||1708|3849||2|0|G|0|||0 142123|R07AX0101|INOmax|lyfjagas|800|ppm|2|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|1|LIN|0|0|0|100|XEU|23801|33377|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||23801|33377||5|H|S|0|||0 142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2767|4769|vetorma|||0|0,9|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2767||2767|4769||1|0||0|||0 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|4359|4961|lyfalmen|V0384|3867|2|10|0|5,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2516||2516|4961||1|0|G|0|||0 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|G|0|SNP|0|0|0|100|XEU|952|2808|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||952||952|2808||1|0|G|0|||0 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|MEA|0|0|1|100|DKK|3424|6211|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Metenamín||3424||3424|6211||2|0|E|0|||0 142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|1|PEU|0|0|0|100|DKK|466420|586607|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||466420||466420|586607||1|0|ES|0|||0 142606|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1056|2951|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||1056||1056|2951||2|0|G|1|30|dagar|0 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2461|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||800||800|2599||2|0|G|0|||0 142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2043|2943|lyfalmen|V0049|2943|2|100|0|66,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1050||1050|2943||2|0|G|0|||0 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16820||1|0||0|||0 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|1|PLS|0|0|0|100|DKK|2318|4688|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2318||2318|4688||1|H|S|0|||0 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|9000|5050|lyfalmen|V0687|4939|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||2581||2581|5050||1|0|E|0|||0 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|4995|8373|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4995||4995|8373||1|0||0|||0 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|599|2322|lyfalmen|V0542|2322|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atenólól||599||599|2322||1|0|G|0|||0 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|1127|3049|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Trópíkamíð||1127||1127|3049|31.10.2020|1|0||0|||0 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1397|3421|lyfalmen|V0173|2676|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1397||1397|3421||1|0|E|0|||0 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|5168|8611|lyfalmen|V0387|7626|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5168||5168|8611||1|0|G|0|||0 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|G|0|MBV|0|0|0|100|DKK|5064|8468|lyfalmen|V0386|7427|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5064||5064|8468||1|0|G|0|||0 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|G|0|ATE|0|0|0|100|DKK|2999|5626|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Litíum||2999||2999|5626||1|0|G|0|||0 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1764|3926|lyfalmen|V0174|2461|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1764||1764|3926||1|0|E|0|||0 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|4124|7174|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4124||4124|7174||1|0|G|0|||0 144490|N07XX0801|Vyndaqel|hylki|61|mg|30|stk|1|stsk.þ||N07XX08|01.10.2020||R|0|1|1|0|1|PEU|0|0|0|100|DKK|1497366|1868815|lyfsjukr|||1|30|0|91,5000|Icepharma hf|Pfizer Europe MA EEIG|Tafamidis||1497366||1497366|1868815||1|0|0|0|||0 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9887|14784|lyfalmen|V0587|14090|2|98|0|52,2700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||9653||9653|14784||1|0|G|1|30|dagar|0 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|tfílát||N05BA02|01.04.2020||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1485|3542|lyfalmen|||2|24|0|8,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1485||1485|3542||1|0||2|50|töflur|0 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|0|0|0|1|JAN|0|1|0|100|DKK|83021|108279|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||83021||83021|108279||1|H|L|0|||0 145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4885|8222|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4885|8222||1|0|G|0|||0 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4829|9332|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4829||4829|9332||1|0||0|||0 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|6528|12555|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||6528||6528|12555||1|0||0|||0 145479|L04AX0402|Lenalidomid Alvogen|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|707227|886104|lyfsjukr|||2|21|0|31,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||707227||707227|886104||2|0|L|0|||0 145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|523|2218|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||523||523|2218||1|0|G|0|||0 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2|0||0|||0 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|7940|15234|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||7940||7940|15234||1|0||0|||0 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|9504|18201|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||9504||9504|18201||1|0||0|||0 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|1|BAM|0|0|1|100|SEK|7183|11385|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7183||7183|11385||2|0|S|0|||0 145691|L03AA1302|Pelgraz|stl|6|mg/spr|0,6|ml|1|spr|áföst nál með nálavörn|L03AA13|01.03.2019||R|0|0|1|0|1|CLU|0|0|0|100|XEU|117542|152701|lyfsjukr|||2|0,6|0|20,0000|Artasan ehf|Accord Healthcare S.L.U.|Pegfilgrastím||117542||117542|152701||1|0|S|0|||0 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|G|0|VIF|0|0|1|100|CHF|5714|9363|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5714||5714|9363||1|0|G|0|||0 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|G|0|VIF|0|0|1|100|CHF|27270|37765|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||27270||27270|37765||1|0|G|0|||0 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|1|RGP|0|1|0|100|DKK|26273|36504|lyfsjukr|||1|1|0|4,8000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||26273||26273|36504||1|H|L|0|||0 146102|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.07.2019|31.10.2020|R|1|0|0|G|0|MYL|0|0|0|100|DKK|6011|6157|lyfalmen|||2|30|0|60,0000|Icepharma hf|Mylan AB|Sólífenacín||3385||3385|6157||2|0|G|0|||0 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|DAN|0|0|0|100|XEU|18249|26616|lyfalmen|V0817|4224|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18249||18249|26616||2|0|E|0|||0 146494|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|15222|12202|lyfalmen|V0441|12202|2|90|0|180,0000|Icepharma hf|Mylan AB|Sólífenacín||7777||7777|12202||2|0|G|0|||0 146529|B06AC0201|Firazyr|stl|30|mg|3|ml|1|áfspr|+ ein nál|B06AC02|01.05.2020||R|0|0|1|0|1|HPI|0|0|0|100|DKK|264248|335162|lyfsjukr|||1|3|0|1,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Icatibant ||264248||264248|335162||1|0|ES|0|||0 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|1066|2965|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1066||1066|2965||1|0||0|||0 146751|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0815|3903|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 146812|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.08.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9341|14355|lyfalmen|V0608|14355|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||9341||9341|14355||1|0|G|0|||0 147481|N06AB0608|Sertralin WH|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1825|2916|lyfalmen|V0322|2916|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||1030||1030|2916||2|0|G|0|||0 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3370||1|0||0|||0 147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BFP|0|0|1|100|XEU|1800|3975|lyfalmen|||2|30|0|3,7500|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1800||1800|3975||1|0|E|0|||0 147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|6431|5311|lyfalmen|V0687|4939|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2770||2770|5311||2|0|E|0|||0 147902|L01XE2901|Lenvima|hylki|10|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|1|0|1|SIE|0|0|0|100|SEK|246580|313188|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||246580||246580|313188||1|0|S|0|||0 147931|D11AX1802|Solaraze 3%|hlaup|3|% w/w|100|g|1|túpa||D11AX18|01.01.2020||R|0|0|0|0|0|ALM|0|0|0|100|XEU|16753|24557|lyfalmen|V1009|24557|1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||16753||16753|24557||1|0|E|0|||0 148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|163628|210019|lyfsjukr|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||163628|210019||2|0|ES|0|||0 148170|J05AE1003|Darunavir Medical Valley|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|1|VAL|0|0|0|100|XEU|52496|69671|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Darunavír||52496||52496|69671||2|0|S|0|||0 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|1|0|0|ROA|0|0|0|100|DKK|102356|133813|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||102356||102356|133813||2|0||0|||0 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1236|2898|lyfalmen|V0577|2898|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||1017||1017|2898||1|0|E|0|||0 148266|QI01AN0101|Evalon|innúðal|||5000|skammtar|1|hgl|+250ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|104840|180702|vetorma|||0|5000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||104840||104840|180702||2|0|0|0|||0 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1839|4029|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1839||1839|4029||1|0|E|0|||0 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|6321|9778|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||6016||6016|9778||1|0|E|0|||0 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|63332|83376|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||63332||63332|83376||1|0|E|0|||0 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|63332|83376|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||63332||63332|83376||1|0|E|0|||0 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|SEK|569|2168|lyfalmen|V0601|2168|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||487||487|2168||1|0|G|0|||0 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|G|0|LFS|0|0|0|100|DKK|1018|2899|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1018||1018|2899||1|0|G|0|||0 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81814||5|H|S|0|||0 148780|J01DH0205|Meropenem WH|sts/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|1|WEH|0|0|1|100|XEU|14574|16638|lyfsjukr|||2|10|0|1,6667|Williams & Halls efh|Williams & Halls ehf|Meropenem||11000||11000|16638||2|0|S|0|||0 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|BAN|1|0|0|100|DKK|3722|7232|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|Xylazinum||3722||3722|7232||2|0||0|||0 149203|R03AC0206|Ventoline|innúðal|0,1|mg/sk|200|skammtar|1|úðaílá|dreifa|R03AC02|01.04.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|481|2160|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||481||481|2160||1|0|G|0|||0 149240|A02BX1301|Gaviscon|mixtúra|||400|ml|1|glas||A02BX13|01.06.2019||L|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4121||1|0||0|||0 149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|1|JCI|0|1|0|100|SEK|283005|358490|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||283005||283005|358490||1|H|L|0|||0 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2517|4962|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2517||2517|4962||1|0|S|0|||0 149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|1|WEH|0|0|0|100|XEU|15701|23109|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||15701||15701|23109||2|H|ES|0|||0 150005|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9856|15064|lyfalmen|V0611|15064|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||9856||9856|15064||1|0|G|0|||0 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||7792||1|0|G|0|||0 150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4613|6591|lyfalmen|V0253|4190|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3700||3700|6591||2|0|G|0|||0 150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|0|1|AEB|0|1|0|100|DKK|173239|221972|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||173239||173239|221972||1|H|L|0|||0 150498|B01AC2202|Prasugrel Krka|filmhtfl|5|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0805|10445|2|30|0|15,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G|0|||0 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|42884|57513|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||42884|57513||1|0|S|0|||0 151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4300|2737|lyfalmen|V0607|2737|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737||2|0|G|0|||0 151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|46994|59276|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||44278||44278|59276||2|0|ES|0|||0 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|G|0|LBK|0|0|0|100|DKK|6203|10036|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6203||6203|10036||1|0|G|0|||0 151207|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|1|glas|1 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|200|0|6,6667|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1573|3663|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1573||1573|3663||1|0|G|0|||0 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|G|0|LUN|0|0|0|100|DKK|31356|42933|lyfalmen|V0607|2737|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||31356||31356|42933||1|0|G|0|||0 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|434|2095|lyfalmen|V0633|2009|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||434||434|2095||1|0|G|0|||0 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4354|7491|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Europe B.V.|Chóríógónadótrópín alfa||||4354|7491||2|0|G|0|||0 151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|5381|3050|lyfalmen|V0682|3050|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1128||1128|3050||2|0|G|0|||0 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|LTH|0|0|1|100|SEK|1141|3068|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1141||1141|3068||1|0||0|||0 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1195|2349||2|0||0|||0 151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1962|2866|lyfalmen|V0234|1823|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||994||994|2866||1|0|G|0|||0 151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|1|0|1|IPC|0|0|0|100|XEU|120041|115278|lyfsjukr|||2|12|0|24,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||88555||88555|115278||2|0|S|0|||0 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|1|HES|0|0|0|100|DKK|1813|3993|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1813||1813|3993||1|H|S|0|||0 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2824|5385|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2824||2824|5385||1|0|G|0|||0 152410|N05AH0416|Quetiapin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|7800|8917|lyfalmen|V0272|8917|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||5390||5390|8917||2|0|0|0|||0 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|AZD|0|0|0|100|SEK|4533|7737|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4533||4533|7737||1|0|G|0|||0 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|ASZ|0|0|0|100|SEK|8287|12904|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||8287||8287|12904||1|0|G|0|||0 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BFP|0|0|1|100|XEU|6873|9628|lyfalmen|||2|90|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||5907||5907|9628||1|0|G|0|||0 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1586|3681|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1586||1586|3681||2|0||0|||0 153179|R03AK0605|Salmex|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GLZ|0|0|0|100|DKK|3691|5510|lyfalmen|V0436|5510|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||2915||2915|5510||2|0|G|0|||0 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|32296|44122|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||32296|44122||1|0|S|0|||0 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||5400||1|0|G|0|||0 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|1|GSE|0|0|0|100|DKK|184167|235563|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Sciences Ireland|Amfóterícín||184167||184167|235563||2|H|ES|0|||0 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|739|2515|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||739||739|2515||1|0|G|0|||0 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|40292|54235|lyfalmen|V0452|54235|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Exemestan||40292||40292|54235||1|0|G|0|||0 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|3733|6636|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3733||3733|6636||1|0|E|0|||0 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1231|3192|lyfalmen|||2|24|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1231||1231|3192||1|0||2|25|töflur|0 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|IKR|726|2131|lyfalmen|V0908|2048|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||460||460|2131||2|0|G|0|||0 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|22317|20664|lyfalmen|V0183|20664|2|1|0|27,9070|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||13925||13925|20664||2|0|G|0|||0 154116|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|6978|5627|lyfalmen|V0995|5627|2|7,5|0|75,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||3000||3000|5627||2|0|G|0|||0 154147|R03AL0801|Trelegy Ellipta|innönddu|||30|skammtar|1|innö.t|92 mcg/55 mcg/22 mcg|R03AL08|01.06.2019||R|0|0|0|G|0|GSD|0|0|0|100|DKK|9038|13938|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Vilanterol, umeclidinium bromide, fluticasone furoate||9038||9038|13938||1|0|G|0|||0 154377|G03CA0325|Estrofem 1 mg|filmhtfl|1|mg|84|stk|1|skífup||G03CA03|01.05.2020||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2340|4719|lyfalmen|||1|84|0|42,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2340||2340|4719||1|0|G|0|||0 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||13569||1|0|G|0|||0 154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|21601|30595|lyfalmen|||1|28|0|42,0000|Eisai AB|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|18286|26667|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||18286||18286|26667||1|0|S|0|||0 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|20893|29699|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||20893||20893|29699||1|0|S|0|||0 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|26137|36332|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||26137||26137|36332||1|0|S|0|||0 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|1|FKA|0|0|0|100|DKK|23846|33434|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||23846||23846|33434||1|0|S|0|||0 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|23911|33516|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||23911||23911|33516||1|0|S|0|||0 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|28979|39926|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||28979||28979|39926||1|0|S|0|||0 154697|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|4821|3824|lyfalmen|V0438|3824|2|30|0|30,0000|Icepharma hf|Mylan AB|Sólífenacín||1690||1690|3824||2|0|G|0|||0 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|15590|22956|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||15590||15590|22956||1|0|S|0|||0 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3122|5795|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3122||3122|5795||1|0|G|0|||0 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|23038|32412|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||23038||23038|32412||1|0|S|0|||0 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3595|2869|lyfalmen|V0334|2549|2|98|0|73,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||996||996|2869||1|0|G|0|||0 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6301|2869|lyfalmen|V0335|2549|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||996||996|2869||1|0|G|0|||0 155121|L04AA4001|Mavenclad|töflur|10|mg|4|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|1|MRP|0|1|0|100|SEK|1314942|1641931|lyfsjukr|||1|4|0|117,6471|Icepharma hf|Merck Europe B.V.|Cladribine||1314942||1314942|1641931||2|0|L|0|||0 155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1712|2309|lyfalmen|V0247|2309|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||589||589|2309||2|0|G|0|||0 155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3199|3981|lyfalmen|V0248|3981|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1804||1804|3981||2|0|G|0|||0 155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|6048|4549|lyfalmen|V0249|4549|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||2217||2217|4549||2|0|G|0|||0 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|18166|26502|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18166||18166|26502||1|0||0|||0 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1593|3691|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1593||1593|3691||1|0|G|0|||0 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|5912|7367|lyfalmen|V0253|4190|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4264||4264|7367||1|0|G|0|||0 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|687|2444|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||687||687|2444||1|0|G|0|||0 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1448|3125|lyfalm11|V0590|3086|2|84|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Desógestrel||1448||1448|3125||1|0||0|||0 155485|L01XX4601|Lynparza|filmhtfl|150|mg|56|stk|1|þpakki||L01XX46|01.03.2020||R|0|0|1|0|1|AZA|0|1|0|100|SEK|384675|484939|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||384675||384675|484939||1|0|L|0|||0 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|RHG|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0 155579|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|39248|52914|lyfalmen|||1|50|0|8,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||39248||39248|52914||1|0|E|0|||0 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|6019|9782|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6019||6019|9782||1|0|E|0|||0 156066|J05AR0603|Efavirenz/Emtricitabine/Tenofovir Krka|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|59860|78985|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||59860||59860|78985||2|0|S|0|||0 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|21006|29842|lyfalmen|V0383|21382|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||21006||21006|29842||1|0|G|0|||0 156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|4589|2737|lyfalmen|V0552|2737|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||900||900|2737||2|0|E|0|||0 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|5338|8845|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5338||5338|8845||2|0|G|0|||0 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|6195|10025|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6195||6195|10025||2|0|G|0|||0 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|MEA|0|0|1|100|DKK|403|2053|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||403||403|2053||2|0|0|0|||0 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|JAS|0|0|0|100|SEK|650|2393|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||650||650|2393||1|0||0|||0 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|0|0|0|RPG|1|0|0|100|DKK|8216|13569|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||7062||7062|13569||2|0|0|1|30|dagar|0 157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13451|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13451||2|0|E|1|30|dagar|0 157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2|0||0|||0 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2|0||2|||0 157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|63903|84098|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||63903||63903|84098||2|H|S|0|||0 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|1|SAR|0|0|0|100|DKK|40490|49364|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||36441||36441|49364||1|0|S|0|||0 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|G|0|HES|0|0|0|100|DKK|1508|3574|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1508||1508|3574||1|0|G|0|||0 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|ALM|0|0|0|100|DKK|6631|10625|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6631||6631|10625||1|0||0|||0 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|1|SNP|0|0|0|100|XEU|1050|2943|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1050||1050|2943||1|H|S|0|||0 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|ASA|0|0|0|100|SEK|20172|28787|lyfalmen|V0910|7540|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||20172|28787||1|0||0|||0 158608|J02AX0501|Mycamine|irþstofn|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|1|APG|0|0|0|100|XEU|46705|62346|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||46705|62346||1|H|ES|0|||0 158619|J02AX0501|Mycamine|irþstofn|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|1|APG|0|0|0|100|XEU|71633|93875|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||71633||71633|93875||1|H|ES|0|||0 158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|GPA|0|0|0|100|XEU|4126|3746|lyfalmen|V0143|3582|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1633||1633|3746||1|0|E|0|||0 158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|260373|330342|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||260373||260373|330342||2|0|L|0|||0 158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|14927|4610|lyfalmen|V0817|4224|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2261||2261|4610||2|0|E|0|||0 158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|1724|2599|lyfalmen|V0967|2599|2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||800||800|2599||2|0||0|||0 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|1853|4048|lyfalmen|V0219|4048|2|5|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||1853||1853|4048||1|0|G|1|30|dagar|0 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3689|6575|lyfalmen|V0220|6450|2|5|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||3689||3689|6575||1|0|G|1|30|dagar|0 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|5327|8830|lyfalmen|V0221|8830|2|5|0|22,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||5327||5327|8830||1|0|G|1|30|dagar|0 159138|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1023|3180|0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0||0|||0 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|5272|8754|lyfalmen|V0223|8754|2|5|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||5272||5272|8754||1|0|G|1|30|dagar|0 159387|N06BA0905|Atomoxetin STADA|hylki|25|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4800|4182|lyfalmen|V0814|4182|2|30|0|9,3750|LYFIS ehf|LYFIS ehf|Atomoxetín||1950||1950|4182||2|0|E|0|||0 159405|A10BD2401|Steglujan|filmhtfl|115|mg|28|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|10998|16404|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10830||10830|16404||1|0|G|0|||0 159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|0|1|IPC|0|1|0|100|SEK|131869|155559|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||119840||119840|155559||2|H|L|0|||0 159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0 159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|1|ESS|0|0|0|100|DKK|45620|60974|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||45620||45620|60974||2|H|S|0|||0 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|698|2459|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||698||698|2459||2|0|G|0|||0 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|1714|3857|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1714||1714|3857||2|0|G|0|||0 159751|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|520|2110|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||445||445|2110||2|0|ES|0|||0 159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0 159765|N05AX1212|Abilify Maintena (Lyfjaver)|sts|400|mg|1|hgl|1|pakki||N05AX12|01.05.2019||R|0|0|0|0|0|LVR|0|0|0|100|DKK|45068|60276|lyfalmen|V0980|60276|3|1|0|30,0800|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||45068||45068|60276||3|0|E|0|||0 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|1|GRP|0|0|0|100|DKK|140796|181622|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||140796||140796|181622||1|H|S|0|||0 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|NIL|1|0|0|100|XEU|4315|8357|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Flunixinum||4315||4315|8357||2|0||0|||0 160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|1|SUG|0|1|0|100|XEU|64340|84651|lyfsjukr|||2|4|0|14,2900|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||64340||64340|84651||2|0|L|0|||0 160195|C09CA0307|Valsartan Jubilant|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|2000|3838|lyfalmen|V0678|3563|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||1700||1700|3838||2|0|G|0|||0 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|G|0|ATE|0|0|1|100|XEU|5880|3119|lyfalmen|V0010|2193|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1178||1178|3119||1|0|E|0|||0 160487|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|7873|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E|1|30|dagar|0 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|G|0|SNP|0|0|0|100|XEU|843|2658|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||843||843|2658||1|0|G|0|||0 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|1|PLS|0|0|0|100|DKK|947|2801|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||947||947|2801||1|H|S|0|||0 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1511|3578|lyfalmen|V0169|2530|1|14|0|8,1667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1511||1511|3578||1|0|E|0|||0 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2609|5089|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2609||2609|5089||1|0|G|0|||0 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|624|2357|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||624||624|2357||1|0|G|0|||0 161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1737|2529|lyfalmen|V0143|1194|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||749||749|2529||1|0|E|0|||0 161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|7692|lyfalmen|V0145|4210|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4500||4500|7692||2|0|E|0|||0 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|G|0|PLS|0|0|0|100|DKK|58900|77770|lyfalmen|V0452|54235|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||58900||58900|77770||1|0|G|0|||0 161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|6687|10702|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||6687|10702||2|0|ES|0|||0 161596|R03BA0501|Flixotide|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.08.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2761|5298|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2761||2761|5298||1|0|G|0|||0 161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|G|0|AGC|0|0|0|100|XEU|28855|39769|lyfalmen|||1|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||28855||28855|39769||1|0|G|0|||0 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|RRD|0|0|0|100|DKK|561015|704257|lyfalmen|||1|60|0|30,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||561015||561015|704257||1|0|E|0|||0 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2000|4251|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||2000||2000|4251||1|0|G|0|||0 162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|13997|7761|lyfalmen|V0145|6315|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4550||4550|7761||2|0|E|0|||0 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|LEV|1|0|0|100|XEU|5811|11195|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|Detomidinum||5811||5811|11195||2|0||0|||0 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2506|3959|lyfalmen|V0041|3959|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1788||1788|3959||2|0|G|0|||0 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BFP|0|0|0|100|XEU|508|2110|lyfalmen|V0500|2082|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||445||445|2110||1|0|G|0|||0 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BFP|0|0|0|100|XEU|735|2510|lyfalmen|||2|100|0|42,5000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||735||735|2510||1|0|G|0|||0 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BFP|0|0|0|100|XEU|459|2130|lyfalmen|V0502|2130|2|60|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||459||459|2130||1|0|G|0|||0 162872|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.10.2019||R|0|0|1|0|1|CLU|0|1|0|100|XEU|26670|37006|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||26670||26670|37006||1|0|L|0|||0 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1227|3187|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1227||1227|3187||1|0|G|0|||0 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|9788|14970|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai GmbH|Rúfínamíð||9788||9788|14970||1|0|G|0|||0 163082|N02BA5103|Triplo|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2018||L|0|0|0|0|0|OEC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|Orifarm Generics A/S|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1|0||0|||0 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|0|0|0|HES|0|0|0|100|DKK|1261|3234|lyfalmen|V0671|2701|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1261||1261|3234||1|0|E|1|30|dagar|0 163164|QH01CA9002|Busol|stl|0,004|mg/ml|10|ml|5|hgl|lausn|QH01CA90|01.11.2018||R|0|0|0|0|0|TPW|1|0|0|100|IKR|14280|27263|vetalmen|||0|50|0||Dýraheilsa ehf|T.P. Whelehan Son & Co. Ltd.|Buserelin||14280||14280|27263||2|0||0|||0 163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|4206|7287|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||4206||4206|7287||2|0|G|0|||0 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|1166|3103|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1166||1166|3103||1|0||0|||0 163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3339|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|6493|10435|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6493||6493|10435||1|0||0|||0 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|11066|16729|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11066||11066|16729||2|H|S|0|||0 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2497|4935|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2497||2497|4935||1|0|G|0|||0 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|1|0|1|FIN|0|1|0|100|DKK|446378|561680|lyfsjukr|||1|112|0||Icepharma hf|Bayer AG|Sorafeníb||446378||446378|561680||2|0|L|0|||0 163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1819|4002|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1819||1819|4002||1|0|G|0|||0 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RHG|0|0|1|100|XEU|626|2360|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm GmbH|Íbúprófen||626||626|2360||2|0|G|0|||0 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1877|4081|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm GmbH|Íbúprófen||1877||1877|4081||2|0|G|0|||0 163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2159|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||500||500|2186||2|0|G|0|||0 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3796|6723|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3796||3796|6723||1|0|S|0|||0 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|1|0|1|NRO|0|0|0|100|DKK|40623|54654|lyfsjukr|||1|100|0||Pharmanovia A/S|Nova Laboratories Ireland Limited|Merkaptópúrín||40623||40623|54654||2|0|S|0|||0 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9884|18922|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||9884||9884|18922||1|0||0|||0 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|352346|444731|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||352346||352346|444731||1|0|L|0|||0 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1022|2905|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1022||1022|2905||2|0|G|0|||0 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1256|3227|lyfalmen|V0314|3227|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1256||1256|3227||2|0|G|0|||0 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|5446|8994|lyfalmen|||1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5446||5446|8994||2|0|G|0|||0 164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||2|0||0|||0 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1|0||0|||0 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1565|3652|lyfalmen|||2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1565||1565|3652||1|0||2|50|töflur|0 165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|21601|30595|lyfalmen|V0667|30595|1|28|0|35,0000|Eisai AB|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|LAS|1|0|0|100|XEU|7109|13658|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||7109||7109|13658||2|0||0|||0 165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2018||R|0|0|0|0|1|ATE|0|0|0|100|XEU|8814|13630|lyfsjukr|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Írinótekan||8814||8814|13630||1|H|S|0|||0 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|168198|215702|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||168198||168198|215702||2|0|L|0|||0 165689|N06AB0406|Citalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|4406|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||2600||2600|5077||2|0|G|0|||0 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|GOP|0|0|1|100|DKK|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||||||||0|0|0|||0 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|202600|258489|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||202600||202600|258489||1|0|L|0|||0 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|4305|7423|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4305||4305|7423||1|0|S|0|||0 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|RPG|1|0|0|100|XEU|6151|11840|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|butylscopolamine and analgesics||||6151|11840||2|0||0|||0 166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8916|6040|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3300||3300|6040||2|0|E|0|||0 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1573|3663|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1573||1573|3663||1|0|G|0|||0 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|1|G|0|PLS|0|0|0|100|DKK|14821|21898|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14821||14821|21898||1|0|G|0|||0 166204|J07BB0205|Influvac|stl|||0,5|ml|10|áfspr||J07BB02|01.11.2017||R|0|0|0|0|0|MDK|0|0|0|100|DKK|8962|13833|lyfalmen|||1|5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir mótefnavakar||||8962|13833||2|0||0|||0 166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2665|2806|lyfalmen|V0113|2806|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0 166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|1|0|1|ABD|0|1|0|100|DKK|126395|163711|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||126395||126395|163711||1|0|L|0|||0 167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|EVO|0|0|0|100|IKR|8346|11312|lyfalmen|V0968|10556|2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||7130||7130|11312||2|0|E|0|||0 167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|43705|58552|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||43705||43705|58552||2|0|L|0|||0 167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3081|lyfalmen|V0826|3075|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3081||2|0|G|0|||0 167887|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|1220|2461|lyfalmen|V0189|2461|2|100|0|50,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||700||700|2461||2|0|G|0|||0 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1844|3078|lyfalmen|V0005|3012|2|28|0|37,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||1148||1148|3078||1|0|E|0|||0 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|1|0|1|GEI|0|0|0|100|DKK|143174|184580|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||143174||143174|184580||2|0|S|0|||0 168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0 168119|B06AC0102|Berinert|sts/irs|500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|1|CSB|0|1|0|100|SEK|103436|135157|lyfsjukr|||1|1|0|0,3571|Icepharma hf|CSL Behring GmbH|C1 hemill||103436||103436|135157||2|0|L|0|||0 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5208|5737|lyfalmen|V0007|4251|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lansóprazól||3080||3080|5737||1|0|E|0|||0 168388|L04AC1301|Taltz|stl|80|mg|1|ml|1|áfpen||L04AC13|01.06.2020||R|0|0|1|0|1|NED|0|1|0|100|XEU|154687|198899|lyfsjukr|||1|1|0|27,5862|Icepharma hf|Eli Lilly Nederland B.V.|Ixekizumab||154687||154687|198899||2|0|L|0|||0 168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2537|4990|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2537||2537|4990||2|0|G|0|||0 168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3021|5656|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3021||3021|5656||2|0|G|0|||0 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|3431|6220|lyfalmen|V0240|5693|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||3431||3431|6220||1|0|G|0|||0 168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|6255|10107|lyfalmen|V0433|9477|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||6255||6255|10107||1|0|G|0|||0 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8106|12655|lyfalmen|V0688|12655|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||8106||8106|12655||2|0|E|0|||0 169293|L01XX2702|Arsenic Trioxide Accord|irþ|1|mg/ml|10|ml|10|hgl||L01XX27|01.05.2020||R|0|0|0|0|1|CLU|0|0|0|100|XEU|545371|684800|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Arsenic trioxide||545371||545371|684800||1|H|0|0|||0 169402|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|2815|2461|lyfalmen|V0994|2461|2|2,5|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||700||700|2461||2|0|G|0|||0 169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1672|3384|lyfalmen|V0411|3384|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1370||1370|3384||2|0|E|0|||0 169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1106|2545|lyfalmen|V0177|2545|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||761||761|2545||2|0|E|0|||0 169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1091|2533|lyfalmen|V0418|2532|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||752||752|2533||2|0|E|0|||0 169872|QG03XA9101|Improvac|stl|||100|ml|1|glas||QG03XA91|01.04.2019||R|0|0|0|0|0|ZBE|0|0|0|100|IKR|6255|12037|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||6255||6255|12037||2|0|0|0|||0 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3406|6186|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3406||3406|6186||2|0||0|||0 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|4196|7273|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||4196||4196|7273||2|0||0|||0 169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|CLE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Clear Eyes Pharma Ltd.|Nafazólín|||||||2|0||0|||0 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|1|RRG|0|1|0|100|DKK|21698|30717|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||21698||21698|30717||2|H|L|0|||0 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|1|RRG|0|1|0|100|DKK|53961|71523|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||53961||53961|71523||2|H|L|0|||0 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5434|8977|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5434||5434|8977||1|0||0|||0 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|1|RRG|0|1|0|100|DKK|108066|140915|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||108066||108066|140915||2|H|L|0|||0 170237|L04AA2701|Gilenya|hylki|0,25|mg|28|stk|1|þpakki||L04AA27|01.07.2019||R|0|1|1|0|1|NEL|0|1|0|100|DKK|273433|346585|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||273433||273433|346585||1|0|L|0|||0 170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|G|0|BFP|0|0|0|100|XEU|975|2270|lyfalmen|V0108|2270|2|100|0|33,3400|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||561||561|2270||1|0|G|0|||0 170335|N02AX0213|Tramadol Krka|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|550|2255|lyfalmen|V0226|2255|2|20|0|6,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||550||550|2255||2|0|G|1|30|dagar|0 170486|C10AX1401|Praluent|stl|75|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|197388|252007|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||197388||197388|252007||1|0|E|0|||0 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|G|0|HSS|0|0|0|100|DKK|11790|17726|lyfalmen|||1|100|0|50,0000|Artasan ehf|Sandoz GmbH|Rífampicín||11790||11790|17726|30.9.2020|1|0|G|0|||0 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2499|4938|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||2499||2499|4938||2|0||0|||0 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|1|SAR|0|0|0|100|DKK|31979|39677|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||28782||28782|39677||1|0|S|0|||0 170758|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|958|2817|lyfalmen|||1|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||958||958|2817||1|0|G|0|||0 170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|Meloxícam||1158||1158|2276||2|0||0|||0 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|1|CPV|0|1|0|100|XEU|53905|71453|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe B.V.|Azasitidín||53905||53905|71453||2|H|L|0|||0 171292|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|12809|13886|lyfalmen|V0441|13558|2|100|0|200,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||9000||9000|13886||2|0|G|0|||0 171340|R01AX0302|Lomuspray|nefúði|21|mcg/sk|15|ml|1|úðaílá|180 sk, lausn|R01AX03|01.04.2020||L|0|0|0|G|0|SNP|0|0|1|100|XEU|||lyfalmen|||1|15|0|15,7500|Vistor hf|Sanofi-aventis Norge AS|Ípratrópínbrómíð|||||3074||1|0|G|0|||0 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|DEC|0|0|0|100|DKK|2819|5519|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|Prednisolonum og sýkingalyf||2819||2819|5519||1|0||0|||0 171486|L04AB0202|Remsima|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|0|0|0|1|HUN|0|1|0|100|DKK|48835|65040|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||48835||48835|65040||1|H|L|0|||0 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3452|6249|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||||3452|6249||2|0||0|||0 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3917|6889|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||3917||3917|6889||2|0||0|||0 171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|G|0|MYL|0|0|0|100|DKK|1304|3293|lyfalmen|||1|30|0|20,0000|Icepharma hf|Mylan AB|Mebeverín||1304||1304|3293||2|0|G|0|||0 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|3035|5675|lyfalmen|V0247|2309|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3035||3035|5675||1|0|G|0|||0 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|5260|8738|lyfalmen|V0248|3981|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||5260||5260|8738||1|0|G|0|||0 172269|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|200|stk|1|þpakki||N03AX14|01.12.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|5000|8380|lyfalmen|V0253|8380|2|200|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||5000||5000|8380||2|0|G|0|||0 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|9731|14892|lyfalmen|V0249|4549|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||9731||9731|14892||1|0|G|0|||0 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|17635|25771|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||17635||17635|25771||1|0|G|0|||0 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|16741|24540|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||16741||16741|24540||1|0||0|||0 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|G|0|RDT|0|0|0|100|DKK|9464|14524|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||9464||9464|14524||1|0|G|0|||0 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2799|2466|lyfalmen|V0284|2365|2|100|0|6,2500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||703||703|2466||1|0|G|0|||0 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7841|8418|lyfalmen|V0118|8414|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||5028||5028|8418||1|0|E|0|||0 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||4186||1|0|E|0|||0 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|1|RAG|0|0|0|100|DKK|12878|19223|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||12878||12878|19223||1|0|S|0|||0 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|1|ATE|0|0|1|100|DKK|3789|4949|lyfsjukr|||2|20|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2507||2507|4949||1|0|S|2|20|lykjur|0 174063|C03EA0115|Amiloride/HCT Alvogen|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|2015|4271|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||2015||2015|4271||2|0|G|0|||0 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|MEA|0|0|1|100|DKK|597|2320|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||597||597|2320||2|0|E|0|||0 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|1476|3529|lyfalmen|||1|5|0|25,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1476||1476|3529||1|0|G|0|||0 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5489|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5489||2|0|G|0|||0 174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|10862|16448|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||10862||10862|16448||1|0|G|0|||0 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|3862|6814|lyfalmen|V0368|4790|1|15|0|75,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3862||3862|6814||1|0|G|0|||0 174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|1|ALO|0|0|0|100|XEU|55131|49943|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||36899||36899|49943||2|0|S|0|||0 174825|N02CX0001|Glitinum|hylki|100|mg|30|stk|1|þpakki||N02CX|01.12.2018||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|30|0||Florealis ehf|Florealis ehf|Tanacetum parthenium|||||||2|0||0|||0 174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|16916|24781|lyfalmen|||1|30|0|70,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||16916||16916|24781||1|0|E|1|30|dagar|0 175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|24431|34174|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||24431|34174||3|0|L|0|||0 175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|7379|9452|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5779||5779|9452||1|0|G|0|||0 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|0|0|0|100|XEU|5495|10596|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||5495||5495|10596||2|0||0|||0 175351|L01XC0203|Truxima|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|1|CTH|0|1|0|100|DKK|190742|243741|lyfsjukr|||2|50|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||190742||190742|243741||1|H|L|0|||0 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|G|0|GPH|0|0|1|100|DKK|2290|2701|lyfalmen|||1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||874||874|2701||1|0|G|0|||0 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|NED|0|0|0|100|XEU|4800|8105|lyfalmen|V0278|3967|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4800||4800|8105||2|0|E|0|||0 176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|G|0|KPA|0|0|1|100|DKK|1418|3450|lyfalmen|||1|100|0||Alvogen|Karo Pharma AB|Hýdrókortisón||1418||1418|3450||2|0|G|0|||0 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2730|4995|lyfalmen|V0429|4354|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2541||2541|4995||2|0|G|0|||0 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|RNE|0|0|1|100|DKK|2833|5397|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||2833||2833|5397||1|0|0|0|||0 176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3105|5772|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||3105||3105|5772||2|0|G|0|||0 176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6790|11703|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6790||6790|11703||2|0||0|||0 176955|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas|+spaði|D01AE16|01.12.2017||R|0|0|0|0|0|GAN|0|0|1|100|XEU|2471|4899|lyfalmen|V0655|4899|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||||2471|4899||2|0|E|0|||0 177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|1|AEB|0|0|0|100|DKK|443410|557989|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||443410||443410|557989||1|H|S|0|||0 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|7910|12385|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7910||7910|12385||2|0|S|0|||0 177199|L01XE3301|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|1|0|1|PEU|0|1|0|100|DKK|364073|459316|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||364073||364073|459316||1|0|L|0|||0 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1044|2935|lyfalmen|V0231|2669|2|300|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||||1044|2935||1|0|0|0|||0 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|DOR|1|0|0|100|XEU|4717|9120|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4717||4717|9120||2|0||0|||0 177723|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3816|3582|lyfalmen|V0143|3582|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1514||1514|3582||2|0|E|0|||0 177754|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|150|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|2718|5239|lyfalmen|V1028|5239|3|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||2718||2718|5239||3|0|E|0|||0 177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|373322|470819|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||373322|470819||2|0|E|0|||0 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|G|0|ATE|0|0|0|100|XEU|9647|12783|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kolkisín||8199||8199|12783||1|0|G|0|||0 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|34995|47535|lyfalmen|V0975|46780|1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||34995||34995|47535||2|0|G|0|||0 178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|1|0|1|NEL|0|1|0|100|DKK|850432|1064211|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||850432||850432|1064211||1|0|L|0|||0 178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|97728|126880|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||97728|126880||3|0|L|0|||0 178752|L04AD0204|Dailiport|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|10436|15862|lyfalmen|||2|50|0|10,0000|Artasan ehf|Sandoz A/S|Tacrolimus||10436||10436|15862||1|0|G|0|||0 178991|N05AH0416|Quetiapin Medical Valley|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|3000|4788|lyfalmen|V0275|4788|2|100|0|12,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||2390||2390|4788||2|0|0|0|||0 179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|1|SDG|0|1|0|100|DKK|142279|165771|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||128051||128051|165771||1|0|L|0|||0 179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9400|14436|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||9400|14436||2|0|G|0|||0 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|18418|26848|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18418||18418|26848||1|0||0|||0 179733|N02AA0507|OxyContin Depot|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|1427|3462|lyfalmen|V0597|2836|1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1427||1427|3462||2|0|G|1|30|dagar|0 179790|N06BA0903|Atomoxetin Medical Valley|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2020||R|1|1|0|0|0|VAL|0|0|0|100|XEU|8155|12722|lyfalmen|V0818|12722|2|28|0|35,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||8155||8155|12722||2|0|E|0|||0 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|1|WIL|0|1|0|100|XEU|120258|156079|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||120258||120258|156079||2|0|L|0|||0 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|G|0|MED|0|0|0|100|IKR|2191|4514|lyfalmen|V0148|4514|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2191||2191|4514||2|0|G|0|||0 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|G|0|PLS|0|0|1|100|DKK|733|2507|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||733||733|2507||1|0|G|0|||0 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|1|PLS|0|0|0|100|DKK|10072|15361|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||10072||10072|15361||1|H|S|0|||0 181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1|0||0|||0 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|6304|10175|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||6304||6304|10175||1|0||0|||0 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||6882||2|0|G|0|||0 182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|2031|2186|lyfalmen|V0556|2186|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||500||500|2186||2|0|E|0|||0 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|9970|15221|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||9970||9970|15221||1|0|G|0|||0 182416|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|glas|47,5 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|1436|3474|lyfalmen|V0048|3012|2|100|0|33,3333|Artasan ehf|Hexal A/S|Metóprólól||1436||1436|3474||1|0|G|0|||0 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|15238|22472|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||15238||15238|22472||2|H|S|0|||0 182561|L01XE0303|Erlotinib WH|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.06.2020||R|0|1|1|0|1|WEH|0|1|0|100|XEU|327886|326083|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlótiníb||256948||256948|326083||2|0|L|0|||0 182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|8527|4515|lyfalmen|V0817|4224|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||2192||2192|4515||1|0|E|0|||0 182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|16988|32400|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||16988||16988|32400||1|0||0|||0 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|0|0|0|RPG|1|0|0|100|XEU|21260|40505|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||21260|40505||2|0||1|30|dagar|0 183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|1|PIP|0|0|1|100|DKK|183139|234285|lyfsjukr|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||183139||183139|234285||1|0|ES|0|||0 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|IBV|1|0|0|100|DKK|5554|10708|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5554||5554|10708||1|0||0|||0 183366|L04AD0204|Dailiport|forðahlk|0,5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|6248|10098|lyfalmen|||2|50|0|5,0000|Artasan ehf|Sandoz A/S|Tacrolimus||6248||6248|10098||1|0|G|0|||0 183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3187|5885|lyfalmen|V0612|5885|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3187||3187|5885||2|0|E|0|||0 183485|L01XE4201|Kisqali|filmhtfl|200|mg|21|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|155715|200177|lyfsjukr|||1|21|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||155715||155715|200177||1|0|L|0|||0 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5963|9705|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5963|9705||1|0|G|0|||0 183794|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|29765|40920|lyfalmen|||3|168|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban ||29765||29765|40920|30.9.2020|3|0|G|0|||0 183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|7173|12363|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||7173||7173|12363||2|0||0|||0 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|G|0|MDK|0|0|0|100|DKK|1224|3183|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mylan Denmark ApS|Flúdrókortisón||1224||1224|3183||2|0|G|0|||0 183924|N06BA0905|Atomoxetin STADA|hylki|40|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|4182|lyfalmen|V0815|4182|2|30|0|15,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1950||1950|4182||2|0|E|0|||0 184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|0|0|0|1|JCI|0|1|0|100|SEK|358323|452165|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||358323||358323|452165||1|H|L|0|||0 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|3267|5995|lyfalmen|V0017|5995|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3267||3267|5995||2|0|G|0|||0 184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|1|BAB|0|0|0|100|DKK|45336|60615|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||45336|60615||2|H|S|0|||0 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|G|0|HES|0|0|0|100|DKK|48334|64406|lyfalmen|V0185|19013|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||48334||48334|64406||1|0|G|0|||0 184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|PHM|0|0|0|100|XEU|13175|25166|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||13175||13175|25166||2|0||0|||0 184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|0|KRK|0|0|0|100|IKR|3362|6125|lyfalmen|V0690|6125|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6125||2|0|E|0|||0 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2|0||0|||0 185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2554|lyfalm11|V0545|1924|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||985||985|2554||2|0||0|||0 185822|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.10.2020||R|1|0|0|0|0|LVR|0|0|1|100|DKK|10035|6620|lyfalmen|V0011|5040|3|100|0|66,6667|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||3721||3721|6620||3|0|E|0|||0 185859|C02AC0201|Intuniv|forðatfl|4|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|13867|20584|lyfalmen|||1|28|0|37,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||13867||13867|20584||1|0|E|0|||0 186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|293183|371149|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||293183|371149||3|0|L|0|||0 186236|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|6024|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|ATE|0|0|1|100|XEU|18332|11528|lyfalmen|V0419|11338|2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||7287||7287|11528||1|0|E|0|||0 186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|16740|20308|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||13666||13666|20308||2|0|G|0|||0 186638|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.10.2019||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1|0||0|||0 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1027|2839|lyfalmen|V0597|2836|2|28|0|3,7300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||974||974|2839||1|0|G|1|30|dagar|0 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|10028|3081|lyfalmen|V0607|2793|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||1150||1150|3081||2|0|G|0|||0 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|6418|10332|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6418||6418|10332||1|0||0|||0 187067|L04AB0205|Flixabi|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|1|0|0|1|SUG|0|1|0|100|XEU|43395|58160|lyfsjukr|||2|1|0|26,6700|Icepharma hf|Samsung Bioepis NL B.V.|Infliximab||43395||43395|58160||2|H|L|0|||0 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2459|4882|lyfalmen|V0462|4882|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4882||2|0|G|0|||0 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|6011|10361|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||6011||6011|10361||2|0||0|||0 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|G|0|MEA|0|0|1|100|DKK|4000|7004|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||4000||4000|7004||2|0|G|0|||0 187612|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|938|2789|lyfalmen|V0066|2737|2|100|0|100,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||938||938|2789||1|0|G|0|||0 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3293||2|0|G|0|||0 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|1|PEU|0|0|0|100|DKK|72898|95475|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Europe MA EEIG|Tigecýklín||72898||72898|95475||1|H|ES|0|||0 188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|G|0|POF|0|0|0|100|XEU|2198|3966|lyfalmen|V0621|2702|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||1793||1793|3966||2|0|G|0|||0 188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016|31.08.2020|R|0|0|0|G|0|TEE|0|0|0|100|NOK|13309|19816|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||13309||13309|19816||1|0|G|||| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|G|0|DEA|0|0|0|100|XEU|3016|5649|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3016||3016|5649||1|0|G|0|||0 188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|5643|9265|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||5643||5643|9265||1|0|G|0|||0 188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1400|3012|lyfalmen|V0458|2979|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||1100||1100|3012||2|0|G|0|||0 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|2931|3631|lyfalmen|V0422|2874|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1550||1550|3631||2|0|G|0|||0 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|1|PSA|0|0|0|100|DKK|9944|14415|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||9385||9385|14415||2|H|S|0|||0 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|1|0|1|JCI|0|0|0|100|SEK|42102|56524|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||42102||42102|56524||1|0|S|0|||0 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|1|HES|0|0|0|100|DKK|7015|11153|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||7015||7015|11153||1|H|S|0|||0 189312|N02CD0101|Aimovig|stl|140|mg|1|ml|1|áfpen||N02CD01|01.12.2019||R|0|0|1|0|0|NEL|0|0|0|100|DKK|79543|103880|lyfalmen|||1|1|0|56,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||79543||79543|103880||1|0|E|0|||0 189430|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|5466|9021|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5466||5466|9021||2|0|G|1|30|dagar|0 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2768|5308|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2768||2768|5308||1|0|G|0|||0 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1058|2954|lyfalmen|V0413|2954|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1058||1058|2954||1|0|G|0|||0 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|512|2203|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||512||512|2203||1|0|G|0|||0 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1759|3919|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1759||1759|3919||2|0|G|0|||0 190696|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1038|2737|lyfalmen|V0685|2737|2|70|0|5,8333|Acare ehf|Medical Valley Invest AB|Pregabalín||900||900|2737||2|0|E|0|||0 190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016|30.09.2020|R|0|1|1|G|0|CLP|0|0|0|100|XEU|23613|33139|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||23613||23613|33139||1|0|G|||| 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4245||1|0|G|0|||0 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3654|6527|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3654||3654|6527||1|0|S|0|||0 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5588|5269|lyfalmen|V0117|5177|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||2740||2740|5269||1|0|E|0|||0 191242|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|þpakki||C07AA07|01.08.2020||R|1|0|0|G|0|MYL|0|0|0|100|SEK|893|2727|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||893||893|2727||2|0|G|0|||0 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3749|6658|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3749||3749|6658||1|0|S|0|||0 191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2149|3108|lyfalmen|V0088|3108|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1170||1170|3108||2|0|G|0|||0 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3968|6959|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3968||3968|6959||1|0|S|0|||0 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 191724|S01ED5119|Cosopt sine|augndr|25|mg/ml|10|ml|1|glas|20mg/ml+5mg/ml|S01ED51|01.05.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3695|6584|lyfalmen|||1|10|0|50,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3695||3695|6584||2|0|G|0|||0 191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.12.2018||R|1|0|0|0|0|ATE|0|0|0|100|XEU|19244|6152|lyfalmen|V0689|6152|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||3381||3381|6152||1|0||0|||0 192030|QD06AA0203|Cyclospray|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|ERO|0|0|0|100|XEU|1177|2313|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||1177||1177|2313||1|0||0|||0 192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||||2|0||0|||0 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|0|ATE|0|0|0|100|XEU|5408|8519|lyfalmen|||2|96|0|48,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||5101||5101|8519||1|0|G|0|||0 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|3140|4562|lyfalmen|V0429|4354|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||2226||2226|4562||1|0|G|0|||0 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|G|0|KPA|0|0|0|100|DKK|2311|4679|lyfalmen|||1|100|0|100,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||2311||2311|4679||2|0|G|0|||0 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|6658|10662|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6658||6658|10662||2|0|S|0|||0 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|1|TIC|0|1|0|100|XEU|153212|197064|lyfsjukr|||2|1|0||Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Dexametasón||153212||153212|197064||1|H|L|0|||0 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2802|2865|lyfalmen|V0233|2325|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||993||993|2865||1|0|G|0|||0 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|G|0|MCS|0|0|0|100|SEK|864|2687|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||864||864|2687||1|0|G|0|||0 193285|N06DX0109|Marbodin|filmhtfl|10|mg|98|stk|1|stsk.þ||N06DX01|01.11.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4000|2737|lyfalmen|V0605|2737|2|98|0|49,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737||2|0|G|0|||0 193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016|31.10.2020|R|1|0|0|0|0|ASD|0|0|0|100|IKR|21696|7689|lyfalmen|||2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||4498||4498|7689||2|0||0|||0 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|G|0|EIG|0|0|0|100|SEK|21601|30595|lyfalmen|V0667|30595|1|28|0|35,0000|Vistor hf|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|20,0000|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2760||1|0|E|0|||0 193975|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfspr||R03DX10|01.12.2018||R|0|0|1|0|1|ZEN|0|1|0|100|SEK|356665|450103|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||356665||356665|450103||1|0|L|0|||0 194245|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3816|3582|lyfalmen|V0143|3582|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1514||1514|3582||2|0|E|0|||0 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|2580|2347|lyfalmen|V0556|2186|2|4|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||617||617|2347||1|0|E|0|||0 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5630|10852|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5630||5630|10852||2|0||0|||0 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5841|5851|lyfalmen|V0012|5851|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||3163||3163|5851||1|0|G|0|||0 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|2955|5565|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||2955||2955|5565||2|0|G|0|||0 195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0 195449|A02BC0403|Rabeprazol Krka|sh-tfl|10|mg|14|stk|1|þpakki||A02BC04|01.01.2019||L|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0||LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0||0|||0 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|BAM|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13320||2|0||0|||0 195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|28570|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28570||2|0|G|0|||0 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|56066|74186|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||56066||56066|74186||2|0|L|0|||0 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|1|0|1|JAN|0|1|0|100|DKK|156634|201320|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||156634||156634|201320||1|0|L|0|||0 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|845|2661|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||845||845|2661||1|0|G|0|||0 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|JAS|0|0|1|100|SEK|677|2430|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||677||677|2430||1|0|E|0|||0 195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|G|0|WEH|0|0|0|100|IKR|3842|3893|lyfalmen|V0205|3838|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1740||1740|3893||2|0|G|0|||0 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|3299|5445|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2868||2868|5445||2|0|G|0|||0 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2485|4918|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||2485||2485|4918||2|0|G|0|||0 196518|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.04.2019||R|0|0|0|0|1|NEL|0|0|0|100|DKK|57691|76241|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Ltd|Tópótecan||57691||57691|76241||1|H|0|0|||0 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||2141||1|0|E|0|||0 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|G|0|AEP|0|0|0|100|DKK|6361|10253|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||6361||6361|10253||2|0|G|0|||0 196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|G|0|OEL|0|0|1|100|DKK|636|2373|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||636||636|2373||1|0|G|0|||0 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|21548|30528|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||21548|30528||1|0|S|0|||0 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|800|2599|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||800||800|2599||2|0|G|0|||0 197320|L04AB0204|Inflectra|st/irþ|100|mg|100|mg|1|hgl||L04AB02|01.06.2020||R|0|0|0|0|1|PEU|0|1|0|100|DKK|43641|58471|lyfsjukr|||2|100|0|26,6700|Icepharma hf|Pfizer Europe MA EEIG|Infliximab||43641||43641|58471||1|H|L|0|||0 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2947|5554|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||2947||2947|5554||2|0||0|||0 197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|263694|334473|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||263694||263694|334473||1|0|E|0|||0 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|2872|3425|lyfalmen|V0116|3063|2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1400||1400|3425||2|0||0|||0 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3429|2806|lyfalmen|V0069|2806|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||950||950|2806||2|0|G|0|||0 198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|4140|7196|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4140||4140|7196||1|0|G|0|||0 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|G|0|PLS|0|0|0|100|DKK|37064|50152|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||37064||37064|50152||1|0|G|0|||0 199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|8598|13332|lyfalmen|V0805|9749|1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||8598|13332||2|0|G|0|||0 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|PLS|0|0|1|100|DKK|648|2390|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||648||648|2390||1|0||2|30|töflur|0 199637|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1022|2299|0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0||0|||0 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|77194|100909|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||77194|100909||1|0|S|0|||0 199903|A10BK0401|Steglatro|filmhtfl|15|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|6110|9908|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Ertugliflozin||6110||6110|9908||1|0|G|0|||0 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|1|BMS|0|1|0|100|DKK|2332202|2907118|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2332202||2332202|2907118||1|H|L|0|||0 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|40154|76351|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||40154||40154|76351||1|0||0|||0 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1912|4130|lyfalmen|||2|20|0|7,5000|Alvogen|ratiopharm GmbH|Amoxicillín||1912||1912|4130||2|0|E|0|||0 370901|L01XE0302|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|1|1|0|1|ALO|0|1|0|100|XEU|262614|309198|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||243372||243372|309198||2|0|L|0|||0 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||10705||1|0|E|0|||0 371826|L01XE3601|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01XE36|01.06.2017||R|0|0|1|0|1|RRG|0|1|0|100|DKK|795865|996344|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib hydrochloride||795865||795865|996344||2|0|L|0|||0 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|3813|6746|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3813||3813|6746||1|0|G|0|||0 372074|L01XX3502|Anagrelide AOP|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.05.2020||R|0|0|1|0|1|AOP|0|0|0|100|XEU|33357|45464|lyfsjukr|||1|100|0||AOP Orphan Pharmaceuticals AG|AOP Orphan Pharmaceuticals AG|Anagrelidum||||33357|45464||2|0|0|0|||0 372121|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.11.2018||R|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0||0|||0 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|3356|6117|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||3356||3356|6117||2|0|G|0|||0 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|1|WIL|0|1|0|100|XEU|7309|11558|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||7309||7309|11558||2|H|L|0|||0 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 372531|N06BA0408|Methylphenidate Teva|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|8559|7873|lyfalmen|V0996|7873|2|30|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||4632||4632|7873||1|0|E|1|30|dagar|0 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2978||2|0|G|0|||0 373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3105|5627|lyfalmen|V0934|5627|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3000||3000|5627||2|0||0|||0 373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|1|CUR|0|0|0|100|XEU|85063|110861|lyfsjukr|||1|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||85063|110861||3|H|S|0|||0 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2770|5311|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5311||2|0|G|0|||0 373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5599|8087|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4787||4787|8087||2|0|G|0|||0 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|13000|19391|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||13000||13000|19391||1|0|G|0|||0 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|87927|114484|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||87927||87927|114484||2|0|S|0|||0 373324|R03AK0601|Seretide|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3912|6882|lyfalmen|V0436|5510|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3912||3912|6882||1|0|G|0|||0 373340|R03AK0601|Seretide|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4778|8074|lyfalmen|V0437|6431|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4778||4778|8074||1|0|G|0|||0 373365|R03AK0601|Seretide|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|6052|9828|lyfalmen|V0981|7458|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||6052||6052|9828||1|0|G|0|||0 373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|MBV|0|0|0|100|DKK|4343|7476|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||4343||4343|7476||1|0||0|||0 373887|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|1|ILT|0|0|0|100|XEU|428031|538862|lyfsjukr|||1|30|0|15,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||428031||428031|538862||2|0|S|0|||0 374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|1|EUS|0|0|0|100|XEU|8679|13444|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||8679||8679|13444||3|H|ES|0|||0 374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|1|0|1|GEB|0|0|0|100|XEU|371373|457890|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||362926||362926|457890||1|0|S|0|||0 374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|1|0|1|NEL|0|1|0|100|DKK|244267|310311|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||244267||244267|310311||1|0|L|0|||0 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|G|0|MCK|0|0|0|100|SEK|492|2175|lyfalmen|V0500|2082|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||492||492|2175||2|0|G|0|||0 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|5635|9254|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5635||5635|9254||1|0|S|0|||0 374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|3923|6898|lyfalmen|V0926|3940|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3923||3923|6898||1|0|G|0|||0 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|G|0|GPH|0|0|1|100|DKK|11095|16769|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||11095||11095|16769||1|0|G|0|||0 374450|L01XE3301|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|1|0|1|PEU|0|1|0|100|DKK|364073|459316|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||364073||364073|459316||1|0|L|0|||0 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|1 hgl og1 áf spr+ 2 aðsk nálar|J07CA06|01.04.2020||R|0|0|0|0|0|SSS|0|0|0|100|XEU|5541|9125|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5541||5541|9125||1|0||0|||0 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|8354|12996|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8354||8354|12996||1|0|G|0|||0 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|11071|16736|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11071||11071|16736||1|0|G|0|||0 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|13141|19585|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13141||13141|19585||1|0|G|0|||0 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|6679|10691|lyfalmen|V0383|10691|2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||6679||6679|10691||1|0|G|0|||0 374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|3774|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||1920||1920|3774||2|0|0|0|||0 375005|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|3356384|4180909|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||3356381||3356381|4180909||2|H|S|0|||0 375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3448|5352|lyfalmen|V0580|5159|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5352||2|0|G|0|||0 375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|1|ACC|0|0|1|100|XEU|11673|17565|lyfsjukr|||2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||11673|17565||1|0|ES|0|||0 375304|N06DX0109|Marbodin|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4000|2737|lyfalmen|||2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737|31.10.2020|2|0|G|0|||0 375508|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|1|glas||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2662|5162|lyfalmen|||1|3|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2662||2662|5162|31.10.2020|2|0|G|0|||0 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|32516|44400|lyfalmen|V0459|43035|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||32516||32516|44400||1|0|G|0|||0 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|5967|9711|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||5967||5967|9711||1|0|G|0|||0 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|17363|25396|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||17363||17363|25396||1|0|G|0|||0 376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|90913|118260|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||90913||90913|118260||1|0|G|0|||0 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|BRO|1|0|0|100|XEU|13034|22465|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||13034||13034|22465||2|0||0|||0 377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|220460|280702|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||220460||220460|280702||1|0|E|0|||0 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|G|0|GPH|0|0|1|100|DKK|9394|8229|lyfalmen|V0182|4394|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4890||4890|8229||1|0|G|0|||0 377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018||R|1|0|0|G|0|TVA|0|0|0|100|DKK|2355|3144|lyfalmen|V0909|3144|2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||1196||1196|3144||2|0|G|0|||0 377577|G03DA0408|Cyclogest|sk-stíll|400|mg|15|stk|1|pakki||G03DA04|01.05.2020||R|0|0|1|G|0|GRI|0|0|0|100|IKR|4291|7404|lyfalmen|||1|15|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Prógesterón||4291||4291|7404|31.10.2020|3|0|G|0|||0 377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|1|SDG|0|1|0|100|DKK|28456|35666|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||25611||25611|35666||1|0|L|0|||0 378432|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|1|0|1|GSE|0|0|0|100|DKK|583627|732380|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||583627||583627|732380||2|0|S|0|||0 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1399|3424|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1399||1399|3424||1|0|G|0|||0 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|ALM|0|0|0|100|XEU|16753|24557|lyfalmen|V1009|24557|1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||16753||16753|24557||1|0|E|0|||0 378801|A10BH0102|Januvia (Lyfjaver)|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.06.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|16052|23592|lyfalmen|V0982|23592|3|98|0|49,0000|Lyfjaver ehf|Lyfjaver ehf|Sítagliptín||16052||16052|23592||3|0|G|0|||0 378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|1806|3984|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1806||1806|3984||1|0|G|0|||0 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1424|3458|lyfalmen|V0677|2753|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1424||1424|3458||1|0|G|0|||0 379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5289|7004|lyfalmen|V0830|7004|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|7004||2|0|G|0|||0 379351|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9358|14378|lyfalmen|V0587|14378|2|100|0|53,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||9358||9358|14378||1|0|G|1|30|dagar|0 379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|195456|249604|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||195456|249604||3|0|L|0|||0 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|127316|164857|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||127316||127316|164857||1|0|L|0|||0 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|1|HES|0|0|0|100|DKK|119850|123948|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||95410||95410|123948||1|0|S|0|||0 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|1|HES|0|0|0|100|DKK|131184|137037|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||104948||104948|137037||1|0|S|0|||0 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|1|HES|0|0|0|100|DKK|167371|173042|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||133897||133897|173042||1|0|S|0|||0 379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|G|0|POF|0|0|0|100|XEU|5971|7345|lyfalmen|V0532|7345|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||4248||4248|7345||2|0|G|0|||0 379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2367|4756|lyfalmen|||2|12,5|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2367||2367|4756||1|0||2|50|túpur|0 379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|3137|5816|lyfalmen|||2|12,5|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||3137||3137|5816||1|0||2|25|túpur|0 379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2386|3302|lyfalmen|V0322|2916|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||1311||1311|3302||1|0|G|0|||0 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2|0||2|||0 380308|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3563|lyfalmen|V0687|2766|2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|30208|41481|lyfalmen|V0653|41481|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||30208|41481||1|0|G|0|||0 380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|615|2344|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||615||615|2344||1|0|G|0|||0 380658|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|9082|10985|lyfalmen|V1010|10985|2|90|0|90,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||6893||6893|10985||2|0|G|0|||0 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|10426|10169|lyfalmen|V0195|10169|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0 380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|591|2311|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||591||591|2311||1|0|G|0|||0 381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3246|5595|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3246||3246|5595||2|0||0|||0 381510|A10BK0101|Forxiga|filmhtfl|5|mg|98|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|23066|32447|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||23066||23066|32447||1|0|G|0|||0 381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|323533|408896|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||323533||323533|408896||1|0||0|||0 382318|S01XA2103|Cystadrops|augndr|3,8|mg/ml|5|ml|1|glas||S01XA21|01.01.2019||R|0|0|1|0|0|OHA|0|0|0|100|XEU|174943|224091|lyfalmen|||1|5|0||Orphan Europe Nordic AB|Orphan Europe SARL|mercaptamine ||174943||174943|224091||3|0||0|||0 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 382474|V03AN0502|Airapy|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|146592|188831|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||146592|188831||3|0|L|0|||0 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|5167|8610|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||5167||5167|8610||1|0|G|0|||0 383037|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfspr||N02CD03|01.11.2019||R|0|0|1|0|0|TGH|0|0|0|100|XEU|76726|100317|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||76726||76726|100317||1|0|E|0|||0 383105|J06BA0104|Cutaquig|stl|165|mg/ml|6|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|1|OCT|0|1|0|100|DKK|12502|18706|lyfsjukr|||1|6|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||12502||12502|18706||1|0|L|0|||0 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|BAN|0|0|0|100|DKK|1317|2237|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||1298||1298|2237||2|0||0|||0 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|120|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0 383672|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.02.2019||R|1|0|0|G|0|NAA|0|0|0|100|DKK|1753|3911|lyfalmen|V0314|3227|1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1753||1753|3911||1|0|G|0|||0 383719|L01BA0402|Pemetrexed W&H|irþ|25|mg/hgl|20|ml|1|hgl||L01BA04|01.05.2020||R|0|0|0|0|1|WEH|0|1|0|100|XEU|169554|217389|lyfsjukr|||2|20|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||169554||169554|217389||2|H|L|0|||0 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|G|0|RTH|0|0|1|100|IKR|3250|2117|lyfalmen|V0006|1224|2|56|0|56,0000|Alvogen|ratiopharm GmbH|Ómeprazól||450||450|2117||2|0|G|0|||0 384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|7337|11597|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||7337||7337|11597||1|0|G|0|||0 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|15|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín|||||||1|0||0|||0 384837|N07BC0102|Buvidal|stl|32|mg|0,64|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14465|21408|lyfsjukr|||1|0,64|0|4,0000|Vistor hf|Camurus AB|Búprenorfín||14465||14465|21408||1|H|L|1|30|dagar|0 384858|L01XE0105|Imatinib ratiopharm|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|1|0|1|RTH|0|1|0|100|XEU|173372|113593|lyfsjukr|||2|30|0||Alvogen|ratiopharm GmbH|Imatiníb||87223||87223|113593||2|0|L|0|||0 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|7773|12197|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7773||7773|12197||1|0||0|||0 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|1|RRD|0|0|0|100|DKK|382976|482826|lyfsjukr|||1|1|0|50,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||382976||382976|482826||1|0|ES|0|||0 386950|L04AB0404|IDACIO|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.08.2020||R|0|1|1|0|1|FKA|0|0|0|100|DKK|37185|50305|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||37185||37185|50305||1|0|0|0|||0 386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|13329|6701|lyfalmen|V0111|6040|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||3780||3780|6701||2|0|E|0|||0 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7970|12468|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||7970||7970|12468||1|0|G|0|||0 387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|1|WEH|0|1|0|100|XEU|152385|196036|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||152385||152385|196036||2|H|L|0|||0 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|950|2806|lyfalmen|V0308|2806|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||950||950|2806||2|0||2|60|mg|0 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5903|11370|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5903||5903|11370||2|0||0|||0 387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10732|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10732||2|H|S|0|||0 388032|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|30|stk|1|þpakki||A02BC05|01.09.2019||L|1|0|0|0|0|JUB|0|0|0|100|IKR|||lyflausa|||2|30|0||Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól|||||||2|0||0|||0 388180|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.2020||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|0|1|PEU|0|0|0|100|DKK|135499|175034|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Temsirolímus||135499||135499|175034||1|H|S|0|||0 388256|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2686|5195|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2686||2686|5195||2|0||0|||0 388264|N01BB2001|Emla|krem|50|mg/g|30|g|1|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3899|6865|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||3899||3899|6865||2|0||0|||0 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2|0||0|||0 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.01.2017|31.08.2020|R|0|0|0|0|1|GPA|0|0|0|100|XEU|11367|17143|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||11367||11367|17143||1|H|S|||| 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.04.1994||R|0|0|0|0|0|MAR|0|0|1|100|DKK|5767|9436|lyfalmen|V1024|9436|1|20|0||Icepharma hf|Aspen Pharma|Blöndur||5767||5767|9436||2|0||0|||0 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|69165|34144|lyfalmen|V0722|34144|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||24407||24407|34144||2|0||0|||0 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|9356|14376|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||9356||9356|14376||2|0|G|0|||0 389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|0|1|WEH|0|0|0|100|XEU|7009|11145|lyfsjukr|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||7009||7009|11145||2|H|S|0|||0 389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|336807|425405|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||336807|425405||2|0|L|0|||0 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|803|2603|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||803||803|2603||1|0|G|0|||0 389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|11830|17781|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||11830||11830|17781||2|0|G|0|||0 389424|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7500|11821|lyfalmen|||2|100|0|300,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||7500||7500|11821||2|0|0|0|||0 389453|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|14|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|450|2117|lyfalmen|||2|14|0|5,6000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||450||450|2117||2|0|E|0|||0 389603|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.11.2020||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|43362|58118|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||43362|58118||2|0|G|0|||0 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|16324|23966|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||16324||16324|23966||1|0|G|0|||0 390439|R01AD0905|Mometason Apofri|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.10.2018||L|0|0|0|G|0|APO|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|LYFIS ehf|Apofri AB|Mómetasón|||||2753||2|0|G|0|||0 390541|R03DX0801|Cinqaero|irþ|10|mg/ml|10|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|1|TVB|0|1|0|100|NOK|68806|90299|lyfsjukr|||1|10|0|14,0845|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||68806||68806|90299||1|H|L|0|||0 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|1|COR|0|0|0|100|DKK|80573|105182|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||80573||80573|105182||1|H|S|0|||0 390835|A04AA0101|Zofran|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.07.2019||R|1|0|0|G|0|NAA|0|0|1|100|DKK|3520|6343|lyfalmen|V0381|5093|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3520||3520|6343||1|0|G|0|||0 390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18190|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18190||2|0|E|1|30|dagar|0 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|6058|9836|lyfalmen|V0429|4354|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6058||6058|9836||1|0|G|0|||0 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2842|5410|lyfalmen|V0037|3312|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2842||2842|5410||1|0|G|0|||0 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|10395|15806|lyfalmen|V0196|6431|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||10395||10395|15806||1|0|G|0|||0 391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|1|0|1|NEL|0|1|0|100|DKK|283340|358907|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||283340||283340|358907||1|0|L|0|||0 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1002|1962|lyfalm11|V0545|1924|2|63|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||504||504|1962||1|0||0|||0 392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|1|0|1|ASR|0|0|0|100|IKR|45000|31099|lyfsjukr|||2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||22000||22000|31099||2|0|ES|0|||0 392196|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.07.2019||R|0|0|0|G|0|BAB|0|0|0|100|DKK|1048|2940|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||1048||1048|2940||2|0|G|0|||0 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|1|0|0|SAO|0|0|0|100|XEU|13613|20235|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||13613||13613|20235||2|0|E|0|||0 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9653|11049|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||6939||6939|11049||1|0|G|0|||0 392438|L04AX0701|Tecfidera|hylki|120|mg|14|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|1|BNB|0|1|0|100|XEU|24799|34639|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||24799||24799|34639||2|0|L|0|||0 393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016|31.10.2020|R|1|0|0|G|0|LYF|0|0|0|100|IKR|2250|2874|lyfalmen|||2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||1000||1000|2874||2|0|G|0|||0 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3474||1|0||0|||0 393939|S01EE0404|Travoprost Alvogen|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|DKK|2347|4150|lyfalmen|V0669|4150|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1927||1927|4150||2|0|G|0|||0 394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|2138|3765|lyfalmen|V0123|3765|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1647||1647|3765||2|0|E|0|||0 394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|54048|71634|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||54048||54048|71634||2|0|ES|0|||0 394768|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|5369|8076|lyfalmen|V0681|7963|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4779||4779|8076||1|0|E|1|30|dagar|0 395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|87506|113951|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||87506||87506|113951||1|0||0|||0 395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|NAS|0|0|0|100|DKK|36780|49793|lyfalmen|||1|15|0|60,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||36780||36780|49793||1|0||0|||0 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|1|RAG|0|0|0|100|DKK|147807|190342|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||147807||147807|190342||1|0|S|0|||0 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|6576|10549|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6576||6576|10549||1|0||0|||0 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|18333|26731|lyfalmen|V0356|26731|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||18333||18333|26731||3|0|G|0|||0 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|5090|8504|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||5090||5090|8504||1|0|G|0|||0 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||5573||1|0|G|0|||0 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|RPG|1|0|0|100|DKK|21902|41723|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||21902||21902|41723||2|0||0|||0 396463|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|dreifa,dreifa|J07CA06|01.04.2019||R|0|0|0|0|0|SSS|0|0|0|100|XEU|55406|73351|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||55406||55406|73351||1|0|0|0|||0 396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2300|2048|lyfalmen|V0006|1224|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2048||2|0|G|0|||0 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|5785|11146|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5785||5785|11146||1|0||0|||0 396873|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|50|stk|1|þpakki||J01CF01|01.07.2019||R|0|0|0|0|0|BFP|0|0|1|100|XEU|3441|6234|lyfalmen|||2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||3441||3441|6234||1|0|0|0|||0 397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4186|3838|lyfalmen|V0686|3631|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|G|0|SHS|0|0|0|100|DKK|2372|2925|lyfalmen|V0250|2723|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||1037||1037|2925||1|0|G|0|||0 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|1|MRP|0|1|0|100|SEK|33192|45255|lyfsjukr|||1|20|0||Icepharma hf|Merck Europe B.V.|Cetúxímab||33192||33192|45255||2|H|L|0|||0 397659|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|10|lykjur|innr.lyf, fleyti|N01AX10|01.05.2020||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3542|6373|lyfsjukr|||2|200|0||Vistor hf|Fresenius Kabi AB|Própófól||3542||3542|6373||1|H|S|0|||0 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5828||1|0|E|0|||0 397933|L04AA0607|Mycofenolsýra Accord|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|32331|44166|lyfalmen|V1008|44166|2|120|0|21,6000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||32331||32331|44166||1|0|G|0|||0 398181|N05CD0804|Midazolam Accord|stl/irl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|1|AEE|0|0|0|100|XEU|1510|3576|lyfsjukr|||2|50|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1510||1510|3576||1|H|S|2|450|mg|0 398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|673|2424|lyfalmen|||2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||673||673|2424||2|0|G|0|||0 398659|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.08.2019||R|0|0|0|0|1|ATE|0|0|0|100|XEU|22763|32064|lyfsjukr|||2|2|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúdarabín||22763||22763|32064||1|H|S|0|||0 399034|C09CA0307|Valsartan Jubilant|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|3500|4113|lyfalmen|V0679|3904|2|98|0|196,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||1900||1900|4113||2|0|G|0|||0 399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|1|0|1|GSD|0|1|0|100|DKK|181041|231676|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||181041||181041|231676||1|0|L|0|||0 399210|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.07.2019||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|0|1|OCT|0|0|0|100|DKK|82606|107754|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||82606||82606|107754||1|H|S|0|||0 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|0|100|DKK|514|2205|lyfalmen|||1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||514||514|2205||1|0|G|1|30|dagar|0 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|G|0|GPH|0|0|0|100|DKK|2777|3169|lyfalmen|V0244|3169|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1214||1214|3169||1|0|G|0|||0 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/sprautu|B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|9279|14270|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9279||9279|14270||1|0|G|0|||0 399825|L01XE3301|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|1|0|1|PEU|0|1|0|100|DKK|364073|459316|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||364073||364073|459316||1|0|L|0|||0 399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|2326|2902|lyfalmen|V0824|2876|2|28|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1020||1020|2902||2|0|G|0|||0 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1264|3238|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1264||1264|3238||1|0|G|0|||0 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis Group PTC ehf|Blöndur||||||||0|0|0|||0 400134|J05AR2201|Symtuza|filmhtfl|||30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|1|0|1|JCI|0|0|0|100|SEK|127306|164844|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||127306||127306|164844||1|0|S|0|||0 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|PLS|0|0|0|100|DKK|2676|5181|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2676||2676|5181||1|0|E|0|||0 400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|G|0|VIF|0|0|1|100|CHF|62221|81971|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||62221||62221|81971||1|0|G|0|||0 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|511|2201|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||511||511|2201||1|0||2|50|töflur|0 400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|565|2276|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||565||565|2276||1|0|G|0|||0 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1622|3730|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||1622||1622|3730||1|0||2|100|töflur|0 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|453|2121|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||453||453|2121||1|0||2|100|töflur|0 400508|N02AE0104|Buprenorphine ratiopharm|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1060|2957|lyfalmen|V0943|2957|2|4|0|2,8000|Alvogen|ratiopharm GmbH|Búprenorfín||1060||1060|2957||2|0|G|1|30|dagar|0 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|5544|9129|lyfalmen|V0612|5493|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||5544||5544|9129||1|0|E|0|||0 400574|L04AX0701|Tecfidera|hylki|240|mg|56|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|1|BNB|0|1|0|100|XEU|158323|203421|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||158323||158323|203421||2|0|L|0|||0 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2398|4573|lyfalmen|V0037|3312|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2234||2234|4573||2|0|G|0|||0 401139|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.04.2020||R|1|1|0|0|1|PEU|0|0|1|100|DKK|22290|31466|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||22290||22290|31466||1|0|ES|0|||0 401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|856|2676|lyfalmen|V0173|2676|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||856||856|2676||2|0|E|0|||0 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|9334|14345|lyfalmen|V0459|14345|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||9334||9334|14345||1|0|G|0|||0 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|848|2665|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||848||848|2665||1|0|G|0|||0 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1244|3210|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1244||1244|3210||1|0|G|0|||0 402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|0|WEH|0|0|0|100|IKR|1032|2918|lyfalmen|||2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1032||1032|2918||2|0|G|0|||0 402141|J05AE1003|Darunavir Medical Valley|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|1|VAL|0|0|0|100|XEU|36716|49712|lyfsjukr|||2|30|0|20,0000|Acare ehf|Medical Valley Invest AB|Darunavír||36716||36716|49712||2|0|S|0|||0 402203|D07AC1302|Ovixan|húðlausn|1|mg/g|100|ml|1|glas||D07AC13|01.08.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1366|3378|lyfalmen|V0952|3378|2|100|0||Vistor hf|Galenica AB|Mómetasón||1366||1366|3378||1|0|G|0|||0 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|1|0|1|SPD|0|0|0|100|DKK|792896|992652|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||792896||792896|992652||1|0|ES|0|||0 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|BID|0|0|0|100|DKK|2044|4017|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Penicillín í blöndum með öðrum sýklalyfjum||2044||2044|4017||1|0||0|||0 402801|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfspr||L04AC16|01.01.2019||R|0|0|1|0|1|JCI|0|1|0|100|SEK|358782|452736|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||358782||358782|452736||1|0|L|0|||0 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|8824|13361|lyfalmen|V0349|13361|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8619||8619|13361||3|0|G|0|||0 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|5320|3086|lyfalmen|V0552|2737|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||1154||1154|3086||1|0|E|0|||0 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|IBV|1|0|0|100|DKK|6730|12939|vetalmen|||0|20|0||Vistor hf|Intervet International BV|Cloprostenolum||6730||6730|12939||1|0||0|||0 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||S01GX01|01.09.2018||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1088|2995|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||||1088|2995||1|0|G|0|||0 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|G|0|AEP|0|0|0|100|DKK|19067|27742|lyfalmen|||1|6|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||19067||19067|27742||2|0|G|0|||0 404136|J01XD0102|Flagyl|irl|5|mg/ml|100|ml|40|pokar||J01XD01|01.04.2020||R|0|0|0|0|1|SNP|0|0|1|100|XEU|22290|31466|lyfsjukr|||1|4000|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||22290||22290|31466||1|0|ES|0|||0 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2818||2|0|G|0|||0 404491|B01AD0201|Actilyse|sts/irs|20|mg|1|hgl|1|pakki||B01AD02|01.12.2019||R|0|0|0|0|1|BOI|0|0|0|100|DKK|40602|54627|lyfsjukr|||1|1|0|0,2000|Vistor hf|Boehringer Ingelheim|Alteplasi||40602||40602|54627||1|H|0|0|||0 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.03.2020||R|0|0|0|0|1|BOI|0|0|0|100|DKK|67896|89148|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||67896||67896|89148||1|H|S|0|||0 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|G|0|MEV|0|0|0|100|DKK|1056|2951|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1056||1056|2951||1|0|G|0|||0 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|DKK|3253|5607|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3253||3253|5607||2|0||0|||0 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2668||1|0||0|||0 405200|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|1|ILT|0|0|0|100|XEU|428031|538862|lyfsjukr|||1|30|0|30,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||428031||428031|538862||2|0|S|0|||0 405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|G|0|KRK|0|0|1|100|IKR|2436|4851|lyfalmen|V0467|4851|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2436||2436|4851||2|0|G|0|||0 405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|1|BAB|0|0|0|100|DKK|34002|46279|lyfsjukr|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||34002|46279||2|H|S|0|||0 405677|J01DD0401|Rocephalin|irs|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|1|ROA|0|0|1|100|DKK|3753|6664|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche A.S.|Ceftríaxón||3753||3753|6664||2|0|ES|0|||0 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|18874|27476|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18874||18874|27476||1|0||0|||0 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|459|2130|lyfalmen|V0502|2130|2|60|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||459||459|2130||1|0|G|0|||0 406106|C10AX1401|Praluent|stl|150|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|197388|252007|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||197388||197388|252007||1|0|E|0|||0 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|18899|27511|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18899||18899|27511||1|0|E|0|||0 406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|1|0|1|AZA|0|1|0|100|SEK|759019|950518|lyfsjukr|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||759019||759019|950518||1|0|L|0|||0 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|57016|75387|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||57016||57016|75387||1|0|E|0|||0 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|66377|87227|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||66377||66377|87227||1|0|E|0|||0 407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cyanocobalamin|||||4750||1|0|G|0|||0 407101|N02AA0507|OxyContin Depot|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|8222|12815|lyfalmen|V0585|8258|1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||8222||8222|12815||2|0|G|1|30|dagar|0 407393|L04AA3701|OLUMIANT|filmhtfl|2|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|1|NED|0|1|0|100|XEU|128746|166635|lyfsjukr|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||128746||128746|166635||2|0|L|0|||0 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|19005|36227|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Penetamathýdrójoðíð||||19005|36227||2|0||0|||0 407586|N06BA0905|Atomoxetin STADA|hylki|80|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|7000|4526|lyfalmen|V0817|4526|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||2200||2200|4526||2|0|E|0|||0 407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2919|5031|vetorma|||0|2,7|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2919||2919|5031||1|0||0|||0 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|378|2018|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||378||378|2018||1|0||2|150|töflur|0 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|679|2432|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||679||679|2432||1|0||2|150|töflur|0 408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|32178|43972|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||32178||32178|43972||1|0|G|0|||0 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|17500|25585|lyfalmen|V0974|21476|1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||17500||17500|25585||2|0|G|0|||0 408166|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|14990|19566|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||13127||13127|19566||1|0|G|0|||0 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|2008|2855|lyfalmen|V0310|2855|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||986||986|2855||2|0||2|60|mg|0 408561|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0 408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|GAN|0|0|0|100|XEU|4749|8034|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4749||4749|8034||2|0||0|||0 408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0813|3903|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 408927|N03AX1408|Levetiracetam STADA|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2688|4251|lyfalmen|V0515|4251|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||2000||2000|4251||2|0|G|0|||0 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3372|5812|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3372||3372|5812||2|0||0|||0 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3960|6948|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3960||3960|6948||1|0|E|0|||0 409115|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.04.2020||R|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0||0|||0 409210|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|30|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|11522|17357|lyfalmen|||2|30|0|16,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||11522||11522|17357||2|0|E|1|30|dagar|0 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|8714|13492|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||8714||8714|13492||1|0|E|0|||0 409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|65529|86155|lyfalmen|V0728|86155|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65529||65529|86155||1|0|E|0|||0 409594|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|105|stk|1|glas||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|1330|3329|lyfalmen|V0414|3235|2|105|0|52,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||1330||1330|3329||2|0|G|0|||0 409673|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|2|mg|28|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|2915|5510|lyfalmen|||3|28|0|9,3333|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||2915||2915|5510||3|0|G|0|||0 409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|1|0|G|0|GRP|0|0|0|100|XEU|16288|23917|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||16288||16288|23917||1|0|G|0|||0 409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|60484|79774|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||60484||60484|79774||1|0|E|0|||0 409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.12.2019||R|1|0|0|G|0|TOG|0|0|0|100|SEK|2149|4456|lyfalmen|||1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||2149||2149|4456|31.10.2020|1|0|G|0|||0 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|7066|11224|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7066||7066|11224||1|0|E|0|||0 409850|J07BA0104|TicoVac Junior|stl|1,2|mcg/sk|0,25|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3533|6361|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3533||3533|6361||1|0||0|||0 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|16483|24185|lyfalmen|V0651|24182|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16483||16483|24185||1|0|G|0|||0 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|3990|6990|lyfalmen|V0196|6431|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3990||3990|6990||2|0|G|0|||0 410223|L01XE2701|IMBRUVICA|filmhtfl|280|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|499523|627778|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||499523||499523|627778||1|0|L|0|||0 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|3810|6017|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||3283||3283|6017||1|0|G|0|||0 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|G|0|MYL|0|0|1|100|SEK|710|2475|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||710||710|2475||2|0|G|0|||0 411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|893|2727|lyfalmen|||2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||893||893|2727||2|0|G|0|||0 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|G|0|MEV|0|0|0|100|DKK|2131|4431|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||2131||2131|4431||1|0|G|0|||0 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|RTH|0|0|1|100|XEU|449|2082|lyfalmen|V0230|2080|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||424||424|2082||2|0|E|0|||0 411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|ASD|0|0|0|100|SEK|1629|2698|lyfalmen|V0692|2334|2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||872||872|2698||2|0|E|0|||0 411409|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|12008|18026|lyfalmen|V0689|3445|3|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||12008||12008|18026||3|0|E|0|||0 411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|G|0|WEH|0|0|0|100|IKR|8924|13781|lyfalmen|V0829|13781|2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13781||2|0|G|0|||0 411723|N06BA0703|Aspendos|töflur|100|mg|90|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|12650|16638|lyfalmen|||2|90|0|30,0000|LYFIS ehf|Medochemie Limited|Modafinil||11000||11000|16638||2|0|E|2|||0 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|1|0|1|VIC|0|0|0|100|DKK|24472|34226|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín||24472||24472|34226||1|0|S|0|||0 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól|||||2292||1|0|E|0|||0 411913|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2695|2874|lyfalmen|V0994|2461|2|2,5|0|25,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||1000||1000|2874||2|0|G|0|||0 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|1|SNP|0|0|0|100|XEU|3170|5861|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3170||3170|5861||1|H|S|0|||0 412395|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|CES|1|0|0|100|DKK|4563|8827|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4563||4563|8827||2|0||0|||0 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5067|9784|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5067||5067|9784||2|0||0|||0 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|1|0|1|BNB|0|0|0|100|XEU|92696|120516|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||92696||92696|120516||2|0|S|0|||0 412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|G|0|TEE|0|0|0|100|NOK|47174|62939|lyfalmen|V0711|12509|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||47174||47174|62939||1|0|G|0|||0 412566|N03AX1213|Gabapentin Teva|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2019||R|1|0|0|G|0|TVA|0|0|0|100|DKK|8044|12570|lyfalmen|V0254|12570|2|100|0|33,3300|Alvogen|Teva B.V.|Gabapentín||8044||8044|12570||2|0|G|0|||0 412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|48068|64070|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||48068||48068|64070||1|0|E|0|||0 412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5864|7004|lyfalmen|V0581|6597|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4000||4000|7004||2|0|G|0|||0 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|3411|6193|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3411||3411|6193||2|0|G|0|||0 413053|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|4379|7525|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4379||4379|7525||2|0|G|1|30|dagar|0 413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|1|OVE|0|0|1|100|DKK|34627|47070|lyfsjukr|||1|50|0||Pharmanovia A/S|Provepharm S.A.S.|Metýltíónín||34627||34627|47070||2|H|S|0|||0 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0 414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1271|3247|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1271||1271|3247||2|0|G|0|||0 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|1|0|1|TGM|0|0|0|100|NOK|91750|119319|lyfsjukr|||1|12|0|24,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||91750||91750|119319||1|0|ES|0|||0 414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|1|WIL|0|0|0|100|XEU|42813|57423|lyfsjukr|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||42813||42813|57423||2|H|S|0|||0 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1343|3346|lyfalmen|||1|90|0|54,0000|Icepharma hf|Les Laboratoires Servier|Indapamíð||1343||1343|3346||2|0|G|0|||0 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|G|0|HES|0|0|0|100|DKK|1268|3243|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1268||1268|3243||1|0|G|0|||0 414921|L04AA4201|Mayzent|filmhtfl|2|mg|28|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|1|NEP|0|0|0|100|DKK|245402|311723|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Limited|Siponimod||245402||245402|311723||1|0|0|0|||0 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|202600|258489|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||202600||202600|258489||1|0|L|0|||0 415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|162007|208003|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||162007||162007|208003||1|0|G|0|||0 415724|G04CA5202|Dutaprostam|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.10.2019||R|0|0|0|G|0|ALO|0|0|0|100|DKK|3265|4837|lyfalmen|V1010|3662|2|30|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Dútasteríð og tamsúlósínhýdroklóríð||2426||2426|4837||2|0|G|0|||0 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|G|0|PSA|0|0|0|100|XEU|5912|8463|lyfalmen|V0253|4190|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||5060||5060|8463||2|0|G|0|||0 416330|A10BD2401|Steglujan|filmhtfl|115|mg|98|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|38244|51426|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||38071||38071|51426||1|0|G|0|||0 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|G|0|MSD|0|0|0|100|DKK|9511|10359|lyfalmen|V0088|3108|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||6438||6438|10359||1|0|G|0|||0 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013|31.08.2020|R|0|0|0|G|0|GPH|0|0|1|100|DKK|4166|7232|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||4166||4166|7232||1|0|G|||| 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|G|0|GOG|0|0|1|100|XEU|2970|5586|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2970||2970|5586||2|0|G|0|||0 417633|A10BJ0601|Ozempic|stl|0,5|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|20200|28823|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||20200||20200|28823||1|0||0|||0 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|1|0|1|VIC|0|0|0|100|DKK|40056|53936|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Abacavír||40056||40056|53936||1|0|S|0|||0 417880|B02BD0401|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD04|01.07.2012||R|0|0|1|0|1|PEU|0|1|0|100|DKK|102173|133586|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||102173||102173|133586||1|0|L|0|||0 417898|C01CA1703|Hypotron|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|RET|0|0|0|100|IKR|17695|25853|lyfalmen|V0969|25853|2|100|0|16,6666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||17695||17695|25853||2|0||0|||0 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|29176|40175|lyfalmen|V0460|40175|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||29176|40175||1|0|G|0|||0 418642|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.02.2019||R|0|1|1|0|1|BIO|0|0|0|100|DKK|30572|41386|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||30133||30133|41386||3|0|S|0|||0 418667|L01XC0203|Truxima|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|1|CTH|0|1|0|100|DKK|76296|99773|lyfsjukr|||2|20|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||76296||76296|99773||1|H|L|0|||0 418714|C10BA0202|Ezetimib/Simvastatin Krka|töflur|50|mg|100|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|18000|24897|lyfalmen|V0615|24897|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||17000||17000|24897||2|0||0|||0 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|LEP|0|0|0|100|DKK|2571|5037|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2571||2571|5037||1|0|G|0|||0 419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|1|ROA|0|0|1|100|DKK|2812|5368|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche A.S.|Ceftríaxón||||2812|5368||2|0|S|0|||0 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|LEP|0|0|0|100|DKK|9356|14376|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||9356||9356|14376||1|0|G|0|||0 419311|N03AX1408|Levetiracetam STADA|mixtúra|100|mg/ml|300|ml|1|glas|+ 10 ml munngj.spr.|N03AX14|01.12.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|11000|16638|lyfalmen|V1000|16638|2|300|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||11000||11000|16638||2|0|G|0|||0 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5426|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5426||2|0|E|1|30|dagar|0 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|1|0|0|ORP|0|0|0|100|XEU|40992|55120|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mercaptamín||40992||40992|55120||3|0|E|0|||0 419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|1|0|0|ORP|0|0|0|100|XEU|14093|20896|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan Europe (S)|Mercaptamín||14093||14093|20896||3|0|E|0|||0 419952|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AD01|01.10.2018||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1877|4081|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||1877||1877|4081||1|0|G|0|||0 419969|S01AD0302|Xorox|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.03.2020||R|0|0|0|G|0|AGE|0|0|1|100|XEU|2313|4682|lyfalmen|||1|4,5|0||Agepha Pharma s.r.o.|Agepha Pharma s.r.o.|Acíklóvír||2313||2313|4682||2|0|G|0|||0 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|12398|18563|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12398||12398|18563||1|0|G|0|||0 420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|1|0|1|GEI|0|0|0|100|DKK|145094|186968|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||145094||145094|186968||2|0|S|0|||0 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|G|0|RTH|0|0|1|100|IKR|4816|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2186||2|0|G|0|||0 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|3849|6796|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||3849||3849|6796||1|0|G|0|||0 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|5485|9047|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||5485||5485|9047||1|0|G|0|||0 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1596|3090|lyfalmen|V0479|3090|2|60|0|6,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1157||1157|3090||2|0|E|0|||0 420639|L01XE2701|IMBRUVICA|filmhtfl|140|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|249408|316705|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||249408||249408|316705||1|0|L|0|||0 420696|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|60|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0 421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4636|lyfalmen|V0214|4636|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1324|3320|lyfalmen|||1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1324||1324|3320||1|0|G|0|||0 421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2000|2779|lyfalmen|V0114|2750|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0 421673|M04AA0303|Febuxostat Medical Valley|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.10.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|9483|14550|lyfalmen|V1011|14550|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|febuxostat||9483||9483|14550||2|0|E|0|||0 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|34793|66180|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||34793||34793|66180||1|0||0|||0 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|XEU|1821|3459|lyfalmen|V0458|2979|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1425||1425|3459||2|0|G|0|||0 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|623|2355|lyfalmen|V0596|2355|2|28|0|1,8600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||623||623|2355||1|0|G|1|30|dagar|0 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|2895|5483|lyfalmen|V0049|2884|1|98|0|62,0667|Vistor hf|Recordati Ireland Limited|Metóprólól||2895||2895|5483||1|0|G|0|||0 422323|L01DB1101|Pixuvri|st/irþ|29|mg|1|hgl|1|pakki||L01DB11|01.02.2020||R|0|0|0|0|1|LLS|0|0|0|100|DKK|100928|132037|lyfsjukr|||1|1|0||Icepharma hf|Les Laboratoires Servier|Pixantron||100928||100928|132037||2|H|0|0|||0 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|7376|11650|lyfalmen|V0054|3896|1|98|0|124,1333|Vistor hf|Recordati Ireland Limited|Metóprólól||7376||7376|11650||1|0|G|0|||0 422340|C02AC0201|Intuniv|forðatfl|1|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|10249|15605|lyfalmen|||1|28|0|9,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||10249||10249|15605||1|0|E|0|||0 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|1|CSB|0|0|0|100|SEK|75390|98627|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||75390||75390|98627||2|H|S|0|||0 422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|48864|65077|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||48864|65077||3|0|L|0|||0 422591|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.10.2020||R|1|0|0|0|0|ASA|0|0|0|100|SEK|20141|28748|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|Astra Zeneca A/S|Rósuvastatín||20141||20141|28748||1|0|E|0|||0 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|2996|5622|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2996||2996|5622||3|0|G|0|||0 422860|N03AF0401|Zebinix|töflur|200|mg|60|stk|1|þpakki||N03AF04|01.12.2018||R|1|0|0|G|0|BPC|0|0|0|100|SEK|11378|17159|lyfalmen|||1|60|0|15,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||11378||11378|17159||1|0|G|0|||0 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9823|15018|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||9823||9823|15018||2|0|G|0|||0 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|BAB|0|0|0|100|DKK|3154|5227|lyfalm11|V0993|4711|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3154|5227||2|0||0|||0 423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|1|LEM|0|0|1|100|XEU|20072|28661|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||20072||20072|28661||2|0|ES|0|||0 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|6024|9789|lyfalmen|V0373|4975|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||6024||6024|9789||2|0|G|0|||0 424199|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|73515|96255|lyfalmen|||1|50|0|33,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||73515||73515|96255||1|0|E|0|||0 424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|12028|18053|lyfalmen|||1|30|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||12028||12028|18053||1|0|E|1|30|dagar|0 424761|A07AA0204|Nystatin Orifarm|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.03.2020||R|0|0|0|0|0|IRO|0|0|1|100|XEU|5800|9481|lyfalmen|||2|100|0||Artasan ehf|Orifarm Generics A/S|Nýstatín||5800||5800|9481||1|0|0|0|||0 424829|N06AX2108|Aritavi|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|10584|4203|lyfalmen|V0694|4203|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||1965||1965|4203||1|0|G|0|||0 424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|G|0|TVA|0|0|0|100|DKK|13744|18732|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||12521||12521|18732||2|0|G|0|||0 425016|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|1|G|0|AZA|0|0|0|100|SEK|22846|26620|lyfalmen|V0183|20664|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||18252||18252|26620||1|0|G|0|||0 425282|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|1|0|1|ACC|0|1|0|100|XEU|20161|28773|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||20161||20161|28773||1|0|L|0|||0 425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|G|0|TTT|0|0|0|100|DKK|14780|21841|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||14780||14780|21841||2|0|G|0|||0 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|1040|2610|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||808||808|2610||2|0|E|0|||0 427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018||R|1|0|1|0|1|SHS|0|0|0|100|DKK|112515|132454|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||101263||101263|132454||1|0|S|0|||0 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2|0||0|||0 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|8740|13528|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||8740||8740|13528||1|0||0|||0 427289|B01AC0603|Hjartamagnýl|sþ-tfl|75|mg|100|stk|1|þpakki||B01AC06|01.04.2019||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1|0|0|0|||0 427556|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|30|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|3296|5225|lyfalmen|V1004|5225|2|30|0|4,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||2708||2708|5225||2|0|E|1|30|dagar|0 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3268||1|0|E|0|||0 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2503||1|0|G|0|||0 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|3431|6220|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3431||3431|6220||2|0|S|0|||0 429358|R03BB0404|Braltus|innönddu|10|mcg|30|stk|1|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|G|0|TVA|0|0|0|100|DKK|4585|7396|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||4285||4285|7396||2|0|G|0|||0 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|1|0|1|MLD|0|0|0|100|DKK|83989|109503|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||83989||83989|109503||1|0|ES|0|||0 429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7106|4172|lyfalmen|V0812|3903|2|28|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1943||1943|4172||1|0|E|0|||0 429759|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|3|glös||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7947|12436|lyfalmen|||1|9|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7947||7947|12436||2|0|G|0|||0 429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|4717|7990|lyfalmen|||2|200|0|66,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||4717||4717|7990||1|0|E|3|||0 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|9897|15120|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9897||9897|15120||3|0|G|0|||0 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|IBV|0|0|0|100|DKK|5873|11313|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Sulfadiazinum og trimethoprimum||5873||5873|11313||1|0||0|||0 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|19067|15639|lyfalmen|V0184|13736|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||10274||10274|15639||2|0|G|0|||0 430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5488|7875|lyfalmen|V0831|7403|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4633||4633|7875||2|0|G|0|||0 430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|G|0|TTT|0|0|0|100|DKK|5992|9745|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5992||5992|9745||2|0|G|0|||0 430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0 431017|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|hgl|+ein spr og tvær nálar|B06AC05|01.09.2020||R|0|0|1|0|1|HPI|0|0|0|100|DKK|2020475|2519416|lyfsjukr|||1|2|0||Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||2020475||2020475|2519416||1|0|0|0|||0 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1171|3110|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1171||1171|3110||1|0||0|||0 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|1453|3498|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1453||1453|3498||1|0|G|0|||0 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3774|6692|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3774||3774|6692||1|0|G|0|||0 431922|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|7042|7004|lyfalmen|V0995|5627|2|7,5|0|75,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||4000||4000|7004||2|0|G|0|||0 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17596|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17596||2|0|E|1|30|dagar|0 431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|1|TPA|0|1|0|100|DKK|324515|410117|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||324515||324515|410117||1|H|L|0|||0 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2132|4432|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2132||2132|4432||1|0|G|0|||0 432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2|0||0|||0 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|3245|3700|lyfalmen|V0693|3700|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1600||1600|3700||2|0|E|0|||0 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2977|4493|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2286||2286|4493||2|0|0|0|||0 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||2176||1|0|E|0|||0 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|G|0|COR|0|0|0|100|DKK|11458|17269|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11458||11458|17269||1|0|G|0|||0 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2581|5050|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2581||2581|5050||1|0|G|1|30|dagar|0 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5670|9302|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5670||5670|9302||1|0|G|1|30|dagar|0 433345|QI08AA0101|Eravac|stl|||0,5|ml|10|hgl|fleyti|QI08AA01|01.05.2020||R|0|0|0|0|0|LHS|0|0|0|100|IKR|14085|24277|vetbolu|||0|5|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Rabbit haemorrhagic disease virus||14085||14085|24277||2|0||0|||0 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|1|0|1|MLD|0|0|0|100|DKK|423638|533398|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||423638||423638|533398||1|0|ES|0|||0 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|1|BAB|0|0|0|100|DKK|162575|208709|lyfsjukr|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||162575||162575|208709||2|H|S|0|||0 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|NOK|68699|105138|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||65222||65222|105138||1|0||0|||0 434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||15098||15098|28814||2|0||0|||0 434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|15214|22438|lyfalmen|||1|0,36|0|1,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||15214||15214|22438||1|0|G|0|||0 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|8162|12732|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai GmbH|Zonisamíð||8162||8162|12732||1|0|G|0|||0 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3272|3838|lyfalmen|V0010|3838|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0 434601|N07BC0102|Buvidal|stl|128|mg|0,36|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|61863|81518|lyfsjukr|||1|0,36|0|16,0000|Vistor hf|Camurus AB|Búprenorfín||61863||61863|81518||1|H|L|1|30|dagar|0 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|MCS|0|0|1|100|SEK|794|2591|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||794||794|2591||1|0|E|0|||0 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|DKK|7154|11345|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||7154||7154|11345||2|0|G|0|||0 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|DKK|7138|11323|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||7138||7138|11323||2|0|G|0|||0 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|10556|16027|lyfalmen|V0315|7282|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10556||10556|16027||2|0|E|0|||0 434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|1|0|1|AMC|0|1|0|100|XEU|2576439|3210880|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeutics Europe Limited|Migalastat||2576439||2576439|3210880||1|0|L|0|||0 435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|1|SDG|0|1|0|100|DKK|14228|21081|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||14228||14228|21081||1|0|L|0|||0 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3847||1|0|G|0|||0 435882|N05CD0806|Buccolam|munnh.l|5|mg|1|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13722|20385|lyfalmen|||2|4|0|1,3333|Shire Services BVBA|Shire Services BVBA|Mídazólam||13722||13722|20385||1|0|E|2|450|mg|0 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|1|AST|0|1|0|100|DKK|223959|285054|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||223959||223959|285054||2|H|L|0|||0 436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|310|1925|lyfalmen|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||310||310|1925||1|0|E|3|||0 436308|J05AR2001|Biktarvy|filmhtfl|275|mg|30|stk|1|glas|50+200+25 mg|J05AR20|01.10.2018||R|0|0|1|0|1|GSE|0|0|0|100|DKK|141349|182310|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Emtricitabine, Tenofovir alafenamide og Bictegravir||141349||141349|182310||2|0|S|0|||0 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|1|0|1|FEL|0|0|0|100|DKK|67574|88741|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||67574||67574|88741||1|0|ES|0|||0 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1127|3049|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1127||1127|3049||1|0||0|||0 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|1|CFS|0|0|0|100|DKK|75574|98860|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||75574||75574|98860||3|0|ES|0|||0 436669|J02AC0106|Fungyn|hylki|150|mg|2|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|POF|0|0|1|100|XEU|559|2109|lyfalmen|V0555|2109|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||444||444|2109||2|0|E|0|||0 436810|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk|Stök áfyllingarpakkning|R03AC19|01.08.2019||R|0|0|0|G|0|BII|0|0|1|100|DKK|4387|7536|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||4387||4387|7536||1|0|G|0|||0 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|G|0|JAS|0|0|0|100|SEK|730|2503|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||730||730|2503||1|0|G|0|||0 437007|N06BA0905|Atomoxetin STADA|hylki|18|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4200|4182|lyfalmen|V0813|4182|2|30|0|6,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1950||1950|4182||2|0|E|0|||0 437221|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|8468|10414|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6478||6478|10414||1|0|G|0|||0 437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|1|FIN|0|1|0|100|DKK|660334|827782|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||660334||660334|827782||2|H|L|0|||0 437581|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|11611|17479|lyfalmen|V0253|4190|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||11611||11611|17479||3|0|G|0|||0 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|22533|31773|lyfalmen|V0712|31773|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||22533||22533|31773||1|0|G|0|||0 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|G|0|DEA|0|0|0|100|XEU|1211|3165|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1211||1211|3165||1|0|G|0|||0 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|1|AST|0|1|0|100|DKK|59043|77951|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||59043||59043|77951||2|H|L|0|||0 438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|DEH|1|0|0|100|XEU|24404|46470|vetalmen|||0|1|0||Vistor hf|Dechra Regulatory B.V.|Clodronic acid||24404||24404|46470||1|0|0|0|||0 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2139|4442|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2139||2139|4442||1|0|S|0|||0 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|G|0|HES|0|0|1|100|DKK|2260|4609|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2260||2260|4609||1|0|G|0|||0 438428|N02AE0101|Bupremyl|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018|31.08.2020|R|0|0|0|G|0|MYL|0|0|0|100|SEK|1185|2271|lyfalmen|||2|4|0|2,8000|Icepharma hf|Mylan AB|Búprenorfín||562||562|2271||2|0|G|||| 438571|A07EC0204|Asacol|töflur|1600|mg|60|stk|1|þpakki|með breyttan.losunarhraða|A07EC02|01.02.2019||R|1|0|0|G|0|TIL|0|0|0|100|DKK|10948|16567|lyfalmen|||1|60|0|64,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||10948||10948|16567|||0|G|0|||0 438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|1758|3918|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1758||1758|3918||1|0|G|0|||0 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|6259|2862|lyfalmen|V0605|2737|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||991||991|2862||2|0|G|0|||0 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|1|0|1|RRG|0|1|0|100|DKK|248635|315744|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafeníb||248635||248635|315744||2|0|L|0|||0 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|167064|214292|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||167064||167064|214292||1|0|S|0|||0 438974|D01AE1501|Lamisil|krem|1|%|15|g|1|túpa||D01AE15|01.10.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0 439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0 439419|B06AC0102|Berinert|sts/irs|2000|ae|1|hgl|1|pakki||B06AC01|01.07.2020||R|0|0|1|0|1|CSB|0|1|0|100|SEK|483703|608102|lyfsjukr|||1|1|0|1,4286|Icepharma hf|CSL Behring GmbH|C1 hemill||483703||483703|608102||2|0|L|0|||0 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|G|0|RDT|0|0|0|100|DKK|5309|8805|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||5309||5309|8805||1|0|G|0|||0 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|21987|31083|lyfalmen|V0615|24399|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||21987||21987|31083||1|0||0|||0 439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|16780|17953|lyfalmen|V0818|12722|2|28|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||11955||11955|17953||1|0|E|0|||0 439822|R03DC0306|Montelukast ratiopharm|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|9345|14360|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||9345||9345|14360||2|0|G|0|||0 440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|182713|233755|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||182713||182713|233755||1|0|G|0|||0 440431|N02AX0213|Tramadol Krka|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|4500|6728|lyfalmen|V0224|6728|2|100|0|66,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||3800||3800|6728||2|0|G|1|30|dagar|0 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3115|5785|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5785||2|0|G|0|||0 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|1|ATE|0|0|1|100|DKK|1448|3491|lyfsjukr|||2|10|0|1,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||1448||1448|3491||1|0|ES|0|||0 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|1|ATE|0|0|1|100|DKK|2285|4643|lyfsjukr|||2|10|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||2285||2285|4643||1|0|ES|0|||0 441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|JAS|0|0|1|100|SEK|1146|3075|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1146||1146|3075||1|0|E|0|||0 441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|1178|3119|lyfalmen|V0046|2500|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1178||1178|3119||1|0|G|0|||0 441451|N02CC0101|Imigran|nefúði|20|mg/sk|0,1|ml|6|úðaílá||N02CC01|01.04.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|6381|10281|lyfalmen|||1|0,6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||6381||6381|10281||1|0|G|0|||0 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|1|0|1|GEI|0|0|0|100|DKK|110906|144447|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||110906||110906|144447||2|0|S|0|||0 442258|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|2.000 PFU bóluefni|J07BK01|01.01.2020||R|0|0|0|0|0|GPH|0|0|0|100|DKK|6110|9908|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||6110||6110|9908||1|0|0|0|||0 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2738|5267|lyfalmen|V0283|3971|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2738||2738|5267||2|0|G|0|||0 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|76890|100524|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||76890||76890|100524||3|0|L|0|||0 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|11472|17288|lyfalmen|V0460|13392|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11472|17288||1|0|G|0|||0 443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1740|3893|lyfalmen|V0560|3498|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1740||1740|3893||2|0||0|||0 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|G|0|NAS|0|0|1|100|DKK|3450|6247|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3450||3450|6247||1|0|G|0|||0 443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|G|0|NAS|0|0|1|100|DKK|27380|37904|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||27380||27380|37904||1|0|G|0|||0 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|25271|35236|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||25271||25271|35236||1|0|G|1|30|dagar|0 443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|1|EUS|0|0|0|100|XEU|26039|36208|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||26039||26039|36208||3|H|ES|0|||0 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|TSA|0|0|1|100|IKR|2475|3700|lyfalmen|V0116|3063|2|14|0|14,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||1600||1600|3700||2|0|E|0|||0 444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2784|5330|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2784||2784|5330||2|0|G|0|||0 444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|1|0|1|NEP|0|0|0|100|DKK|1734044|2163176|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1734044||1734044|2163176||1|0|S|0|||0 444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BFP|0|0|1|100|XEU|2213|4211|lyfalmen|V0337|4211|2|30|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1971||1971|4211||1|0|E|0|||0 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|DKK|3212|5919|lyfalmen|V0061|3673|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3212||3212|5919||2|0|E|0|||0 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|21951|31037|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||21951||21951|31037||2|H|S|0|||0 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|2311|4679|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2311||2311|4679||2|0|G|0|||0 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|3537|6366|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||3537||3537|6366||2|0|G|0|||0 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|G|0|IRO|0|0|0|100|XEU|5418|8955|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||5418||5418|8955||1|0|G|0|||0 444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|170629|218726|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||170629||170629|218726||2|0|L|0|||0 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|G|0|BOE|0|0|0|100|DKK|19989|29011|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||19989||19989|29011||1|0|G|0|||0 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|5049|8447|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||5049||5049|8447||1|0|G|0|||0 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|G|0|LEO|0|0|1|100|DKK|2055|4326|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||2055||2055|4326||1|0|G|0|||0 445169|L01XX1907|Irinotecan Accord|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.06.2020||R|0|0|0|0|1|AEE|0|0|0|100|XEU|43922|58826|lyfsjukr|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Írinótekan||43922||43922|58826||1|H|S|0|||0 445240|N05CH0104|Melatonin Vitabalans|töflur|5|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|7000|5902|lyfalmen|||2|50|0|125,0000|LYFIS ehf|LYFIS ehf|Melatonin||3200||3200|5902||2|0|0|0|||0 445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|7384|3050|lyfalmen|V0684|3050|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1128||1128|3050||2|0|G|0|||0 445580|H05BX0105|Cinacalcet Accord|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2018|31.10.2020|R|1|0|0|0|0|AEE|0|0|0|100|XEU|54403|17168|lyfalmen|||2|28|0|42,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||11385||11385|17168||1|0||0|||0 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|6102|9897|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6102||6102|9897||1|0|G|0|||0 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|1|G|0|EIG|0|0|0|100|SEK|16836|24671|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai GmbH|Rúfínamíð||16836||16836|24671||1|0|G|0|||0 446639|C10BA0202|Ezetimib/Simvastatin Krka|töflur|30|mg|100|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|17377|22144|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||15000||15000|22144||2|0||0|||0 447013|L04AB0402|Imraldi|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.03.2019||R|0|1|1|0|1|SUG|0|1|0|100|XEU|62655|82520|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||62655||62655|82520||2|0|L|0|||0 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|G|0|KNM|0|0|0|100|IKR|7968|5214|lyfalmen|V0694|4203|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2700||2700|5214||2|0|G|0|||0 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|11903|17881|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||11903||11903|17881||1|0|G|0|||0 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|6663|10669|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6663||6663|10669||1|0|G|0|||0 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8376|13027|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||8376||8376|13027||1|0|G|0|||0 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8667|13427|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8667||8667|13427||1|0|G|0|||0 447357|A10AE0407|Toujeo [DoubleStar]|stl|300|ein/ml|3|ml|3|áfpen|áfylltir lyfjapennar|A10AE04|01.09.2019||R|0|1|0|G|0|SDH|0|0|0|100|XEU|12204|18296|lyfalmen|||1|9|0|67,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||12204||12204|18296||1|0|G|0|||0 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2999|3673|lyfalmen|V0948|3563|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||1580||1580|3673||2|0|G|0|||0 447608|J06BA0104|Cutaquig|stl|165|mg/ml|12|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|1|OCT|0|1|0|100|DKK|25003|34897|lyfsjukr|||1|12|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||25003||25003|34897||1|0|L|0|||0 447939|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|84|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|28000|38688|lyfalmen|||2|84|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||28000||28000|38688||2|0|E|0|||0 448122|A02BA0208|Asýran|filmhtfl|300|mg|90|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|R|1|0|0|G|0|TEE|0|0|1|100|XEU|1799|3974|lyfalmen|||2|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín||1799||1799|3974||1|0|G|||| 448253|A10AB0505|Fiasp|stl|100|ein/ml|10|ml|1|hgl||A10AB05|01.02.2019||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3079|5736|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3079||3079|5736||1|0|G|0|||0 448379|G03AD0103|Levonorgestrel Apofri|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.12.2019||L|0|0|0|0|0|APO|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|LYFIS ehf|Apofri AB|Levonorgestrel|||||||2|0||0|||0 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|G|0|HES|0|0|1|100|DKK|2140|4443|lyfalmen|V0202|4109|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||2140||2140|4443||1|0|G|0|||0 448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|4087|4636|lyfalmen|V0214|4636|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0 448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|65529|86155|lyfalmen|V0727|86155|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65529||65529|86155||1|0|E|0|||0 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|1|RAU|0|0|0|100|XEU|1178|3119|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1178||1178|3119||2|H|S|0|||0 449480|B02BC3002|TISSEEL|vefjalím|||4|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|1|BAM|0|0|0|100|SEK|34974|47509|lyfsjukr|||1|4|0||Icepharma hf|Baxter Medical AB|Blöndur||34974||34974|47509||2|H|S|0|||0 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2271|3474|lyfalmen|V0686|2033|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1436||1436|3474||2|0|E|0|||0 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1937|3184|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1225||1225|3184||2|0|G|0|||0 449697|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfpen||R03DX10|01.05.2020||R|0|0|1|0|1|ZEN|0|1|0|100|SEK|356666|450104|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||356666||356666|450104||1|0|L|0|||0 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|1|ATE|0|0|1|100|DKK|5416|8953|lyfsjukr|||2|10|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||5416||5416|8953||1|0|ES|0|||0 449842|L01XX2401|Oncaspar|stl/irs|750|ein/ml|5|ml|1|hgl||L01XX24|01.04.2019||R|0|0|0|0|1|LLS|0|0|0|100|DKK|257931|327305|lyfsjukr|||1|5|0||Icepharma hf|Les Laboratoires Servier|Pegaspargase||||257931|327305||2|H|S|0|||0 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|3556|6392|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||3556||3556|6392||2|0|G|0|||0 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|0|0|0|LEV|1|0|0|100|XEU|4986|9630|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4986||4986|9630||2|0||1|30|dagar|0 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1265|3239|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1265||1265|3239||2|0|G|0|||0 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|1|MBV|0|0|0|100|DKK|130260|168518|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||130260||130260|168518||1|H|S|0|||0 450216|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0814|3903|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|1|BOE|0|0|0|100|DKK|379698|478749|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||379698||379698|478749||1|H|S|0|||0 450537|N05CD0806|Buccolam|munnh.l|10|mg|2|ml|4|spr|munngjaf.spr|N05CD08|01.11.2019||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13722|20385|lyfalmen|||2|8|0|2,6667|Shire Services BVBA|Shire Services BVBA|Mídazólam||13722||13722|20385||1|0|E|2|450|mg|0 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|SNP|0|0|0|100|XEU|2580|4150|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1927||1927|4150||1|0||2|30|töflur|0 450846|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|4000|ml|1|glas|HDPE plastílát|QN01AX94|01.03.2019||R|0|0|0|0|0|SAS|0|0|0|100|NOK|249923|402876|veteldis|||0|4000|0||Vistor hf|Scan Aqua AS|Isoeugenol||249923||249923|402876||1|0||0|||0 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|XEU|9019|15545|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||9019||9019|15545||2|0||0|||0 450993|R07AX0101|INOmax|lyfjagas|800|ppm|10|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|1|LIN|0|0|0|100|XEU|21962|31051|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||21962|31051||5|H|S|0|||0 451135|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|3500|6315|lyfalmen|||3|84|0|7,0000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||3500||3500|6315||3|0|G|0|||0 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|OTS|0|0|0|100|DKK|45069|60277|lyfalmen|V0980|60276|1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||45069||45069|60277||1|0|E|0|||0 451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|G|0|ATE|0|0|1|100|XEU|693|2452|lyfalmen|||2|25|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prednisólón||693||693|2452||1|0|G|0|||0 451428|B06AC0102|Berinert|sts/irs|1500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|1|CSB|0|1|0|100|SEK|316610|400285|lyfsjukr|||1|1|0|1,0714|Icepharma hf|CSL Behring GmbH|C1 hemill||316610||316610|400285||2|0|L|0|||0 451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0 451670|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2594|3563|lyfalmen|V0687|3457|2|70|0|35,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0 451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|G|0|ATE|0|0|0|100|XEU|10713|16243|lyfalmen|V0608|14355|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||10713||10713|16243||1|0|G|0|||0 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|DKK|41123|55286|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||41123||41123|55286||2|0|G|0|||0 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|120|0||Alvogen|Trimb Healthcare AB|Ketókónazól|||||||2|0||0|||0 452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1|0||0|||0 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|8345|12984|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||8345||8345|12984||2|0|G|0|||0 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5813||2|0||0|||0 452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|1|0|1|RRG|0|1|0|100|DKK|855708|1070772|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||855708|1070772||2|0|L|0|||0 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3500|2874|lyfalmen|V0010|2193|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2874||2|0|G|0|||0 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|MEA|0|0|1|100|DKK|8955|13824|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||8955||8955|13824||2|0|E|0|||0 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|8468|13153|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||8468||8468|13153||2|H|S|0|||0 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|1433|3470|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1433||1433|3470||2|0|G|1|30|dagar|0 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|4301|7418|lyfalmen|||1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||4301||4301|7418||2|0|G|1|30|dagar|0 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|2738|5267|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2738||2738|5267||2|0|G|1|30|dagar|0 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|BOA|0|0|0|100|XEU|1515|2611|vetorma|||0|6,4|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||1515||1515|2611||1|0||0|||0 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|8254|12859|lyfalmen|||1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||8254||8254|12859||2|0|G|1|30|dagar|0 453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|108170|141044|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||108170|141044||2|0|E|0|||0 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|15395|22688|lyfalmen|||1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||15395||15395|22688||2|0|G|1|30|dagar|0 453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|6315|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3500||3500|6315||2|0|G|0|||0 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|Bel|1|0|0|100|DKK|5459|10527|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||5459||5459|10527||2|0||0|||0 454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|9089|14008|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9089||9089|14008||1|0|G|0|||0 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|36628|45641|lyfalmen|V0342|11588|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||33497||33497|45641||1|0|G|0|||0 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0||0|||0 454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|1|0|0|BIM|0|0|0|100|SEK|405642|511016|lyfalmen|||1|120|0||Icepharma hf|BioMarin International Limited|Saprópterín||405642||405642|511016||2|0||0|||0 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|BID|0|0|0|100|DKK|1181|2321|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín (BAN)||1181||1181|2321||1|0||0|||0 454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|1100|2461|lyfalmen|V0174|2461|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||700||700|2461||2|0|E|0|||0 455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|4985|8359|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4985||4985|8359||1|0|S|0|||0 455223|J05AR0303|Emtricitabine/Tenofovir disoproxil Krka|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.08.2017||R|0|1|1|0|1|KNM|0|1|0|100|IKR|50000|66514|lyfsjukr|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Tenófóvír dísóproxíl og emtrícítabín||||50000|66514||2|0|L|0|||0 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7999|12508|lyfalmen|V0713|10695|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7999||7999|12508||1|0|G|0|||0 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1139916|1424248|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1139916||1139916|1424248||2|0|L|0|||0 455398|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|30208|41481|lyfalmen|V0653|41481|3|168|0|42,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban ||30208||30208|41481||3|0|G|0|||0 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|837|2650|lyfalmen|||2|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||837||837|2650||1|0|E|0|||0 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|ATE|0|0|1|100|XEU|945|2799|lyfalmen|||2|15|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||945||945|2799||1|0|E|0|||0 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1768|3931|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||1768||1768|3931||1|0|E|0|||0 456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|4724|8000|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||4724||4724|8000||2|0|G|0|||0 456795|L01XE3501|Tagrisso|filmhtfl|80|mg|30|stk|1|stsk.þ||L01XE35|01.06.2019||R|0|0|1|0|1|ZEN|0|1|0|100|SEK|946922|1184217|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||946922||946922|1184217||1|0|L|0|||0 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|4926|7004|lyfalmen|V0277|6859|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||4000||4000|7004||2|0|G|0|||0 457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7106|4369|lyfalmen|V0816|4224|2|28|0|21,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||2086||2086|4369||1|0|E|0|||0 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|51988|56656|lyfalmen|V0451|56656|2|1|0|83,7200|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||42206||42206|56656||2|0|G|0|||0 457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.04.2019||R|1|0|0|G|0|BFP|0|0|0|100|XEU|3748|6657|lyfalmen|V0326|6518|2|98|0|147,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||3748||3748|6657||1|0|0|0|||0 457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|XEU|1625|3735|lyfalmen|V0561|3735|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1625||1625|3735||2|0||0|||0 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|PEU|0|0|0|100|DKK|6587|10564|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6587||6587|10564||1|0||0|||0 457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3038|5679|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3038||3038|5679||2|0|G|0|||0 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|2795|2234|lyfalmen|V0003|2234|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||535||535|2234||1|0|E|0|||0 457755|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|5415|8951|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5415||5415|8951||1|0|G|0|||0 457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|LHS|0|0|0|100|XEU|11466|19763|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11466||11466|19763||2|0||0|||0 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|CHE|0|0|1|100|DKK|1177|3118|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1177||1177|3118||1|0|E|2|150|hylki|0 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|1|0|1|FIN|0|1|0|100|DKK|405937|511383|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||405937||405937|511383||2|0|L|0|||0 458266|L04AB0402|Imraldi|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.03.2019||R|0|1|1|0|1|SUG|0|1|0|100|XEU|62655|82520|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||62655||62655|82520||2|0|L|0|||0 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1277|3256|lyfalmen|V0577|2898|1|20|0|6,6667|Alvogen|Karo Pharma AB|Pívmecillínam||1277||1277|3256||2|0|E|0|||0 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|117631|152811|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||117631||117631|152811||3|0|L|0|||0 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|10386|15060|lyfalmen|V0653|14815|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||9853||9853|15060||1|0|G|0|||0 458838|M09AX0701|Spinraza|stl|12|mg|5|ml|1|hgl|lausn|M09AX07|01.11.2018||R|0|0|0|0|1|BNB|0|1|0|100|XEU|12358214|15376644|lyfsjukr|||1|5|0|120,0000|Icepharma hf|Biogen Netherlands B.V.|Nusinersen||12358194||12358194|15376644||2|H|L|0|||0 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|1|0|1|NEL|0|1|0|100|DKK|901665|1127930|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||901665||901665|1127930||1|0|L|0|||0 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|87927|114484|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||87927||87927|114484||2|0|S|0|||0 459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|1|BAB|0|0|0|100|DKK|22668|31944|lyfsjukr|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||22668|31944||2|H|S|0|||0 459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|16808|lyfalmen|V0964|16808|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||11123||11123|16808||2|0|G|0|||0 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|1|PLS|0|0|1|100|DKK|881|2711|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||881||881|2711||1|0|ES|0|||0 459405|L01XE2701|IMBRUVICA|filmhtfl|560|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|1007907|1260065|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||1007907||1007907|1260065||1|0|L|0|||0 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|1|PLS|0|0|1|100|DKK|1614|3719|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1614||1614|3719||1|0|ES|0|||0 459423|N07BC0102|Buvidal|stl|16|mg|0,32|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14465|21408|lyfsjukr|||1|0,32|0|2,0000|Vistor hf|Camurus AB|Búprenorfín||14465||14465|21408||1|H|L|1|30|dagar|0 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|21819|41566|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|Cefovecinum||21819||21819|41566||2|0||0|||0 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|2514|2365|lyfalmen|V0284|2365|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||630||630|2365||2|0|G|0|||0 459838|N05AH0416|Quetiapin Medical Valley|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|10500|11546|lyfalmen|V0261|11408|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||7300||7300|11546||2|0|0|0|||0 459845|A10BD2301|Segluromet|filmhtfl|1007,5|mg|56|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|6343|10228|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||6343||6343|10228||1|0|G|0|||0 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|G|0|MEA|0|0|1|100|DKK|2107|4398|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||2107||2107|4398||2|0|G|0|||0 459926|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.04.2019||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír|||||||1|0|0|0|||0 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|1|AEE|0|1|0|100|XEU|146341|188518|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare B.V.|Bendamústín||146341||146341|188518||1|H|L|0|||0 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|G|0|HSS|0|0|0|100|DKK|9736|14899|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||9736||9736|14899||1|0|G|0|||0 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|1|RRG|0|1|0|100|DKK|260452|330441|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||260452||260452|330441||2|H|L|0|||0 460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|7744|4366|lyfalmen|V0144|4142|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2084||2084|4366||1|0|E|0|||0 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|5287|9495|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||4915||4915|9495||2|0|0|0|||0 460889|N02AE0105|Buprenorphine Alvogen|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|IKR|1060|2957|lyfalmen|V0943|2957|2|4|0|2,8000|Alvogen|Alvogen|Búprenorfín||1060||1060|2957||2|0|G|1|30|dagar|0 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5050|8286|lyfalmen|V0585|8258|2|98|0|26,1300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4932||4932|8286||1|0|G|1|30|dagar|0 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|1|0|1|NEL|0|1|0|100|DKK|469997|591056|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||469997||469997|591056||1|0|L|0|||0 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1916||2|0|E|0|||0 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1175166|1468089|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1175166||1175166|1468089||2|0|L|0|||0 461563|V03AB1506|Nyxoid|nefúði|1,8|mg|0,1|ml|2|stsk.í||V03AB15|01.03.2020||R|0|1|0|0|0|MIP|0|0|1|100|DKK|6682|10695|lyfalmen|||1|0,2|0||Icepharma hf|Mundipharma Corporation (Ireland) Ltd|Naloxón||6682||6682|10695||2|0|E|0|||0 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|1|MBV|0|0|0|100|DKK|325649|411527|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||325649||325649|411527||1|H|S|0|||0 461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|19225|27959|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||19225||19225|27959||1|0|G|0|||0 462130|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0816|4224|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|0|1|IND|0|0|0|100|DKK|4210|7293|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||4210||4210|7293||1|0|ES|1|30|dagar|0 462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4245|7341|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4245||4245|7341||2|0|G|0|||0 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|5821|2874|lyfalmen|V0605|2793|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1000||1000|2874||2|0|G|0|||0 463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.04.2020||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2813|5370|lyfalmen|V0325|5209|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||2813||2813|5370||1|0|0|0|||0 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|1|0|1|JCI|0|0|0|100|SEK|52798|70053|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||52798|70053||1|0|S|0|||0 463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|4779|8076|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||4779|8076||1|0|G|0|||0 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.11.2020||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2041|4307|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2041||2041|4307||1|0|G|0|||0 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2|0||0|||0 463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0 464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|3606|6215|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3606||3606|6215||1|0||0|||0 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 464170|N02BA5104|Treo Citrus|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2019||L|0|0|0|0|0|MEA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2130|3425|lyfalmen|V0947|3287|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||1400||1400|3425||2|0|G|0|||0 464327|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|10|hgl||B01AB01|01.07.2019||R|0|0|0|0|1|LEP|0|0|0|100|DKK|8053|12582|lyfsjukr|||1|50|0|25,0000|Vistor hf|LEO Pharma A/S|Heparín||8053||8053|12582||1|H|S|0|||0 464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|G|0|ATE|0|0|0|100|XEU|17299|25308|lyfalmen|V0718|25308|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||17299||17299|25308||1|0|G|0|||0 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|1|G|0|WIL|0|0|0|100|XEU|6821|10886|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||6821||6821|10886||2|0|G|0|||0 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|TSA|0|0|1|100|IKR|1713|2668|lyfalmen|V0967|2599|2|14|0|7,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||850||850|2668||2|0|E|0|||0 464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|V0677|2753|2|140|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mómetasón|||||3147||1|0|G|0|||0 464827|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|505|2048|lyfalmen|V0188|2048|2|30|0|15,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||400||400|2048||2|0|G|0|||0 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|G|0|ATE|0|0|0|100|DKK|2795|5345|lyfalmen|V0376|5345|2|7,5|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Latanóprost||2795||2795|5345||1|0|G|0|||0 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1470|2889|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Penicillín í blöndum með öðrum sýklalyfjum||1470||1470|2889||1|0||0|||0 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|G|0|MDK|0|0|0|100|DKK|2105|4395|lyfalmen|||1|98|0|49,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||2105||2105|4395||2|0|G|0|||0 465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3367|6132|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3367||3367|6132||2|0|G|0|||0 465472|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.04.2019|30.09.2020|R|0|1|0|0|1|GRP|0|0|0|100|XEU|11378|5768|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||3102||3102|5768||1|H|0|||| 465772|L01XC0302|Kanjinti|st/irþ|150|mg|1|hgl|1|pakki||L01XC03|01.12.2018||R|0|0|0|0|1|AEB|0|1|0|100|DKK|80758|105416|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||80758||80758|105416||1|H|L|0|||0 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013|30.09.2020|R|1|0|0|G|0|RTH|0|0|0|100|IKR|2763|3012|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Flúoxetín||1100||1100|3012||2|0|G|||| 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|644|2384|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||644||644|2384||1|0|G|1|30|dagar|0 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2005|4258|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2005||2005|4258||1|0|G|1|30|dagar|0 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|1329|2978|lyfalm11|V0545|1924|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1329|2978||2|0||0|||0 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1520|3590|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1520||1520|3590||1|0|G|1|30|dagar|0 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5268|8749|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5268||5268|8749||1|0|G|1|30|dagar|0 466276|J01XD0103|Metronidazol Normon|irl|5|mg/ml|100|ml|50|pokar||J01XD01|01.09.2019||R|0|0|0|0|1|LNA|0|0|1|100|XEU|31133|37658|lyfsjukr|||2|5000|0|16,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Metrónídazól||27186||27186|37658||2|0|0|0|||0 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|1|RRG|0|1|0|100|DKK|271832|344594|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||271832||271832|344594||2|H|L|0|||0 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|19142|27845|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai GmbH|Zonisamíð||19142||19142|27845||1|0|G|0|||0 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2826|5388|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2826||2826|5388||1|0|G|1|30|dagar|0 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|7315|11566|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||7315||7315|11566||1|0|G|0|||0 466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1|0||0|||0 466667|L01AA0501|LEDAGA|hlaup|160|mcg/g|60|g|1|túpa||L01AA05|01.03.2020||R|0|1|0|0|1|HEL|0|0|0|100|XEU|388868|490154|lyfsjukr|||1|60|0||Recordati AB|Helsinn Birex Pharmaceuticals Ltd.|Chlormethine||388868||388868|490154||3|0|0|0|||0 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|4650|7898|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4650||4650|7898||1|0|G|1|30|dagar|0 466723|V03AN0502|Airapy|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|21843|30901|lyfalmen|V0728|28718|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||21843||21843|30901||1|0|E|0|||0 466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|WEH|0|0|1|100|IKR|361|1831|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||242||242|1831||2|0|E|0|||0 467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7252|6647|lyfalmen|V0622|6647|2|30|0|54,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3741||3741|6647||1|0|E|1|30|dagar|0 467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6167|10629|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||6167||6167|10629||2|0||0|||0 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|6267|10124|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6267||6267|10124||2|0|S|0|||0 467473|H02AB0912|Alkindi|kyrnhylk|2|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|31155|42678|lyfalmen|||1|50|0|3,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||31155||31155|42678||2|0|G|0|||0 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|12427|18602|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||12427||12427|18602||1|0|G|0|||0 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|6389|10292|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||6389||6389|10292||2|0||0|||0 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|23323|32773|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||23323||23323|32773||1|0|G|0|||0 467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|SGB|0|0|0|100|XEU|11888|17861|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||11888||11888|17861||1|0|E|0|||0 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|1|PIP|0|0|1|100|DKK|82961|108203|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||82961||82961|108203||1|0|ES|0|||0 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|1|JAS|0|0|0|100|SEK|417|2072|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||417||417|2072||1|0|S|0|||0 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|6275|7366|lyfalmen|V0317|3663|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4263||4263|7366||1|0|G|0|||0 468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016|30.09.2020|R|1|0|0|0|0|ASD|0|0|0|100|SEK|14474|8756|lyfalmen|||2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||5273||5273|8756||2|0||||| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|7730|7338|lyfalmen|V0318|4406|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4243||4243|7338||1|0|G|0|||0 468374|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|1001|2876|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1001||1001|2876||1|0|G|0|||0 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|2414|4161|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2414||2414|4161||2|0||0|||0 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|3547|5403|lyfalmen|V0467|4950|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||2837||2837|5403||1|0|G|0|||0 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7664|12047|lyfalmen|V0712|10591|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7664||7664|12047||1|0|G|0|||0 469152|N06BA0408|Methylphenidate Teva|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|6621|6024|lyfalmen|V0960|6024|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3288||3288|6024||1|0|E|1|30|dagar|0 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|PLS|0|0|0|100|DKK|3345|6102|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3345||3345|6102||1|0|E|0|||0 469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|AEP|0|0|0|100|DKK|3631|5815|lyfalm11|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||3631||3631|5815||2|0||0|||0 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|7148|11336|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7148||7148|11336||1|0|S|0|||0 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|2583|3312|lyfalmen|V0037|3312|2|20|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||1318||1318|3312||1|0|G|0|||0 469899|C01CA1703|Hypotron|töflur|2,5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|RET|0|0|0|100|IKR|14250|21112|lyfalmen|V0968|21112|2|100|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||14250||14250|21112||2|0||0|||0 469912|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|þpakki||C01AA05|01.08.2020||R|1|0|0|G|0|AEP|0|0|0|100|DKK|401|2050|lyfalmen|V1025|2050|1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||401||401|2050||2|0|G|0|||0 469990|L04AB0403|Amgevita|stl|40|mg/penna|0,8|ml|2|áfpen|SureClick penni|L04AB04|01.06.2020||R|0|1|1|0|1|AEB|0|1|0|100|DKK|64357|84672|lyfsjukr|||1|1,6|0|27,5860|Vistor hf|Amgen Europe B.V.|Adalimumab||64357||64357|84672||1|0|L|0|||0 470202|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|15116|19090|lyfalmen|||2|180|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12781||12781|19090|31.8.2020|2|0|G|||| 470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|1|0|1|IPC|0|0|0|100|DKK|50530|60846|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||45519||45519|60846||2|0|S|0|||0 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4248|7345|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4248||4248|7345||1|0|G|0|||0 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|G|0|AEP|0|0|0|100|DKK|6382|10282|lyfalmen|||1|5|0|10,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||6382||6382|10282||2|0|G|0|||0 470817|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|65529|86155|lyfalmen|V0728|86155|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65529||65529|86155||1|0|E|0|||0 471066|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|516|2208|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck AB|Levótýroxínnatríum||516||516|2208||2|0|G|0|||0 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|ORC|1|0|0|100|DKK|4896|9459|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4896||4896|9459||1|0||0|||0 471970|N05CH0105|Slenyto|forðatfl|5|mg|30|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|17647|13419|lyfalmen|||2|30|0|75,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||8661||8661|13419||2|0|0|0|||0 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1785|3955|lyfalmen|V0048|2952|1|98|0|31,0333|Vistor hf|Recordati Ireland Limited|Metóprólól||1785||1785|3955||1|0|G|0|||0 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3945|6928|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3945||3945|6928||1|0||0|||0 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|1|TEA|0|0|0|100|SEK|8704|13478|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||8704||8704|13478||1|H|S|0|||0 472610|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|98|stk|1|þpakki||N06AX21|01.12.2018||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5438|5587|lyfalmen|V0811|5557|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2971||2971|5587||2|0|G|0|||0 472741|N03AX1402|Keppra (Lyfjaver)|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|22536|31777|lyfalmen|V0516|5902|3|100|0|66,6700|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||22536||22536|31777||3|0|G|0|||0 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.12.2019||R|1|0|0|G|0|MBV|0|0|1|100|DKK|3298|6037|lyfalmen|V0458|2979|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||3298||3298|6037||1|0|G|0|||0 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2706|5222|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2706||2706|5222||1|0|G|0|||0 473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|G|0|ATN|0|0|1|100|DKK|1491|3550|lyfalmen|||1|5|0|5,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Ketórólak||1491||1491|3550||2|0|G|0|||0 473879|B01AF0101|Xarelto|filmhtfl|2,5|mg|196|stk|1|þpakki||B01AF01|01.05.2020||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30692|42093|lyfalmen|V0974|42093|1|196|0|24,5000|Icepharma hf|Bayer AG|Rivaoxaban||30692||30692|42093||2|0|G|0|||0 473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|1|SUG|0|1|0|100|XEU|91021|118397|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||91021||91021|118397||2|0|L|0|||0 473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4735|8015|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4735||4735|8015||1|0|G|0|||0 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2|0||0|||0 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|PHM|0|0|0|100|DKK|31266|59488|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||31266||31266|59488||2|0||0|||0 475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2904|5495|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2904||2904|5495||2|0|E|0|||0 475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2|0||2|||0 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0 476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||5695||5695|10975||2|0||0|||0 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|63841|84020|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||63841|84020||1|0|S|0|||0 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|4526|7728|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4526|7728||2|0|S|0|||0 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|16276|23900|lyfalmen|V0954|6836|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||16276||16276|23900||1|0|E|0|||0 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|4685|7946|lyfalmen|V0934|5627|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4685||4685|7946||1|0||0|||0 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|1|0|1|AEB|0|1|0|100|XEU|60833|80215|lyfsjukr|||1|27|0||Vistor hf|Amgen Europe B.V.|Apremilast||60833||60833|80215||1|0|L|0|||0 477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|1|SUG|0|1|0|100|XEU|91021|118397|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||91021||91021|118397||2|0|L|0|||0 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|10359|9481|lyfalmen|V0272|8917|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5800||5800|9481||2|0|G|0|||0 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||2|0||0|||0 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||1|0||0|||0 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|550|2112|lyfalmen|V0500|2082|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||446||446|2112||1|0|G|0|||0 478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|18177|26517|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||18177||18177|26517||1|0|G|0|||0 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|1|0|0|100|XEU|7798|14965|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||7798||7798|14965||2|0||0|||0 478386|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.10.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3875|5613|lyfalm11|V0983|5613|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3467||3467|5613||2|0||0|||0 478808|R03DX0901|Nucala|stl|100|mg|1|pennar|1|pakki||R03DX09|01.07.2020||R|0|0|1|0|1|GSD|0|1|0|100|DKK|181041|231676|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||181041||181041|231676||1|0|L|0|||0 478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|2221|3012|lyfalmen|V0825|2811|2|28|0|28,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0 479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|MVX|0|0|0|100|IKR|4900|8105|lyfalmen|V0115|8077|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4800||4800|8105||2|0|E|0|||0 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|125847|163030|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||125847||125847|163030||1|0|L|0|||0 479954|L01XC1701|OPDIVO|irþ|10|mg/ml|24|ml|1|hgl||L01XC17|01.10.2019||R|0|1|0|0|1|BMS|0|1|0|100|DKK|425050|535154|lyfsjukr|||1|24|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||425050||425050|535154||1|H|L|0|||0 479991|L01XX5001|Ninlaro|hylki|4|mg|1|stk|3|þpakki|Hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|1|0|1|TPA|0|0|0|100|DKK|868925|1087211|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||868925||868925|1087211||1|0|S|0|||0 480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|OCO|0|0|0|100|DKK|3389|6600|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||3389||3389|6600||2|0||0|||0 480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4531|6569|lyfalmen|V0080|6569|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3684||3684|6569||2|0|G|0|||0 480750|B01AF0101|Xarelto|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.12.2018||R|1|1|0|G|0|FIN|0|0|0|100|DKK|33658|45844|lyfalmen|V0975|45844|1|98|0|49,0000|Icepharma hf|Bayer AG|Rivaoxaban||33658||33658|45844||2|0|G|0|||0 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|GPH|0|0|0|100|DKK|13483|20056|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||13483||13483|20056||1|0||0|||0 481208|D07AC1302|Ovixan|krem|1|mg/g|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|722|2492|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||722||722|2492||1|0|G|0|||0 481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|25104|35025|lyfalmen|||2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|35025||2|0|G|0|||0 481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6158|7963|lyfalmen|V0681|7963|2|30|0|27,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||4697||4697|7963||1|0|E|1|30|dagar|0 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|1|100|DKK|268|1867|lyfalmen|V0055|1864|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||268||268|1867||1|0|G|1|30|dagar|0 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|G|0|BAB|0|0|0|100|DKK|16167|23750|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||16167||16167|23750||2|0|G|0|||0 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2|0||0|||0 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|0|1|AEB|0|1|0|100|DKK|61434|80975|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||61434||61434|80975||1|H|L|0|||0 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|32665|44588|lyfalmen|V0977|44258|1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||32665|44588||2|0|G|0|||0 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|6776|10824|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|albumin||6776||6776|10824||2|H|S|0|||0 483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|47926|63890|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||47926||47926|63890||2|H|S|0|||0 483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|G|0|DAN|0|0|0|100|XEU|5242|8713|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5242||5242|8713||2|0|G|0|||0 483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|G|0|BFP|0|0|0|100|XEU|2392|4790|lyfalmen|V0368|4790|2|15|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Brímónidín||2392||2392|4790||1|0|G|0|||0 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|G|0|SHS|0|0|1|100|DKK|6986|11113|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6986||6986|11113||1|0|G|0|||0 483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2486|4920|lyfalmen|||2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4920||2|0|G|0|||0 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|G|0|MEV|0|0|0|100|DKK|1191|3137|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1191||1191|3137||1|0|G|0|||0 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|0|G|0|ATE|0|0|1|100|XEU|299|1864|lyfalmen|V0055|1864|2|20|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||266||266|1864||1|0|G|1|30|dagar|0 484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|362285|457092|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||362285||362285|457092||1|0|E|0|||0 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|1|0|1|AEB|0|0|0|100|DKK|129872|168036|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||129872||129872|168036||1|0|S|0|||0 484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996|31.08.2020|R|0|0|0|G|0|MEA|0|0|1|100|DKK|1201|3151|lyfalmen|||1|300|0|50,0000|Icepharma hf|Meda AB|Benzýdamín||1201||1201|3151||2|0|G|||| 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|10669|16183|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||10669||10669|16183||2|0|G|0|||0 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|48615|64762|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||48615||48615|64762||1|0|G|0|||0 484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|9052|13957|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||9052||9052|13957||1|0|G|0|||0 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|G|0|ANS|0|0|1|100|XEU|1453|3498|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1453||1453|3498||2|0|G|0|||0 485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|G|0|ATN|0|0|0|100|DKK|8946|13811|lyfalmen|||1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8946||8946|13811||2|0|G|0|||0 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|405199|510465|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||405199||405199|510465||1|0|L|0|||0 485462|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|30|mg|30|stk|1|þpakki|20+10 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|6492|9226|lyfalmen|V1006|9226|2|30|0|8,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5615||5615|9226||2|0|E|1|30|dagar|0 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|15000|22144|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||15000||15000|22144||1|0|G|0|||0 485553|L04AX0402|Lenalidomid Alvogen|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|671875|842136|lyfsjukr|||2|21|0|21,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||671875||671875|842136||2|0|L|0|||0 485592|QL04AD0101|Sporimune vet.|mixtúra|50|mg/ml|25|ml|1|glas||QL04AD01|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|6751|12978|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ciclosporin||6751||6751|12978||2|0||0|||0 485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|4800|4595|lyfalmen|V0116|4595|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2250||2250|4595||2|0||0|||0 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|1|0|1|VIC|0|0|0|100|DKK|75333|98555|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||75333||75333|98555||1|0|S|0|||0 485799|A10BK0401|Steglatro|filmhtfl|5|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|6110|9908|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Ertugliflozin||6110||6110|9908||1|0|G|0|||0 485911|L04AX0402|Lenalidomid Alvogen|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|731988|916899|lyfsjukr|||2|21|0|10,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||731988||731988|916899||2|0|L|0|||0 486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|15|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|G|0|HES|0|0|1|100|DKK|363|1998|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||363||363|1998||1|0|G|0|||0 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|G|0|HES|0|0|1|100|DKK|570|2282|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||570||570|2282||1|0|G|0|||0 487105|L01XE2801|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01XE28|01.05.2017||R|1|0|1|0|1|NEL|0|1|0|100|DKK|860293|1076475|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||860293||860293|1076475||1|0|L|0|||0 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|1912|4130|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||1912||1912|4130||1|0|G|0|||0 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|26376|36634|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||26376||26376|36634||1|0|L|0|||0 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|IKR|2489|4924|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||2489||2489|4924||2|0|G|0|||0 487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9432|18065|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||9432||9432|18065||1|0||0|||0 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|1|0|1|NEL|0|1|0|100|DKK|238178|302738|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||238178||238178|302738||1|0|L|0|||0 488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|2908|5500|lyfalmen|||1|50|0|14,2857|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||2908||2908|5500||1|0|G|0|||0 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|8068|12603|lyfalmen|||1|50|0|35,7143|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||8068||8068|12603||1|0|G|0|||0 488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 489128|A10BD2301|Segluromet|filmhtfl|1007,5|mg|196|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|22012|31114|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||22012||22012|31114||1|0|G|0|||0 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|6461|10391|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6461||6461|10391||3|0|G|0|||0 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|85097|110904|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||85097|110904||1|0|S|0|||0 489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0 489349|N03AX0901|Lamictal|dreifit.|5|mg|60|stk|1|glas||N03AX09|01.10.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1677|3806|lyfalmen|||1|60|0|1,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1677||1677|3806||1|0|G|0|||0 489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|21377|30311|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||21377||21377|30311||1|0|E|0|||0 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|G|0|IRO|0|0|0|100|XEU|4351|7487|lyfalmen|V0133|7487|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4351||4351|7487||1|0|G|0|||0 490525|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.2020||R|0|0|0|G|0|RDT|0|0|0|100|DKK|2516|4961|lyfalmen|||1|25|0|0,1667|Vistor hf|Recordati Ireland Limited|Metóprólól||2516||2516|4961||1|0|G|0|||0 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|PLS|0|0|0|100|DKK|11133|11433|lyfalmen|V0112|2806|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7218||7218|11433||1|0|E|0|||0 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|PLS|0|0|0|100|DKK|13591|15327|lyfalmen|V0113|2806|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10047||10047|15327||1|0|E|0|||0 490823|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|21201|27439|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||18847||18847|27439||1|0|G|0|||0 490827|J01CF0503|Flucloxacillin WH|sts/irs|1000|mg|10|hgl|1|pakki||J01CF05|01.08.2020||R|0|0|0|0|1|WEH|0|0|1|100|XEU|15833|23290|lyfsjukr|||2|10|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Flúkloxacillín||15833||15833|23290||2|0|0|0|||0 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|PLS|0|0|0|100|DKK|15959|18952|lyfalmen|V0114|2806|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12681||12681|18952||1|0|E|0|||0 491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|21601|30595|lyfalmen|V0665|30595|1|28|0|21,0000|Eisai AB|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|1|0|1|GSE|0|0|0|100|DKK|1470674|1835618|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||1470674||1470674|1835618||2|0|S|0|||0 491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|1|JCI|0|1|0|100|SEK|374368|472120|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||374368||374368|472120||1|0|L|0|||0 491257|A10BK0401|Steglatro|filmhtfl|5|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|21357|30286|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Ertugliflozin||21357||21357|30286||1|0|G|0|||0 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|1|0|1|PEU|0|1|0|100|DKK|127316|164857|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||127316||127316|164857||1|0|L|0|||0 491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|1|AEB|0|0|0|100|DKK|46840|62517|lyfsjukr|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||46840||46840|62517||1|H|S|0|||0 491660|N05CD0806|Buccolam|munnh.l|7,5|mg|1,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13722|20385|lyfalmen|||2|6|0|2,0000|Shire Services BVBA|Shire Services BVBA|Mídazólam||13722||13722|20385||1|0|E|2|450|mg|0 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|ASD|0|0|0|100|SEK|2366|3664|lyfalmen|V0693|3453|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||1574||1574|3664||2|0|E|0|||0 491758|H01CB0203|Octreoanne|sts|10|mg|10|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|1|TVI|0|0|0|100|NOK|107434|116773|lyfsjukr|||2|10|0|14,2900|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||89737||89737|116773||1|0|S|0|||0 492114|J07BB0205|Influvac|stl|||0,5|ml|1|áfspr|með nál|J07BB02|01.08.2017||R|0|0|0|0|0|MDK|0|0|0|100|DKK|896|2731|lyfalmen|||1|0,5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir mótefnavakar||896||896|2731||2|0||0|||0 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|566307|710839|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||566307||566307|710839||1|0|L|0|||0 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2844|5412|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2844||2844|5412||2|0|G|0|||0 492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|G|0|TEA|0|0|1|100|SEK|1613|3718|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1613||1613|3718||1|0|G|0|||0 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0||0|||0 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|AZD|0|0|1|100|SEK|6751|10790|lyfalmen|V0002|6816|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6751||6751|10790||1|0|E|0|||0 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0||0|||0 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|17941|26192|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||17941||17941|26192||1|0||0|||0 492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2|0||0|||0 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2|0||1|30|dagar|0 493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7106|4172|lyfalmen|V0813|3903|2|28|0|6,3000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1943||1943|4172||1|0|E|0|||0 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|24588|34373|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24588||24588|34373||1|0|G|0|||0 493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|114091|148408|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||114091||114091|148408||1|0|G|0|||0 493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|1|JCI|0|1|0|100|SEK|70877|92919|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||70877||70877|92919||1|H|L|0|||0 493782|L04AD0204|Dailiport|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|30837|42276|lyfalmen|||2|50|0|30,0000|Artasan ehf|Sandoz A/S|Tacrolimus||30837||30837|42276||1|0|G|0|||0 493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3273|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0 493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0113|2750|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1199|3148|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1199||1199|3148||1|0|G|0|||0 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|G|0|HES|0|0|0|100|DKK|3542|6373|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||3542||3542|6373||1|0|G|0|||0 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|1|RRG|0|1|0|100|DKK|80784|105449|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||80784||80784|105449||2|H|L|0|||0 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|1|RRG|0|1|0|100|DKK|202080|257842|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||202080||202080|257842||2|H|L|0|||0 494474|J02AC0106|Fungyn|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|1250|2007|lyfalmen|V0551|2007|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||370||370|2007||2|0|E|0|||0 494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|MBP|0|0|0|100|IKR|7287|7162|lyfalmen|V0145|4210|2|8|0|16,0000|BGP Products ApS|Mylan S.A.S|Tadalafíl||4115||4115|7162||2|0|E|0|||0 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2128|4427|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2128||2128|4427||1|0||0|||0 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0||0|||0 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2323|4695|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2323||2323|4695||1|0|G|0|||0 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3375|6143|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3375||3375|6143||1|0|G|0|||0 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|OCO|0|0|0|100|IKR|3363|6551|vetalmen|||0|100|0||Icepharma hf|Orion Corporation (I)|Magnesíum súlfat||3363||3363|6551||2|0||0|||0 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|G|0|BII|0|0|0|100|DKK|3513|6333|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||3513||3513|6333||1|0|G|0|||0 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|1|CFS|0|0|0|100|DKK|944681|1181430|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||944681||944681|1181430||3|0|ES|0|||0 495203|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|446483|561811|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||446483||446483|561811||2|H|S|0|||0 495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|3000|3838|lyfalmen|V0010|3838|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|G|0|NAA|0|0|1|100|DKK|22593|8425|lyfalmen|V0384|5801|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5033||5033|8425||1|0|G|0|||0 495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|1|ACC|0|0|1|100|XEU|77441|101221|lyfsjukr|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||77441||77441|101221||1|0|ES|0|||0 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|5621|9235|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||5621||5621|9235||1|0||0|||0 496076|N06BA0408|Methylphenidate Teva|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|10073|10136|lyfalmen|V0997|10136|2|30|0|60,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||6276||6276|10136||1|0|E|1|30|dagar|0 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4706|9099|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4706||4706|9099||2|0||0|||0 496614|B03BB0108|Folsyra Evolan|töflur|5|mg|105|stk|1|þpakki||B03BB01|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|2100|4388|lyfalmen|||2|105|0|1312,5000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2100||2100|4388||2|0|G|0|||0 496912|N02AA0507|OxyContin Depot|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|959|2818|lyfalmen|V0596|2355|1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||959||959|2818||2|0|G|1|30|dagar|0 496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klemastín|||||5708||1|0||0|||0 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|482|2161|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||482||482|2161||1|0|G|1|30|dagar|0 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|870|2695|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||870||870|2695||1|0|G|1|30|dagar|0 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|1|APE|0|0|1|100|XEU|232508|295686|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||232508||232508|295686||1|0|S|0|||0 497083|H02AB0912|Alkindi|kyrnhylk|1|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|15577|22938|lyfalmen|||1|50|0|1,6667|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||15577||15577|22938||2|0|G|0|||0 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|3319|6066|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3319||3319|6066||1|0|G|1|30|dagar|0 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990|30.09.2020|R|1|0|0|G|0|GPA|0|0|0|100|XEU|617|2347|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||617||617|2347||1|0|G|||| 497730|H03BB0212|Thiamazole Uni-Pharma|töflur|5|mg|100|stk|1|þpakki||H03BB02|01.12.2018||R|0|0|0|G|0|UNI|0|0|0|100|XEU|4366|7507|lyfalmen|||2|100|0|50,0000|Artasan ehf|Uni-Pharma Kleon Tsetis|thiamazole||4366||4366|7507||1|0|G|0|||0 497905|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|glas|23,75 mg metoprololsuccinat|C07AB02|01.01.2020||R|1|0|0|G|0|SSA|0|0|0|100|DKK|916|2759|lyfalmen|V0050|2530|2|100|0|16,6667|Artasan ehf|Hexal A/S|Metóprólól||916||916|2759||1|0|G|0|||0 497995|S01EC0304|Dorzolamide Alvogen|augndr|20|mg/ml|5|ml|1|ílát||S01EC03|01.01.2019||R|0|0|0|G|0|POF|0|0|0|100|XEU|2014|4270|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||2014||2014|4270||2|0|G|0|||0 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2300|4664|lyfalmen|V0472|4664|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4664||2|0|G|0|||0 498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6806|3050|lyfalmen|V0683|3050|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1128||1128|3050||2|0|G|0|||0 498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|SAS|0|0|0|100|NOK|66541|107264|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||66541||66541|107264||1|0||0|||0 498656|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2019||R|1|0|0|G|0|BFP|0|0|0|100|XEU|7418|5469|lyfalmen|V0234|5469|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2885||2885|5469||1|0|G|0|||0 498877|N06BA0905|Atomoxetin STADA|hylki|10|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4000|4182|lyfalmen|V0812|4182|2|30|0|3,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1950||1950|4182||2|0|E|0|||0 498978|G03AC0904|Desirett|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.03.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|1587|3086|lyfalm11|V0590|3086|2|84|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Desógestrel||1416||1416|3086||2|0||0|||0 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|PLS|0|0|0|100|DKK|25536|35572|lyfalmen|V0718|25308|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||25536||25536|35572||1|0|G|0|||0 499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|21601|30595|lyfalmen|V0664|30595|1|28|0|14,0000|Eisai AB|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9400|14436|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||9400|14436||2|0|G|0|||0 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|6449|10374|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||6449||6449|10374||2|0|G|0|||0 499865|J01FA0905|Clarithromycin Alvogen|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.10.2020||R|1|0|0|0|0|POF|0|0|1|100|IKR|2475|3700|lyfalmen|V0116|3063|2|14|0|14,0000|Alvogen|Alvogen|Klaritrómýcín||1600||1600|3700||2|0|E|0|||0 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|10575|16053|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||10575||10575|16053||1|0||0|||0 500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|900|2530|lyfalmen|V0050|2530|2|100|0|16,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||750||750|2530||2|0|G|0|||0 500476|L01XE3901|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01XE39|01.04.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|2117390|2639952|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||2117390||2117390|2639952||1|0|L|0|||0 500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|1|0|1|GSE|0|0|0|100|DKK|66477|87354|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||66477||66477|87354||2|0|S|0|||0 501204|R03DX0801|Cinqaero|irþ|10|mg/ml|2,5|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|1|TVB|0|1|0|100|NOK|17280|25282|lyfsjukr|||1|2,5|0|3,5211|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||17280||17280|25282||1|H|L|0|||0 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|6083|9871|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||6083||6083|9871||1|0|G|0|||0 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2015||R|1|1|0|0|0|HES|0|0|0|100|DKK|14993|15602|lyfalmen|V0997|10136|1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||10247||10247|15602||1|0|E|1|30|dagar|0 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29022|39981|lyfalmen|V0974|36080|1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||29022||29022|39981||2|0|G|0|||0 501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 501950|R03DC0306|Montelukast ratiopharm|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|5800|9481|lyfalmen|V0490|9481|2|98|0|98,0000|Alvogen|Teva Sweden AB|Montelúkast||5800||5800|9481||2|0|G|0|||0 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2495|4932|lyfalmen|V0434|4932|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2495||2495|4932||2|0|G|0|||0 502157|L01XC2801|Imfinzi|irþ|50|mg/ml|2,4|ml|1|hgl|120 mg/2,4 ml|L01XC28|01.06.2019||R|0|0|0|0|1|AZE|0|1|0|100|SEK|112112|145947|lyfsjukr|||1|2,4|0||Vistor hf|AstraZeneca AB|Durvalumab||||112112|145947||1|H|L|0|||0 502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3816|4043|lyfalmen|V0143|3582|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1849||1849|4043||2|0|E|0|||0 502423|H05BX0106|Cinacalcet ratiopharm|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.04.2019||R|1|0|0|0|0|RTH|0|0|0|100|XEU|63950|20046|lyfalmen|||2|28|0|42,0000|Alvogen|ratiopharm GmbH|Cinacalcet||13476||13476|20046|31.10.2020|2|0|0|0|||0 502486|S01LA0501|Eylea|stl|40|mg/ml|1|áf.spr|1|pakki||S01LA05|01.08.2020||R|0|1|0|0|1|FIN|0|1|0|100|DKK|124826|161760|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||124826||124826|161760||2|H|L|0|||0 502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|1774|3940|lyfalmen|V0926|3940|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||1774||1774|3940||2|0|G|0|||0 502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3335|5748|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||3335||3335|5748||2|0||0|||0 502790|A10BD2401|Steglujan|filmhtfl|105|mg|28|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|10998|16404|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10830||10830|16404||1|0|G|0|||0 502843|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfpen|m. áfastri nál og nálarhlíf|L04AC16|01.03.2019||R|0|0|1|0|1|JCI|0|1|0|100|SEK|358782|452736|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||358782||358782|452736||1|0|L|0|||0 502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|5950|9688|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||5950||5950|9688||1|0|G|0|||0 503078|N02BE0115|Paracet|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.04.2019||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0|0|0|||0 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|G|0|EIG|0|0|0|100|SEK|21601|30595|lyfalmen|V0665|30595|1|28|0|21,0000|Vistor hf|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|G|0|ZEN|0|0|0|100|SEK|5097|8513|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||5097||5097|8513||1|0|G|0|||0 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|4417|7577|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|albumin||4417||4417|7577||2|H|S|0|||0 504026|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.10.2019||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1573|2986|lyfalmen|V0494|2836|2|90|0|180,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||1081||1081|2986||1|0|G|0|||0 504120|R03AL0302|Anoro Ellipta|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|6716|10742|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og umeclidinium bromide||6716||6716|10742||1|0|G|0|||0 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|1|0|1|UPJ|0|0|0|100|DKK|39013|52617|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Upjohn EESV|Síldenafíl||39013||39013|52617||1|0|ES|0|||0 504231|N02AB0310|Fentanyl Alvogen|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|2131|4431|lyfalmen|V0219|4048|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||2131||2131|4431||2|0|G|1|30|dagar|0 504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|588|2307|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||588||588|2307||1|0|G|0|||0 504763|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.09.2020||R|0|1|0|0|1|GRP|0|0|0|100|XEU|11750|5907|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||3203||3203|5907||1|H|0|0|||0 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|14396|27483|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||14396||14396|27483||1|0||0|||0 505003|S01ED5122|Fixopost|augndr|||0,2|ml|30|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|2611|5092|lyfalmen|||2|6|0|30,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||2611||2611|5092||1|0|G|0|||0 505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2874|lyfalmen|V0335|2601|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2874||2|0|G|0|||0 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 505803|N06BA0703|Aspendos|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|5200|7829|lyfalmen|V0657|7829|2|30|0|10,0000|LYFIS ehf|Medochemie Limited|Modafinil||4600||4600|7829||2|0|E|2|||0 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|1|PLS|0|0|0|100|DKK|3273|6003|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3273||3273|6003||1|H|S|0|||0 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|1|PLS|0|0|0|100|DKK|8183|12761|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8183||8183|12761||1|H|S|0|||0 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|G|0|EIG|0|0|0|100|SEK|21601|30595|lyfalmen|V0664|30595|1|28|0|14,0000|Vistor hf|Eisai GmbH|Perampanel||21601||21601|30595||1|0|G|0|||0 506553|C01CA1703|Hypotron|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|RET|0|0|0|100|IKR|7114|11290|lyfalmen|V0968|10556|2|50|0|4,1666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||7114||7114|11290||2|0||0|||0 506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5601|7554|lyfalmen|V0831|7554|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4400||4400|7554||2|0|G|0|||0 506938|N02AA0507|OxyContin Depot|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|15335|22605|lyfalmen|V0587|14090|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||15335||15335|22605||2|0|G|1|30|dagar|0 507822|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0812|3903|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|4233|7324|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||4233||4233|7324||2|0|G|0|||0 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|2006|4259|lyfalmen|V0092|4259|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||2006||2006|4259||1|0|G|0|||0 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|G|0|AML|0|0|1|100|SEK|908|2748|lyfalmen|||1|5|0||Amdipharm Limited|Amdipharm Limited|Fúsidínsýra||908||908|2748||2|0|G|0|||0 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3276|3838|lyfalmen|V0687|2766|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|762|2299|lyfalmen|V0555|2109|2|2|0|1,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||582||582|2299||1|0|E|0|||0 508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|MVA|0|0|0|100|DKK|21071|29924|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||21071||21071|29924||1|0||0|||0 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5253|10136|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5253|10136||2|0||0|||0 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4732|9148|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4732||4732|9148||2|0||0|||0 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|14022|26773|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||14022||14022|26773||2|0||0|||0 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|1|SGB|0|1|0|100|XEU|666376|835296|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||666376||666376|835296||1|H|L|0|||0 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|G|0|LBK|0|0|0|100|DKK|9202|14164|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9202||9202|14164||1|0|G|0|||0 509050|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.06.2020||R|0|1|1|G|0|ATE|0|0|0|100|XEU|7072|5957|lyfalmen|V0187|5957|2|50|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mýcófenólsýra||3240||3240|5957||1|0|G|0|||0 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2|0||0|||0 509259|J07BB0209|VaxigripTetra|stl|15|mcg|0,5|ml|1|áfspr|dreifa í áf. sprautu|J07BB02|01.06.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|1493|3553|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Inflúensa, hreinsaðir mótefnavakar||1493||1493|3553||2|0||0|||0 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2|0||0|||0 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|BAB|0|0|0|100|DKK|2262|4128|lyfalm11|V0134|3477|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||2262||2262|4128||2|0||0|||0 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|1|0|1|VIC|0|0|0|100|DKK|46487|62070|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín og lamívúdín||46487||46487|62070||1|0|S|0|||0 509776|A02BC0513|Esomeprazole Jubilant|sþ-tfl|40|mg|56|stk|1|þpakki||A02BC05|01.09.2019||R|1|0|0|0|0|JUB|0|0|1|100|IKR|3164|4113|lyfalmen|V0012|3277|2|56|0|74,6700|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól||1900||1900|4113||2|0|E|0|||0 509806|L01XC2401|Darzalex|stl|1800|mg|15|ml|1|hgl|120mg/ml|L01XC24|01.10.2020||R|0|1|0|0|1|JCI|0|1|0|100|SEK|849014|1062447|lyfsjukr|||1|15|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||849014||849014|1062447||1|H|L|0|||0 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|24257|33954|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche Registration GmbH|Epóetín||24257||24257|33954||2|0|S|0|||0 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|64916|85379|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche Registration GmbH|Epóetín||64916||64916|85379||2|0|S|0|||0 510462|J01DH0205|Meropenem WH|sts/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|1|WEH|0|0|1|100|XEU|25634|26369|lyfsjukr|||2|10|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Meropenem||18070||18070|26369||2|0|S|0|||0 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|495|2179|lyfalmen|V0601|2168|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||495||495|2179||1|0|G|0|||0 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|154530|198703|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||154530|198703||1|0|S|0|||0 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4281|3970|lyfalmen|V0445|2984|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fínasteríð||1796||1796|3970||1|0|G|0|||0 510983|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|4149|4939|lyfalmen|V0687|4939|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||2500||2500|4939||2|0|E|0|||0 511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|ATE|0|0|1|100|XEU|836|2649|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||836||836|2649||1|0|E|3|||0 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2767|5306|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2767||2767|5306||1|0|G|0|||0 511418|A10BD2301|Segluromet|filmhtfl|1002,5|mg|196|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|22012|31114|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||22012||22012|31114||1|0|G|0|||0 511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|1|WIL|0|0|0|100|XEU|2716|5236|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2716|5236||2|H|S|0|||0 511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|45642|61002|lyfalmen|||1|1,08|0|3,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||45642||45642|61002||1|0|G|0|||0 511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 511900|B02BC3002|TISSEEL|vefjalím|||2|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|1|BAM|0|0|0|100|SEK|17487|25567|lyfsjukr|||1|2|0||Icepharma hf|Baxter Medical AB|Blöndur||17487||17487|25567||2|H|S|0|||0 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|BAB|0|0|0|100|DKK|16690|21905|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||16690||16690|21905||2|0|E|0|||0 512465|J05AR0304|Emtricitabine/Tenofovir disoproxil Mylan|filmhtfl|445|mg|30|stk|1|þpakki|200+245 mg|J05AR03|01.06.2020||R|1|1|1|0|1|ASD|0|1|0|100|DKK|54697|72454|lyfsjukr|||2|30|0|30,0000|Icepharma hf|Mylan S.A.S.|Tenófóvír dísóproxíl og emtrícítabín||54697||54697|72454||2|0|L|0|||0 512477|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.01.2020||R|1|0|0|G|0|SHS|0|0|1|100|DKK|2877|2371|lyfalmen|V0006|2186|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||634||634|2371||1|0|G|0|||0 512532|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|1|FKA|0|0|0|100|DKK|6890|10981|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||6890||6890|10981||1|0|S|0|||0 512821|H02AB0912|Alkindi|kyrnhylk|0,5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|7789|12219|lyfalmen|||1|50|0|0,8333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||7789||7789|12219||2|0|G|0|||0 512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1971|3563|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1500||1500|3563||2|0|G|0|||0 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1098|2439|lyfalmen|V0109|2419|2|100|0|66,6700|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||684||684|2439||1|0|G|0|||0 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2|0||0|||0 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|3901|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||1985||1985|3901||2|0|0|0|||0 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|2767|5420|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2767||2767|5420||2|0||0|||0 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2177|3943|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2006||2006|3943||2|0|0|0|||0 513993|N02BG0901|Penthrox|innö.guf|99,9|%|3|ml|1|glas||N02BG09|01.10.2019||R|0|0|0|0|1|MUP|0|0|0|100|DKK|5281|8767|lyfsjukr|||1|3|0||Icepharma hf|Mundipharma A/S|Methoxyflurane||5281||5281|8767||2|H|0|0|||0 514029|C03DA0407|Eplerenon Krka|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9764|6040|lyfalmen|V0111|6040|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||3300||3300|6040||2|0||0|||0 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2000|4251|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4251||2|0|G|0|||0 514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6000|7554|lyfalmen|V0910|7540|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4400||4400|7554||2|0|G|0|||0 514280|J07BB0207|Influvac Tetra|stl|||0,5|ml|10|áf.spr|með nál|J07BB02|01.10.2019||R|0|0|0|0|0|MDK|0|0|0|100|DKK|16665|24436|lyfalmen|||1|5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir mótefnavakar||16665||16665|24436||2|0||0|||0 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|DAN|0|0|0|100|XEU|18767|27329|lyfalmen|V0818|12722|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||18767|27329||2|0|E|0|||0 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|2131|2530|lyfalmen|V0692|2501|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2530||2|0|G|0|||0 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|0|PLS|0|0|0|100|DKK|4331|5529|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2929||2929|5529||1|0|G|0|||0 515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2|0||0|||0 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|13004|19397|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||13004||13004|19397||3|0|G|0|||0 515699|C08CA0106|Amlodipin Medical Valley|töflur|5|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1651|2589|lyfalmen|V0056|2589|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||793||793|2589||2|0|G|0|||0 516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|129110|167088|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||129110|167088||2|0|L|0|||0 516694|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.08.2019||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1800|3136|lyfalmen|V0069|2750|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1190||1190|3136||2|0|G|0|||0 516803|L01XE0105|Imatinib ratiopharm|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|1|0|1|RTH|0|1|0|100|XEU|107423|71517|lyfsjukr|||2|120|0||Alvogen|ratiopharm GmbH|Imatiníb||53956||53956|71517||2|0|L|0|||0 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|7340|11601|lyfalmen|V0384|11601|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||7340||7340|11601||1|0|G|0|||0 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|9000|5077|lyfalmen|V0273|5077|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||2600||2600|5077||2|0|G|0|||0 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3128|5803|lyfalmen|V0462|3661|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3128||3128|5803||1|0|G|0|||0 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|31853|43561|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai GmbH|Rúfínamíð||31853||31853|43561||1|0|G|0|||0 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3328|6079|lyfalmen|V0471|3723|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3328||3328|6079||1|0|G|0|||0 517803|H02AB0208|Dexavit|stl|4|mg/ml|1|ml|3|lykjur||H02AB02|01.03.2019||R|0|0|0|0|0|VIT|0|0|1|100|DKK|3810|6742|lyfalmen|||2|3|0|8,0000|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||3810||3810|6742||1|0|0|0|||0 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3581|6427|lyfalmen|V0472|3498|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3581||3581|6427||1|0|G|0|||0 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|30475|41818|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||30475||30475|41818||2|H|S|0|||0 517914|QI09AL0801|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL08|01.01.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|10577|18231|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||10577||10577|18231||2|0||0|||0 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|12509|lyfalmen|V0711|12509|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||8000||8000|12509||2|0|G|0|||0 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|1149|3079|lyfalmen|||1|20|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||1149||1149|3079||1|0|G|0|||0 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|4762|8052|lyfalmen|||1|100|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||4762||4762|8052|31.10.2020|1|0|G|0|||0 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|MBV|0|0|0|100|DKK|2143|3981|lyfalm11|V0590|3086|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||2143||2143|3981||1|0||0|||0 518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1301|3289|lyfalmen|V0004|2839|2|28|0|18,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||1301||1301|3289||1|0|E|0|||0 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|16807|24631|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||16807||16807|24631||1|0|G|0|||0 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|1032|2918|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1032||1032|2918||2|0|E|0|||0 519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|2728|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8739||2|0|G|0|||0 519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|792|2113|lyfalmen|V0564|2113|2|100|0|50,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||447||447|2113||2|0|G|0|||0 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|Sulfadiazinum og trimethoprimum||||2463|4841||2|0||0|||0 519172|L01XE0303|Erlotinib WH|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.06.2020||R|0|1|1|0|1|WEH|0|1|0|100|XEU|279337|309198|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlótiníb||243372||243372|309198||2|0|L|0|||0 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|AEP|0|0|1|100|DKK|1124|3045|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1124||1124|3045||2|0|E|0|||0 519722|N07BC0102|Buvidal|stl|64|mg|0,18|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|61863|81518|lyfsjukr|||1|0,18|0|8,0000|Vistor hf|Camurus AB|Búprenorfín||61863||61863|81518||1|H|L|1|30|dagar|0 519755|L01XE3901|Rydapt|hylki|25|mg|56|stk|1|þpakki|2x28|L01XE39|01.03.2020||R|0|0|1|0|1|NEL|0|1|0|100|DKK|1023645|1279639|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1023645||1023645|1279639||1|0|L|0|||0 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|3231|5945|lyfalmen|V0515|4251|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3231||3231|5945||1|0|G|0|||0 520082|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|112|stk|1|þpakki||C09CA01|01.07.2020||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1629|3740|lyfalmen|V0213|3740|2|112|0|28,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1629||1629|3740||2|0|G|0|||0 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|24262|33960|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||24262||24262|33960||1|0|G|0|||0 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|18417|26847|lyfalmen|V0143|3582|1|12|0|12,0000|Icepharma hf|Upjohn EESV|Síldenafíl||18417||18417|26847||1|0|E|0|||0 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|5993|9747|lyfalmen|V0144|1381|1|4|0|8,0000|Icepharma hf|Upjohn EESV|Síldenafíl||5993||5993|9747||1|0|E|0|||0 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|16581|24320|lyfalmen|V0144|4142|1|12|0|24,0000|Icepharma hf|Upjohn EESV|Síldenafíl||16581||16581|24320||1|0|E|0|||0 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1507|2785|lyfalmen|V0056|2312|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||935||935|2785||1|0|G|0|||0 520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|0|1|IND|0|0|0|100|DKK|12559|18784|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||12559||12559|18784||1|0|ES|1|30|dagar|0 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2437|2785|lyfalmen|V0057|2312|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||935||935|2785||1|0|G|0|||0 520633|N06AB0607|Sertralin Krka|filmhtfl|100|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|9292|8380|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Sertralín||5000||5000|8380||2|0|G|0|||0 520659|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|12533|9685|lyfalmen|V0440|9648|2|90|0|90,0000|Icepharma hf|Mylan AB|Sólífenacín||5948||5948|9685||2|0|G|0|||0 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|687|2444|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||687||687|2444||2|0|G|0|||0 520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0 521273|B01AA0303|Warfarin Teva|töflur|3|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1714|3857|lyfalmen|||2|100|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1714||1714|3857||1|0|G|0|||0 521428|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 522158|L01XC0302|Kanjinti|st/irþ|420|mg|1|hgl|1|pakki||L01XC03|01.07.2020||R|0|0|0|0|1|AEB|0|1|0|100|DKK|216914|276292|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||216914||216914|276292||1|H|L|0|||0 522175|N02BE0124|Paracaff|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE01|01.04.2019||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,7666|Acare ehf|Acare ehf|Paracetamól|||||||2|0|0|0|||0 522290|C01BD0702|Dronedarone STADA|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2020||R|1|1|1|0|0|ASR|0|0|0|100|IKR|12900|19253|lyfalmen|V1027|19253|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Dronedarón||12900||12900|19253||2|0|E|0|||0 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|92696|120516|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||92696||92696|120516||2|0|S|0|||0 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|1|NEL|0|0|0|100|DKK|157478|202370|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||157478||157478|202370||1|H|S|0|||0 522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2|0||0|||0 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5174|3670|lyfalmen|V0285|3287|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||1578||1578|3670||1|0|G|0|||0 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1916||1|0|G|0|||0 523346|L01XC0304|Ontruzant|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.05.2020||R|0|0|0|0|1|SUN|0|1|0|100|DKK|87417|113839|lyfsjukr|||1|150|0||Vistor hf|Samsung Bioepis NL B.V.|Trastuzumab||87417||87417|113839||1|H|L|0|||0 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|181697|232491|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||181697||181697|232491||1|H|S|0|||0 523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1754|2691|lyfalmen|V0144|1381|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||867||867|2691||1|0|E|0|||0 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|1|0|1|NEL|0|1|0|100|DKK|371577|468649|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||371577||371577|468649||1|0|L|0|||0 523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2|0||0|||0 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1018|2899|lyfalmen|V0903|2618|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1018||1018|2899||1|0|G|0|||0 523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10278|7004|lyfalmen|V0954|6976|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||4000||4000|7004||2|0|E|0|||0 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1627|3737|lyfalmen|V0584|3737|2|28|0|7,4700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||1627||1627|3737||1|0|G|1|30|dagar|0 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|G|0|TOG|0|0|0|100|SEK|359|1992|lyfalmen|||1|28|0|21,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||359||359|1992||1|0|G|0|||0 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0 524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|3042|lyfalmen|||2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1122||1122|3042||2|0|G|0|||0 524630|N03AX1610|Pregabalin Medical Valley|hylki|300|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2900|3824|lyfalmen|||2|70|0|70,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1690||1690|3824|31.10.2020|2|0|E|0|||0 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|GAL|0|0|0|100|XEU|7345|11608|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||7345||7345|11608||2|0|E|0|||0 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1375|3390|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||1375||1375|3390||2|0|G|0|||0 525122|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GLZ|0|0|0|100|DKK|4233|6431|lyfalmen|V0437|6431|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||3584||3584|6431||2|0|G|0|||0 525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|1|BAM|0|0|1|100|SEK|4795|8098|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4795||4795|8098||2|0|S|0|||0 525689|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfpen||N02CD03|01.07.2020||R|0|0|1|0|0|TGH|0|0|0|100|XEU|82398|100317|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||76726||76726|100317||1|0|E|0|||0 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|33118|45161|lyfalmen|V0977|45161|1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||33118|45161||2|0|G|0|||0 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|5214|8674|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||5214||5214|8674||2|H|S|0|||0 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|4746|8030|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||4746||4746|8030||2|H|S|0|||0 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|2652|5148|lyfsjukr|||2|1000|0|2,5000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2652|5148||2|0|ES|0|||0 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4863||2|0||0|||0 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4925||2|0||0|||0 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|6385|10286|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||6385||6385|10286||1|0|G|0|||0 526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|9168|5902|lyfalmen|V0516|5902|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3200||3200|5902||2|0|G|0|||0 526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|11133|lyfalmen|V0423|11133|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||7000||7000|11133||2|0|G|0|||0 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|15733|6943|lyfalmen|V0111|6040|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||3956||3956|6943||2|0|E|0|||0 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|4047|7068|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4047||4047|7068||1|0|G|0|||0 527132|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|18|stk|1|þpakki||N02CC04|01.06.2019||R|0|0|0|G|0|MSD|0|0|0|100|DKK|6852|10929|lyfalmen|V0621|8106|1|18|0|18,0000|Vistor hf|M.S.D.|Rizatriptan||6852||6852|10929||1|0|G|0|||0 527412|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.11.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|4172|6849|lyfalmen|V0054|3975|2|100|0|133,3333|Artasan ehf|Hexal A/S|Metóprólól||3888||3888|6849||1|0|G|0|||0 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|11366|7075|lyfalmen|V0516|5902|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4052||4052|7075||1|0|G|0|||0 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1640|3755|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1640||1640|3755||1|0|G|0|||0 527632|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|áfpen|FlexTouch|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5558|9148|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5558||5558|9148||1|0|G|0|||0 527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2273|3150|lyfalmen|V0825|2811|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1200||1200|3150||2|0|G|0|||0 527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|266551|338026|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||266551||266551|338026||1|0|G|0|||0 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|RPG|0|0|0|100|XEU|1873|3681|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|Prednisolonum og sýkingalyf||1873||1873|3681||2|0||0|||0 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1031|2500|lyfalmen|V0046|2500|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||728||728|2500||1|0|G|0|||0 528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3884|6844|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3884||3884|6844||2|0||0|||0 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13632|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13632||2|0|G|0|||0 528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Skópólamín|||||3251||1|0||0|||0 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|10039|6624|lyfalmen|V0011|5040|1|100|0|66,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||3724||3724|6624||1|0|G|0|||0 528303|N02AA0507|OxyContin Depot|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|2728|5253|lyfalmen|V0584|3737|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2728||2728|5253||2|0|G|1|30|dagar|0 528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|668|2349|lyfalmen|V0562|2349|2|100|0|33,3300|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||618||618|2349||2|0|G|0|||0 528418|D07AC1302|Ovixan|krem|1|mg/g|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|2073|4351|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||2073||2073|4351||1|0|G|0|||0 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|G|0|FEL|0|0|0|100|DKK|6783|10834|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6783||6783|10834||1|0|G|0|||0 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|G|0|RTH|0|0|0|100|XEU|4801|8106|lyfalmen|V0621|8106|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||4801||4801|8106||2|0|G|0|||0 528948|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|17299|25308|lyfalmen|V0718|25308|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||17299||17299|25308||1|0|G|0|||0 529142|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|100|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|5698|9067|lyfalmen|V1003|9067|2|100|0|6,6667|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5499||5499|9067||2|0|E|1|30|dagar|0 529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|KNM|0|0|0|100|IKR|9787|14969|lyfalmen|V0963|14969|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||9787||9787|14969||2|0|E|0|||0 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|1|PLS|0|0|0|100|DKK|66733|87677|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||66733||66733|87677||1|H|S|0|||0 529955|J05AE0803|Atazanavir Krka|hylki|300|mg|30|stk|1|glas||J05AE08|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|39565|53315|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Atazanavír||39565||39565|53315||2|0|S|0|||0 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7560||1|0|E|0|||0 530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2488|3081|lyfalmen|V0824|3081|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3081||2|0|G|0|||0 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|1674|3290|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||1674||1674|3290||2|0||0|||0 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2933|5535|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2933||2933|5535||1|0|G|0|||0 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|6531|10487|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6531||6531|10487||1|0|S|0|||0 531360|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|7215|6887|lyfalmen|V0622|6647|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3915||3915|6887||1|0|E|1|30|dagar|0 531382|A10BK0401|Steglatro|filmhtfl|15|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|21381|30316|lyfalmen|||1|98|0|147,0000|Vistor hf|M.S.D.|Ertugliflozin||21381||21381|30316||1|0|G|0|||0 531501|N05CH0105|Slenyto|forðatfl|1|mg|60|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|7190|6267|lyfalmen|||2|60|0|30,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||3465||3465|6267||2|0|0|0|||0 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|JAS|0|0|0|100|SEK|861|2683|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||861||861|2683||1|0||0|||0 532526|L04AA4201|Mayzent|filmhtfl|0,25|mg|12|stk|1|þpakki|Skammtastillingarpakkning|L04AA42|01.11.2020||R|1|1|1|0|1|NEP|0|0|0|100|DKK|26293|36529|lyfsjukr|||1|12|0||Vistor hf|Novartis Europharm Limited|Siponimod||26293||26293|36529||1|0|0|0|||0 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|G|0|WEH|0|0|0|100|XEU|47581|12886|lyfalmen|V0711|11169|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||8274||8274|12886||2|0|G|0|||0 532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|0|1|WEH|0|1|0|100|XEU|120912|156892|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||120912||120912|156892||2|H|L|0|||0 532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|27322|47092|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||27322||27322|47092||2|0||0|||0 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|2006|4259|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2006||2006|4259||2|0|S|0|||0 532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1389|3410|lyfalmen|||2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1389||1389|3410||1|0|E|3|||0 533001|A10BA0205|Metformin EQL|filmhtfl|500|mg|105|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|500|2186|lyfalmen|V0500|2186|2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Metformín||500||500|2186||2|0|G|0|||0 533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|255945|324835|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||255945||255945|324835||2|0|L|0|||0 533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|1|RRG|0|1|0|100|DKK|831340|1040465|lyfsjukr|||1|10|0|91,1854|Icepharma hf|Roche Registration GmbH|Ocrelizumab||||831340|1040465||2|H|L|0|||0 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|23237|32664|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||23237||23237|32664||1|0|G|0|||0 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|1|G|0|PEU|0|0|0|100|DKK|60295|79535|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||60295||60295|79535||1|0|G|0|||0 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|CES|0|0|0|100|XEU|3083|6020|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Amoxicillinum||3083||3083|6020||2|0||0|||0 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|5481|5283|lyfalmen|V0117|5283|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2750||2750|5283||2|0|E|0|||0 534712|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2480|4911|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2480||2480|4911||2|0|G|1|30|dagar|0 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|5378|8900|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5378||5378|8900||2|H|S|0|||0 534942|R01AD5801|Dymista|nefúði|187|mcg/sk|120|skammtar|1|glas|137+50mcg|R01AD58|01.10.2019||R|0|0|0|G|0|MEA|0|0|1|100|DKK|3238|5955|lyfalmen|||1|120|0|30,0000|Icepharma hf|Meda AB|Fluticasone í samsetningum||3238||3238|5955||2|0|G|0|||0 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|2307|4673|lyfalmen|V0092|4259|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2307||2307|4673||1|0|G|0|||0 535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2575|4438|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2575||2575|4438||1|0||0|||0 535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2378|2984|lyfalmen|V0826|2870|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1080||1080|2984||2|0|G|0|||0 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2|0||0|||0 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|385|2028|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||385||385|2028||1|0|G|0|||0 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|400|2048|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||400||400|2048||1|0|G|0|||0 536179|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|10|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|1|AEE|0|0|0|100|XEU|6409|10319|lyfsjukr|||2|100|0|33,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||6409||6409|10319||1|H|S|2|450|mg|0 536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0112|2750|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0 536429|A02BA0208|Asýran|filmhtfl|150|mg|30|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|L|1|0|0|0|0|TEE|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín|||||||1|0||||| 536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|90217|117380|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||90217||90217|117380||1|0|E|0|||0 536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|POF|0|0|1|100|IKR|14133|10995|lyfalmen|V0419|10582|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||6900||6900|10995||2|0|E|0|||0 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|2689|5199|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2689||2689|5199||2|H|S|0|||0 536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9856|15064|lyfalmen|V0611|15064|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||9856||9856|15064||1|0|G|0|||0 536958|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|2|stk|1|þpakki||N02CC04|01.08.2020||L|0|0|0|0|0|POF|0|0|0|100|XEU|||lyflausa|||2|2|0|2,0000|Alvogen|Alvogen|Rizatriptan|||||||2|0|0|0|||0 537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|1|0|1|GSE|0|0|0|100|DKK|66477|87354|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||66477||66477|87354||2|0|S|0|||0 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|1|FKA|0|0|1|100|DKK|5664|9294|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5664||5664|9294||1|0|S|0|||0 537580|R03DC0306|Montelukast ratiopharm|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.07.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|9164|14111|lyfalmen|V0492|14111|2|98|0|39,2000|Alvogen|Teva Sweden AB|Montelúkast||9164||9164|14111||2|0|G|0|||0 537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1500|3563|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G|0|||0 537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|14000|13473|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13473||2|0|G|0|||0 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2486||1|0|G|0|||0 537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||2|0||0|||0 538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7862|12319|lyfalmen|V0609|12319|2|56|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||7862||7862|12319||1|0|E|0|||0 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0 538272|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|1166|3103|lyfalmen|||3|12|0|0,5000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||1166||1166|3103||3|0|G|0|||0 538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3062|5712|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3062||3062|5712||2|0|G|0|||0 538713|R03BB0702|Incruse Ellipta|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4772|8066|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Umeclidiniumbrómið||4772||4772|8066||1|0|G|0|||0 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|1|G|0|SNP|0|0|0|100|XEU|8800|13610|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||8800||8800|13610||1|0|G|0|||0 539310|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|rörlyk|Penfill|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5268|8749|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5268||5268|8749||1|0|G|0|||0 539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|1|BMS|0|1|0|100|DKK|70010|91822|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||70010||70010|91822||1|H|L|0|||0 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|806|2607|lyfalmen|||2|25|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||806||806|2607||1|0||2|130|töflur|0 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|0|100|DKK|901|2738|lyfalmen|||2|100|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||901||901|2738||1|0||2|130|töflur|0 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1|0||0|||0 539793|L01XE4201|Kisqali|filmhtfl|200|mg|63|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|530148|665867|lyfsjukr|||1|63|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||530148||530148|665867||1|0|L|0|||0 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1845|4037|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1845||1845|4037||1|0|G|0|||0 539990|C10AX0905|Ezetimibe ratiopharm|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.12.2018||R|1|0|0|0|0|RTH|0|0|0|100|DKK|10065|7010|lyfalmen|V0954|6836|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Ezetimíb||4005||4005|7010||2|0||0|||0 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|1|FKA|0|0|0|100|DKK|19776|28718|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||19776||19776|28718||1|0|S|0|||0 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|44894|14217|lyfalmen|V0721|8409|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||9241||9241|14217||2|0||0|||0 540141|N03AX1213|Gabapentin Teva|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.10.2019||R|1|0|0|G|0|TVA|0|0|0|100|DKK|13943|18856|lyfalmen|V0256|18856|2|100|0|44,4400|Alvogen|Teva B.V.|Gabapentín||12611||12611|18856||2|0|G|0|||0 540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|1|TEA|0|0|0|100|SEK|22965|32320|lyfsjukr|||1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||22965||22965|32320||1|H|S|0|||0 540503|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|60|pokar|lausn|B05BB01|01.03.2020||R|0|0|0|0|1|BAM|0|0|1|100|DKK|7951|12442|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7951||7951|12442||2|0|S|0|||0 540752|H01CB0203|Octreoanne|sts|30|mg|30|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|1|TVI|0|0|0|100|NOK|171628|163138|lyfsjukr|||2|30|0|42,8600|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||125934||125934|163138||1|0|S|0|||0 540854|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3631|lyfalmen|V0686|3631|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1550||1550|3631||2|0|E|0|||0 540857|L01XC3201|Tecentriq|irþ|840|mg|14|ml|1|hgl|lausn|L01XC32|01.02.2020||R|0|1|0|0|1|RRG|0|1|0|100|DKK|519889|653108|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||519889||519889|653108||2|H|L|0|||0 540859|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0813|3903|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|1|0|1|CPV|0|1|0|100|XEU|690736|865593|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||||690736|865593||2|0|L|0|||0 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 541493|N03AX1602|Lyrica (Lyfjaver)|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|2449|4869|lyfalmen|V0685|2190|3|56|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||2449||2449|4869||3|0|E|0|||0 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|202600|258489|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||202600||202600|258489||1|0|L|0|||0 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|1|LEM|0|0|1|100|XEU|5562|9153|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||5562||5562|9153||2|0|ES|0|||0 542291|L01BC0603|Ecansya|filmhtfl|150|mg|60|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|4301|7418|lyfsjukr|||2|60|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||4301||4301|7418||2|0|S|0|||0 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|G|0|WEH|0|0|0|100|XEU|5688|3050|lyfalmen|V0682|3050|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1128||1128|3050||2|0|G|0|||0 542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|mælipumpa|G03CA03|01.07.2019||R|0|0|0|G|0|BES|0|0|0|100|DKK|1165|3101|lyfalmen|||2|64|0||Vistor hf|Besins Healthcare Ireland Limited|Estradíól||1165||1165|3101||1|0|G|0|||0 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|4159|7222|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||4159||4159|7222||2|0|S|0|||0 542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|XEU|18902|6829|lyfalmen|V0720|6829|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||3873||3873|6829||2|0||0|||0 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|18281|26660|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||18281||18281|26660||1|0|G|0|||0 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|G|0|BFP|0|0|0|100|IKR|3122|4030|lyfalmen|V0203|4026|2|12|0|84,0000|Vistor hf|Bluefish Pharmaceuticals AB|Alendrónsýra||1840||1840|4030||1|0|G|0|||0 543374|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|G|0|POF|0|0|0|100|XEU|1658|3780|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1658||1658|3780||2|0|G|0|||0 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|1|BAM|0|0|0|100|SEK|94299|122543|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||94299||94299|122543||2|H|S|0|||0 543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 544374|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|1|0|1|GSE|0|0|0|100|DKK|583627|732380|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||583627||583627|732380||2|0|S|0|||0 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|1|CSB|0|1|0|100|SEK|392358|494495|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||392358||392358|494495||2|H|L|0|||0 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|12451|18635|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12451||12451|18635||1|0|G|0|||0 544571|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|SHS|0|0|0|100|DKK|8974|10961|lyfalmen|V0145|4210|2|8|0|16,0000|Artasan ehf|Sandoz A/S|Tadalafíl||6875||6875|10961||1|0|E|0|||0 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37583|lyfalmen|||2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37583||2|0|G|0|||0 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|1|RRG|0|1|0|100|DKK|284925|360878|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||284925||284925|360878||2|H|L|0|||0 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|RTH|0|0|0|100|XEU|1734|3477|lyfalm11|V0134|3477|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1734||1734|3477||2|0||0|||0 545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0 545639|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3533|3865|lyfalmen|V0438|3824|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||1720||1720|3865||2|0|G|0|||0 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|947|2801|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||947||947|2801||1|0||0|||0 545705|N02AB0310|Fentanyl Alvogen|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5894|9445|lyfalmen|V0223|8754|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||5774||5774|9445||2|0|G|1|30|dagar|0 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|899|2735|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||899||899|2735||1|0|G|0|||0 545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|1|0|G|0|ATE|0|0|1|100|XEU|1272|2618|lyfalmen|V0903|2618|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prómetazín||814||814|2618||1|0|G|0|||0 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|2067|4343|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2067||2067|4343||1|0|G|0|||0 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|31054|42551|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||31054||31054|42551||1|0|G|0|||0 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|25038|34942|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||25038||25038|34942||1|0|G|0|||0 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|31237|42782|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||31237||31237|42782||1|0|G|0|||0 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|26538|36839|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||26538||26538|36839||1|0|G|0|||0 546319|A02BA0208|Asýran|filmhtfl|150|mg|10|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|L|1|0|0|0|0|TEE|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín|||||||1|0||||| 546660|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|570|2282|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||570||570|2282||2|0|G|1|30|dagar|0 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|4449|4337|lyfalmen|V0010|3916|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||2063||2063|4337||1|0|G|0|||0 547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|G|0|FER|0|0|0|100|DKK|16378|24041|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16378||16378|24041||1|0|G|0|||0 547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|1|RAU|0|0|1|100|XEU|3258|5982|lyfsjukr|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||3258||3258|5982||2|0|S|0|||0 547200|C09DA0312|Valsartan/Hydroklortiazid Jubilant|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|4100|6866|lyfalmen|V0581|6597|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan og þvagræsilyf||3900||3900|6866||2|0|G|0|||0 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|ORC|0|0|1|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5334||1|0||0|||0 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|1|RGP|0|0|0|100|DKK|9927|15161|lyfsjukr|||1|100|0|0,3800|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||9927||9927|15161||1|H|S|0|||0 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|1|RGP|0|0|0|100|DKK|3192|5891|lyfsjukr|||1|10|0|0,1000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||3192||3192|5891||1|H|S|0|||0 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|6806|10866|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6806|10866||2|0|S|0|||0 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|1|0|1|FIN|0|0|0|100|DKK|109657|142894|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||109657||109657|142894||2|0|S|0|||0 548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|2294|4655|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2294||2294|4655||2|0|G|0|||0 548162|M04AA0304|Aburic|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.03.2020||R|1|0|0|0|0|WEH|0|0|0|100|XEU|9483|14550|lyfalmen|V1011|14550|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|febuxostat||9483||9483|14550||2|0|E|0|||0 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|479|2157|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||479||479|2157||1|0|G|0|||0 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2215||1|0|G|0|||0 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|154089|198155|lyfsjukr|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||154089||154089|198155||2|H|S|0|||0 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|G|0|JAS|0|0|0|100|SEK|7132|11314|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||7132||7132|11314||1|0|G|0|||0 549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5283|lyfalmen|V0117|5283|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2750||2750|5283||2|0|E|0|||0 549476|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|10136|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0 549545|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.2020||R|0|0|0|0|0|CES|1|0|0|100|DKK|4563|8827|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4563||4563|8827||2|0||0|||0 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|32665|44588|lyfalmen|V0976|44258|1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||32665|44588||2|0|G|0|||0 550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|G|0|SAO|0|0|1|100|XEU|969|2832|lyfalmen|||2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||969||969|2832||2|0|G|0|||0 550147|QN01BB0201|Lidor vet.|stl|20|mg/ml|50|ml|1|hgl|lausn|QN01BB02|01.05.2019||R|0|0|0|0|0|RPG|1|0|0|100|XEU|1372|2697|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Lidocaine||1372||1372|2697||2|0||0|||0 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1600|2161|lyfalmen|V0551|2007|2|7|0|1,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||482||482|2161||1|0|E|0|||0 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.05.2019||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2518|4964|lyfalmen|V0471|4964|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4964||2|0|G|0|||0 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|G|0|BOI|0|0|0|100|DKK|1779|3947|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1779||1779|3947|31.10.2020|1|0|G|0|||0 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1|0||0|||0 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|1|BAM|0|0|0|100|SEK|7891|12359|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7891||7891|12359||2|H|S|0|||0 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|G|0|MEA|0|0|1|100|DKK|5184|8633|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||5184||5184|8633||2|0|G|0|||0 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1812|2276|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2691|3966|lyfalmen|V0467|2772|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|V0003|1117|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E|0|||0 551904|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|56740|75038|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||56740||56740|75038||1|H|L|0|||0 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2821|2276|lyfalmen|V0003|2234|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|5587|3966|lyfalmen|V0010|2193|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|1692|3827|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1692||1692|3827||2|0|S|0|||0 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0 552481|R06AE0501|Postafen|töflur|25|mg|20|stk|1|þpakki||R06AE05|01.05.2018||L|1|0|0|0|0|GOP|0|0|1|100|DKK|||lyflausa|||1|20|0|10,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1|0|0|0|||0 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|GBP|16502|26601|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||16502||16502|26601||1|0||0|||0 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|3305|6047|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3305||3305|6047||1|0|G|0|||0 552913|QJ01GB0301|Genta-Equine|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01GB03|01.01.2019||R|0|0|0|0|0|FRA|1|0|0|100|IKR|3657|7109|vetalmen|||0|100|0||Dýraheilsa ehf|Franklin Pharmaceuticals Ltd.|Gentamicin||3657||3657|7109||2|0||0|||0 553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|170731|218853|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||170731||170731|218853||2|H|S|0|||0 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|G|0|PLS|0|0|0|100|DKK|6603|10586|lyfalmen|V0237|10586|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||6603|10586||1|0|G|0|||0 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2493|4929|lyfalmen|V0237|3529|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||2493||2493|4929||1|0|G|0|||0 553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|G|0|EVO|0|0|1|100|IKR|5684|9321|lyfalmen|||2|100|0|66,6666|LYFIS ehf|Evolan Pharma AB|Alímemazín||5684||5684|9321||2|0|G|0|||0 553387|J01CR0205|Spectracillin|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.12.2018||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1430|2530|lyfalmen|V0169|2530|2|14|0|8,1667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill||750||750|2530||2|0||0|||0 553580|QN01BB0202|BelOcain vet.|stl|20|mg/ml|100|ml|12|hgl|lausn|QN01BB02|01.06.2019||R|0|0|0|0|0|Bel|1|0|0|100|IKR|15300|24075|vetalmen|||0|1200|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Lidocaine||12600||12600|24075||2|0||0|||0 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|1|0|1|NEL|0|1|0|100|DKK|469997|591056|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||469997||469997|591056||1|0|L|0|||0 554131|L01XC0303|Trazimera|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|1|PEU|0|1|0|100|DKK|90572|117829|lyfsjukr|||1|150|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||90572||90572|117829||1|H|L|0|||0 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|BID|1|0|0|100|DKK|9911|18974|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||9911||9911|18974||1|0||0|||0 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6820|6106|lyfalmen|V0029|6106|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klópídógrel||3348||3348|6106||1|0|G|0|||0 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1331164|1662107|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1331164||1331164|1662107||2|0|L|0|||0 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|1|0|1|NEL|0|1|0|100|DKK|177074|226742|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||177074||177074|226742||1|0|L|0|||0 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1713|3856|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1713||1713|3856||1|0|G|0|||0 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|2384|4779|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2384||2384|4779||1|0|G|0|||0 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1218|3174|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1218||1218|3174||1|0|G|0|||0 556146|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|21|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|2011|3012|lyfalmen|V0461|3012|2|21|0|5,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||1100||1100|3012||2|0|E|0|||0 556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2|0||0|||0 556578|N02BE5106|Panodil Extra|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE51|01.12.2019||L|1|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||1|0|0|0|||0 556694|C10AX1401|Praluent|stl|150|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|75364|98594|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||75364||75364|98594||1|0|E|0|||0 556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|VAL|0|0|0|100|DKK|12163|6976|lyfalmen|V0954|6976|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3980||3980|6976||2|0|E|0|||0 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|19815|28771|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||19815||19815|28771||2|0|L|0|||0 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|5009|8392|lyfalmen|V0972|7357|1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||5009||5009|8392||1|0|G|0|||0 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|10478|15920|lyfalmen|V0973|12914|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||10478||10478|15920||1|0|G|0|||0 557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10964|4326|lyfalmen|V0814|3903|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||2055||2055|4326||2|0|E|0|||0 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|1471|3523|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1471||1471|3523||2|0|G|0|||0 558386|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.07.2020||L|0|0|0|0|0|MAR|0|0|1|100|DKK|||lyfalmen|V1024|9436|1|20|0||Icepharma hf|Aspen Pharma|Blöndur|||||9436||2|0||0|||0 558417|L01XE1401|Bosulif|filmhtfl|400|mg|28|stk|1|þpakki||L01XE14|01.03.2019||R|1|0|1|0|1|PEU|0|1|0|100|DKK|533019|669438|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||533019||533019|669438||1|0|L|0|||0 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|1|NEL|0|1|0|100|DKK|237683|302122|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||237683|302122||1|0|L|0|||0 558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 559165|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.06.2020||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0 559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|4798|8102|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4798||4798|8102||1|0|G|0|||0 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1955||1|0|G|0|||0 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|1|CBV|0|1|0|100|XEU|42580|57129|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe B.V.|Paklítaxel||42580||42580|57129||2|H|L|0|||0 560293|L01XX4601|Lynparza|filmhtfl|100|mg|56|stk|1|þpakki||L01XX46|01.03.2020||R|0|0|1|0|1|AZA|0|1|0|100|SEK|384675|484939|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||384675||384675|484939||1|0|L|0|||0 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Acíklóvír|||||||1|0||0|||0 560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|1|COR|0|0|0|100|DKK|113413|147565|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||113413||113413|147565||1|H|S|0|||0 560682|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|1|0|1|ACC|0|1|0|100|XEU|176272|125852|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||96915||96915|125852||1|0|L|0|||0 561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 561239|L01XE2701|IMBRUVICA|filmhtfl|420|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|749637|938850|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||749637||749637|938850||1|0|L|0|||0 561745|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|innöndunartæki og 1 áfylling|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7168|11364|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||7168||7168|11364||1|0|G|0|||0 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|202600|258489|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||202600||202600|258489||1|0|L|0|||0 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1707|3139|lyfalmen|V0098|2488|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1192||1192|3139||1|0|G|0|||0 562176|B02BD0401|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD04|01.02.2013||R|0|0|1|0|1|PEU|0|0|0|100|DKK|51161|67982|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||51161||51161|67982||1|0|S|0|||0 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|4327|7454|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4327||4327|7454||1|0|G|0|||0 562419|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|979176|1224332|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||979176||979176|1224332||2|H|S|0|||0 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|1|RGP|0|1|0|100|DKK|87179|113538|lyfsjukr|||1|1|0|16,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||87179||87179|113538||1|H|L|0|||0 562774|H01CB0203|Octreoanne|sts|20|mg|20|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|1|TVI|0|0|0|100|NOK|134579|128118|lyfsjukr|||2|20|0|28,5700|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||98707||98707|128118||1|0|S|0|||0 563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015|31.10.2020|R|0|0|0|G|0|BOE|0|0|0|100|DKK|6547|10509|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||6547||6547|10509||1|0|G|0|||0 563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|34146|46461|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||34146||34146|46461||2|H|S|0|||0 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1419|3451|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1419||1419|3451||1|0|G|1|30|dagar|0 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|24530|9864|lyfalmen|V0720|6829|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||6078||6078|9864||2|0||0|||0 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3842|6786|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||||3842|6786||2|0|G|0|||0 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1398|2748||2|0||0|||0 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|RRD|0|0|0|100|DKK|472509|594180|lyfalmen|||1|60|0|15,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||472509||472509|594180||1|0|E|0|||0 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||10463||10463|18034||2|0||0|||0 563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2|0||0|||0 564048|J07BA0103|TicoVac|stl|2,4|mcg/sk|0,5|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3806|6736|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3806||3806|6736||1|0||0|||0 564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3200|5902|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||3200||3200|5902||2|0|G|0|||0 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|20694|29447|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||20694||20694|29447||3|0|L|0|||0 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|G|0|MBV|0|0|1|100|DKK|913|2755|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||913||913|2755||1|0|G|0|||0 564448|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1514|2697|lyfalmen|V0056|2312|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||871||871|2697||1|0|G|0|||0 564607|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4858|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E|1|30|dagar|0 564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2457|4235|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2457||2457|4235||1|0||0|||0 564892|H05BX0106|Cinacalcet ratiopharm|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.04.2019||R|1|0|0|0|0|RTH|0|0|0|100|XEU|42870|8409|lyfalmen|V0721|8409|2|28|0|28,0000|Alvogen|ratiopharm GmbH|Cinacalcet||5021||5021|8409||2|0|0|0|||0 565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2723|5246|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2723||2723|5246||1|0|S|0|||0 565303|C01CA0303|Noradrenalina Normon|irþ|1|mg/ml|10|ml|100|lykjur|lausn|C01CA03|01.04.2019||R|0|0|0|0|1|LNA|0|0|0|100|XEU|286065|308927|lyfsjukr|||2|1000|0||Williams & Halls efh|Laboratorios Normon, S.A.|Noradrenalín||243154||243154|308927||2|H|0|0|||0 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|8782|6109|lyfalmen|V0286|5627|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3350||3350|6109||2|0|G|0|||0 565423|A02BA0208|Asýran|filmhtfl|150|mg|60|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|R|1|0|0|G|0|TEE|0|0|1|100|XEU|920|2764|lyfalmen|||2|60|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín||920||920|2764||1|0|G|||| 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8894|17044|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|maropitant||||8894|17044||2|0||0|||0 565921|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|glas|95 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|2344|4381|lyfalmen|V0049|2943|2|100|0|66,6667|Artasan ehf|Hexal A/S|Metóprólól||2095||2095|4381||1|0|G|0|||0 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|1|FEL|0|0|0|100|DKK|24577|34359|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||24577||24577|34359||1|H|S|0|||0 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1573|3663|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1573||1573|3663||1|0|G|0|||0 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|15214|22438|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||15214||15214|22438||1|0|G|0|||0 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|1|0|1|NEL|0|0|0|100|DKK|192923|246453|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||192923||192923|246453||1|0|S|0|||0 567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3587|2806|lyfalmen|V0114|2806|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|G|0|APE|0|0|0|100|XEU|16483|24185|lyfalmen|V0651|24182|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16483||16483|24185||1|0|G|0|||0 567371|M05BA0306|Pamidronatdinatrium Pfizer|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|1|PLS|0|0|0|100|DKK|6359|10250|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||6359||6359|10250||1|H|S|0|||0 567372|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC05|01.09.2019||R|1|0|0|0|0|JUB|0|0|1|100|IKR|2000|4113|lyfalmen|V0011|2822|2|56|0|37,3300|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól||1900||1900|4113||2|0|E|0|||0 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||3403||2|0|G|0|||0 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5963|9705|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5963|9705||1|0|G|0|||0 567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|2129|4428|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2129||2129|4428||1|0|G|0|||0 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2713|5232|lyfalmen|V0291|2048|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2713||2713|5232||1|0|G|0|||0 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|3648|6519|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||3648||3648|6519||2|0|G|0|||0 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0 567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|364395|459717|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||364395|459717||2|0|E|0|||0 567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0 567837|G04BE0808|Tadalafil Sandoz|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.01.2018|30.09.2020|R|1|0|0|0|0|SHS|0|0|0|100|DKK|10004|15267|lyfalmen|||2|28|0|14,0000|Artasan ehf|Sandoz A/S|Tadalafíl||10004||10004|15267||1|0|E|||| 567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 568054|N02CD0101|Aimovig|stl|70|mg|1|ml|1|áfpen||N02CD01|01.12.2018||R|0|0|1|0|0|NEL|0|0|0|100|DKK|71173|93293|lyfalmen|||1|1|0|28,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||71173||71173|93293||1|0|E|0|||0 568324|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6651|11464|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6651||6651|11464||2|0|0|0|||0 568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|2446|2870|lyfalmen|V0826|2870|2|28|0|42,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||997||997|2870||2|0|G|0|||0 568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2874|lyfalmen|V0334|2601|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2874||2|0|G|0|||0 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1058|2954|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||1058||1058|2954||1|0||0|||0 568745|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.02.2020||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|28|0|18,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0|0|0|||0 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2649|2968|lyfalmen|V0058|2807|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||1068||1068|2968||1|0|G|0|||0 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4017|3480|lyfalmen|V0059|3262|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||1440||1440|3480||1|0|G|0|||0 569171|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|25|stk|1|þpakki||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|759|2543|lyfalmen|||2|25|0|12,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||759||759|2543||2|0|G|0|||0 569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2159|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||500||500|2186||2|0|G|0|||0 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|0|1|0|1|VIC|0|0|0|100|DKK|134204|173423|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare BV|Abacavír, dolutegravír og lamivudín||134204||134204|173423||1|0|S|0|||0 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|10789|16348|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10789||10789|16348||2|H|S|0|||0 569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|4800|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2874||2|0|G|0|||0 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|1|HES|0|0|0|100|DKK|13872|20591|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13872||13872|20591||1|0|S|0|||0 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|1|HES|0|0|0|100|DKK|15952|23454|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||15952||15952|23454||1|0|S|0|||0 569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|5971|lyfalmen|V0811|5670|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3250||3250|5971||2|0|G|0|||0 570106|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|100|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|10831|14660|lyfalmen|V1005|14660|2|100|0|13,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||9563||9563|14660||2|0|E|1|30|dagar|0 570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3933|2694|lyfalmen|V0110|2694|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||869||869|2694||2|0|G|0|||0 570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2619|5103|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2619||2619|5103||2|0|G|0|||0 570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2135|4437|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2135||2135|4437||1|0|G|0|||0 570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|3584|6431|lyfalmen|V0196|6431|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||3584||3584|6431||2|0|G|0|||0 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|EST|0|0|0|100|DKK|3484|6780|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3484||3484|6780||1|0||0|||0 571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|650|2048|lyfalmen|V0908|2048|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||400||400|2048||2|0|G|0|||0 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|3637|6504|lyfalmen|V0384|5801|2|15|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||3637||3637|6504||2|0|G|0|||0 571181|R07AA0201|Curosurf|innönddr|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|1|CHI|0|0|0|100|XEU|74638|97676|lyfsjukr|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||74638||74638|97676||1|H|S|0|||0 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|1|RRG|0|1|0|100|DKK|560729|703901|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||560729||560729|703901||2|H|L|0|||0 571667|N03AX1602|Lyrica (Lyfjaver)|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|17022|24927|lyfalmen|V0687|4939|3|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||17022||17022|24927||3|0|E|0|||0 571872|J01CR0206|Amoxicillin/Clavulanic Acid Normon|sts/irs|1200|mg|100|hgl|1|pakki|1000+200 mg|J01CR02|01.09.2019||R|0|0|0|0|1|LNA|0|0|1|100|XEU|58750|77581|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Amoxicillín og beta-laktamasa hemill||58750||58750|77581||2|0|0|0|||0 571902|N05AH0416|Quetiapin Medical Valley|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|5400|7540|lyfalmen|V0910|7540|2|100|0|37,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||4390||4390|7540||2|0|0|0|||0 572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|1|CLU|0|1|0|100|XEU|39488|53218|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||39488||39488|53218||1|0|L|0|||0 572119|J01DD0206|Ceftazidima Normon|sts|1|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|1|LNA|0|0|1|100|XEU|92152|103714|lyfsjukr|||2|50|0|12,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||79412||79412|103714||2|0|0|0|||0 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|75997|99395|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||75997||75997|99395||1|0|G|0|||0 572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2695||2|0|G|0|||0 572777|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|7194|3050|lyfalmen|V0684|3050|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1128||1128|3050||2|0|G|0|||0 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|3276|6007|lyfalmen|V0994|2461|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||3276||3276|6007||1|0|G|0|||0 573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|1|0|1|GSE|0|0|0|100|DKK|2206029|2750194|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||2206029|2750194||2|0|S|0|||0 573477|L01XC0301|Herceptin|st/irþ|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|1|RRG|0|1|0|100|DKK|91213|118640|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||91213||91213|118640||2|H|L|0|||0 573579|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6631|3050|lyfalmen|V0683|3050|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1128||1128|3050||2|0|G|0|||0 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|1|PLS|0|0|1|100|DKK|15247|18379|lyfsjukr|||1|10|0|1,6667|Icepharma hf|Pfizer ApS|Meropenem||12265||12265|18379||1|0|ES|0|||0 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|1|PLS|0|0|1|100|DKK|24824|28754|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Pfizer ApS|Meropenem||20146||20146|28754||1|0|ES|0|||0 573863|V03AB3403|FOMEPIZOLE SERB|irþ|5|mg/ml|20|ml|5|lykjur||V03AB34|01.06.2020||R|0|0|0|0|1|SER|0|0|0|100|XEU|99245|128799|lyfsjukr|||1|100|0||SERB SA|SERB SA|Fómepízól||99245||99245|128799||3|H|S|0|||0 574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2|0||0|||0 574395|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.06.2020||R|0|0|0|0|1|AEE|0|0|0|100|XEU|1510|3576|lyfsjukr|||2|10|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1510||1510|3576||1|H|S|2|450|mg|0 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|1|RRG|0|1|0|100|DKK|436823|549797|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||436823||436823|549797||2|H|L|0|||0 574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|9409|14448|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||9409||9409|14448||1|0|G|0|||0 574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|G|0|PLS|0|0|0|100|DKK|7917|7652|lyfalmen|V0322|2858|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4471||4471|7652||1|0|G|0|||0 575356|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|14927|4610|lyfalmen|V0817|4224|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2261||2261|4610||2|0|E|0|||0 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|13500|7652|lyfalmen|V0323|4166|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4471||4471|7652||1|0|G|0|||0 575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|25663|35732|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||25663||25663|35732||1|0|E|0|||0 575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|1|WIL|0|1|0|100|XEU|41027|55165|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||41027||41027|55165||2|H|L|0|||0 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|794723|994924|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||794723||794723|994924||1|H|S|0|||0 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1379|2369|lyfalmen|V0159|2369|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||633||633|2369||2|0|E|0|||0 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1690|3173|lyfalmen|V0160|2914|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1217||1217|3173||2|0|E|0|||0 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1537|2829|lyfalmen|V0158|2829|2|20|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||967||967|2829||2|0|E|0|||0 575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|91284|118730|lyfalmen|||1|2,16|0|6,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||91284||91284|118730||1|0|G|0|||0 575959|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|7873|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E|1|30|dagar|0 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1290626|1611689|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1290626||1290626|1611689||2|0|L|0|||0 576253|B01AC2202|Prasugrel Krka|filmhtfl|10|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0806|10445|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G|0|||0 576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Dexmedetomidinum||5680||5680|10947||2|0||0|||0 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|G|0|AEP|0|0|0|100|DKK|9086|14004|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||9086||9086|14004||2|0|G|0|||0 576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|13500|16914|lyfalmen|V0680|16753|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||11200||11200|16914||2|0||0|||0 577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|489|2171|lyfalmen|||2|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||489||489|2171||1|0|E|3|||0 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|21843|30901|lyfalmen|V0727|28718|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||21843||21843|30901||1|0|E|0|||0 577505|L04AC0701|RoActemra|stl|162|mg|4|áf-penni|1|pakki||L04AC07|01.03.2019||R|0|1|1|0|1|RRG|0|1|0|100|DKK|150602|193818|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||150602||150602|193818||2|0|L|0|||0 577616|N06BA0905|Atomoxetin STADA|hylki|60|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|4526|lyfalmen|V0816|4526|2|30|0|22,5000|LYFIS ehf|LYFIS ehf|Atomoxetín||2200||2200|4526||2|0|E|0|||0 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|11619|17490|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11619||11619|17490||2|H|S|0|||0 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4749|8034|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4749||4749|8034||1|0||0|||0 578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|341463|431196|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||341463||341463|431196||2|H|S|0|||0 578537|J05AR2501|DOVATO|filmhtfl|350|mg|30|stk|1|glas|50 mg/300 mg|J05AR25|01.09.2020||R|1|0|1|0|1|VIC|0|0|0|100|DKK|109070|142164|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravir og lamivudin||109070||109070|142164||1|0|0|0|||0 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|7196|12403|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||7196||7196|12403||2|0||0|||0 578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|ERC|0|0|0|100|DKK|1119|3038|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||1119||1119|3038||1|0|E|0|||0 579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|14658|14436|lyfalmen|V0423|11133|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||9400||9400|14436||2|0|G|0|||0 579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|G|0|MDK|0|0|0|100|DKK|2629|5116|lyfalmen|||1|98|0|98,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||2629||2629|5116||2|0|G|0|||0 579184|L01CD0205|Docetaxel Accord|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.06.2020||R|0|0|0|0|1|CLU|0|0|0|100|XEU|36440|49363|lyfsjukr|||2|8|0||Artasan ehf|Accord Healthcare S.L.U.|Docetaxel||36440||36440|49363||1|H|S|0|||0 579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|1|BMS|0|1|0|100|DKK|174939|224086|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||174939||174939|224086||1|H|L|0|||0 579322|L01BC0503|Gemcitabine W&H|irs|1000|mg|1000|mg|1|hgl|innrennslistofn|L01BC05|01.02.2019||R|0|0|0|0|1|WEH|0|0|0|100|IKR|7952|12443|lyfsjukr|||2|1000|0||Williams & Halls efh|Williams & Halls ehf|Gemcitabín||7952||7952|12443||2|H|S|0|||0 579491|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Innöndunartæki og 3 áfyllingar|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|21331|28257|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||19441||19441|28257||1|0|G|0|||0 579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|0|0|0|ATE|0|0|1|100|IKR|1810|3989|lyfalmen|||2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1810||1810|3989||1|0|E|3|||0 579910|L04AA3701|OLUMIANT|filmhtfl|4|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|1|NED|0|1|0|100|XEU|128746|166635|lyfsjukr|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||128746||128746|166635||2|0|L|0|||0 579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|10572|16049|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||10572||10572|16049||1|0|G|0|||0 579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|3302|2544|lyfalmen|V0107|2461|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||760||760|2544||2|0|E|0|||0 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BFP|0|0|0|100|XEU|15149|10530|lyfalmen|V0111|6040|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||6562||6562|10530||2|0|E|0|||0 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8801|13612|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8801||8801|13612||1|0||0|||0 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|1|FKD|0|0|0|100|DKK|10916|16523|lyfsjukr|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||10916||10916|16523||1|H|S|0|||0 580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|4140|7196|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4140||4140|7196||1|0|G|0|||0 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|1601|3702|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1601||1601|3702||2|0|S|0|||0 581379|C08CA0106|Amlodipin Medical Valley|töflur|10|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2910|2589|lyfalmen|V0057|2589|2|112|0|224,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||793||793|2589||2|0|G|0|||0 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3341|6096|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3341||3341|6096||2|0|G|0|||0 581474|N02BA5105|Treo Hindbær|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.06.2020||L|0|0|0|0|0|MDK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|XEU|3662|6538|lyfalmen|||2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||3662||3662|6538||2|0|G|0|||0 581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|24209|lyfalmen|||2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||16500||16500|24209||2|0|G|0|||0 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|ANI|1|0|0|100|XEU|14774|28200|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14774||14774|28200||2|0||2|||0 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2480|4911|lyfalmen|V0669|4150|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2480||2480|4911||1|0|G|0|||0 582004|L01XE2901|Lenvima|hylki|4|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|1|0|1|SIE|0|0|0|100|SEK|246580|313188|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||246580||246580|313188||1|0|S|0|||0 582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2|0||0|||0 582096|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|4377|7357|lyfalmen|V0972|7357|2|100|0|30,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||4257||4257|7357||2|0|G|0|||0 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|17698|25857|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||17698||17698|25857||3|0|G|0|||0 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|1|GEH|0|0|0|100|NOK|22625|31890|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Iohexol||22625||22625|31890||2|H|S|0|||0 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|18427|26861|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Iohexol||18427||18427|26861||2|H|S|0|||0 582611|A10BJ0601|Ozempic|stl|1|mg|3|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|20200|28823|lyfalmen|||1|3|0|27,2727|Vistor hf|Novo-Nordisk|Semaglutide||20200||20200|28823||1|0||0|||0 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|55282|73194|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Iohexol||55282||55282|73194||2|H|S|0|||0 582671|H02AB0912|Alkindi|kyrnhylk|5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|77888|101786|lyfalmen|||1|50|0|8,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||77888||77888|101786||2|0|G|0|||0 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|23007|32373|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||23007||23007|32373||2|H|S|0|||0 582981|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.06.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3875|5613|lyfalm11|V0983|5613|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3467||3467|5613||2|0||0|||0 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|33639|45820|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||33639||33639|45820||2|0|L|0|||0 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|G|0|PLS|0|0|0|100|DKK|2097|4384|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2097||2097|4384||1|0|G|0|||0 583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|47001|62720|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||47001||47001|62720||2|H|S|0|||0 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1222|3180|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1222||1222|3180||2|0|G|0|||0 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|79374|103666|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||79374||79374|103666||2|H|S|0|||0 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|25147|35080|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||25147||25147|35080||2|H|S|0|||0 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|40234|54162|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||40234||40234|54162||2|H|S|0|||0 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|75440|98690|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||75440||75440|98690||2|H|S|0|||0 583888|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4061|5792|lyfalmen|V0985|5792|2|30|0|60,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||3120||3120|5792||2|0|G|0|||0 583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|1|RAU|0|0|1|100|XEU|1761|3922|lyfsjukr|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1761||1761|3922||2|0|S|0|||0 584577|A04AD1202|Aprepitant Medical Valley|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.07.2019||R|1|0|0|0|1|VAL|0|0|1|100|XEU|8505|10149|lyfsjukr|||2|3|0|1,7273|Acare ehf|Medical Valley Invest AB|Aprepitant||6285||6285|10149||2|0|S|0|||0 584738|N03AX1212|Gabapenstad|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|1|0|G|0|ASR|0|0|0|100|IKR|1800|3975|lyfalmen|V0250|3268|2|120|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1800||1800|3975||2|0|G|0|||0 584834|N06AX2701|Spravato|nefúði|28|mg|28|mg|1|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|0|0|100|SEK|33867|46109|lyfalmen|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||33867||33867|46109||1|H||0|||0 584851|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.09.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|637|2375|lyfalmen|V0448|2375|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||637||637|2375||1|0|G|0|||0 585283|S01ED5122|Fixopost|augndr|||0,2|ml|90|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|7698|12093|lyfalmen|||2|18|0|90,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||7698||7698|12093||1|0|G|0|||0 585287|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|65529|86155|lyfalmen|V0727|86155|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65529||65529|86155||1|0|E|0|||0 585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|1|MBV|0|1|0|100|DKK|546047|685641|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||546047||546047|685641||1|H|L|0|||0 585458|M02AA1502|Voltaren|hlaup|11,6|mg/g|75|g|1|túpa||M02AA15|01.11.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|75|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|19190|27911|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||19190||19190|27911||1|0|G|0|||0 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|LEP|0|0|1|100|DKK|6325|10204|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||6325||6325|10204||1|0||0|||0 585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2500|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||500||500|2186||2|0|G|0|||0 585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|G|0|AEP|0|0|0|100|DKK|12698|18975|lyfalmen|||1|4|0|20,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||12698||12698|18975||2|0|G|0|||0 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|GPH|0|0|0|100|DKK|4285|7396|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4285||4285|7396||1|0||0|||0 585905|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|11089|10720|lyfalmen|V0440|10720|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||6700||6700|10720||2|0|G|0|||0 585914|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|142033|183161|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||142033||142033|183161||1|H|L|0|||0 586005|N03AX1212|Gabapenstad|hylki|400|mg|100|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|1|0|G|0|ASR|0|0|0|100|IKR|1833|3150|lyfalmen|V0251|3150|2|100|0|22,2200|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1200||1200|3150||2|0|G|0|||0 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|28765|39656|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||28765||28765|39656||1|0|G|0|||0 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|1|LEM|0|0|1|100|XEU|13382|19917|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||13382||13382|19917||2|0|ES|0|||0 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|0|1|MLT|0|1|1|100|DKK|335161|423358|lyfsjukr|||1|224|0|56,0000|BGP Products AsP|Mylan Ireland Limited|Tobramýcín||335161||335161|423358||2|0|L|0|||0 586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|71811|94100|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||71811||71811|94100||1|0|E|0|||0 586579|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2861|lyfalmen|V0335|2861|2|110|0|165,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||990||990|2861||2|0|G|0|||0 586627|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|30|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2358|4743|lyfalmen|||2|30|0|90,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||2358||2358|4743||2|0|0|0|||0 586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7106|4172|lyfalmen|V0815|3903|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1943||1943|4172||1|0|E|0|||0 586939|N05AH0415|Quetiapin Krka|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.07.2019||R|0|0|0|G|0|KRK|0|0|0|100|IKR|12500|11408|lyfalmen|V0261|11408|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||7200||7200|11408||2|0|0|0|||0 586959|L01BC0207|Flúoróúracil Accord|stl/irl|50|mg/ml|100|ml|1|hgl||L01BC02|01.12.2019||R|0|0|0|0|1|AEE|0|0|0|100|XEU|4740|8022|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare B.V.|Flúóróúracíl||4740||4740|8022||1|H|0|0|||0 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|30264|41552|lyfalmen|V0652|41552|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||30264|41552||1|0|G|0|||0 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4588|6690|lyfalmen|V0196|6431|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||3772||3772|6690||1|0|G|0|||0 587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|1|0|1|JAN|0|1|0|100|DKK|165802|212723|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||165802||165802|212723||1|0|L|0|||0 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|6643|10641|lyfalmen|V0095|10641|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||6643||6643|10641||1|0|E|0|||0 587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|WEH|0|0|0|100|IKR|11132|16820|lyfalmen|V0957|16820|2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||11132||11132|16820||2|0|E|0|||0 587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4425|6781|lyfalmen|V0081|6781|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3838||3838|6781||2|0|G|0|||0 588134|L04AC1201|Kyntheum|stl|210|mg|1,5|ml|2|áf.spr||L04AC12|01.10.2018||R|0|0|1|0|1|OEL|0|1|0|100|DKK|174868|223998|lyfsjukr|||1|3|0|28,0000|Vistor hf|LEO Pharma A/S|Brodalumab||174868||174868|223998||1|0|L|0|||0 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|G|0|WEH|0|0|0|100|XEU|6742|3050|lyfalmen|V0683|3050|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1128||1128|3050||2|0|G|0|||0 588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|1|PEU|0|0|0|100|DKK|714666|895356|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||714666||714666|895356||1|0|ES|0|||0 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1993|4241|lyfalmen|V0461|2869|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1993||1993|4241||1|0|E|0|||0 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|18384|13391|lyfalmen|V0282|13018|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||8641||8641|13391||1|0|G|0|||0 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|1|0|1|NEL|0|1|0|100|DKK|670666|840632|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||670666||670666|840632||1|0|L|0|||0 589302|N02AX0213|Tramadol Krka|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|3500|5352|lyfalmen|V0228|5352|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2800||2800|5352||2|0|G|1|30|dagar|0 589312|N03AX2201|Fycompa|mixtúra|0,5|mg/ml|340|ml|1|glas||N03AX22|01.10.2019||R|0|0|0|G|0|SIE|0|0|0|100|SEK|26510|36803|lyfalmen|||1|340|0|21,2500|Eisai AB|Eisai GmbH|Perampanel||26510||26510|36803||1|0|G|0|||0 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|10976|16605|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||10976||10976|16605||2|H|S|0|||0 589893|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4555|6158|lyfalmen|V0691|6025|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3386||3386|6158||1|0|E|1|30|dagar|0 590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|1|0|1|CLU|0|0|0|100|XEU|42748|57341|lyfsjukr|||2|90|0|36,0000|Artasan ehf|Accord Healthcare S.L.U.|Síldenafíl||42748||42748|57341||1|0|ES|0|||0 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3143|5085|lyfalmen|V0041|3880|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísósorbíð mónónítrat||2606||2606|5085||1|0|G|0|||0 590825|L01XX5001|Ninlaro|hylki|2,3|mg|1|stk|3|þpakki|hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|1|0|1|TPA|0|0|0|100|DKK|868925|1087211|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||868925||868925|1087211||1|0|S|0|||0 590845|N06AB0406|Citalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.01.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1600|3700|lyfalmen|V0317|3663|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||1600||1600|3700||2|0|G|0|||0 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|1|BOI|0|0|0|100|DKK|151923|195461|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||151923||151923|195461||1|H|S|0|||0 590947|H05BX0105|Cinacalcet Accord|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|AEE|0|0|0|100|XEU|37213|9169|lyfalmen|V0721|8409|2|28|0|28,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||5573||5573|9169||1|0||0|||0 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|9735|14897|lyfalmen|V0347|14897|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||9735||9735|14897||3|0|G|0|||0 591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|1|0|1|PEU|0|1|0|100|DKK|125153|162167|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||125153||125153|162167||1|0|L|0|||0 591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2123|4420|lyfalmen|V0561|3735|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||2123||2123|4420||2|0||0|||0 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1193|3140|lyfalmen|V0168|2917|1|21|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1193||1193|3140||1|0|E|0|||0 591812|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|142033|183161|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||142033||142033|183161||1|H|L|0|||0 592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|2496|4933|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2496||2496|4933||2|0|ES|0|||0 592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|V0825|3012|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0 592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3899|7568|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3899||3899|7568||1|0||0|||0 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|1|0|1|GEB|0|0|0|100|XEU|742731|927527|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||740533||740533|927527||1|0|S|0|||0 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|977|2843|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche A.S.|Klónazepam||977||977|2843||2|0|G|2|450|töflur|0 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1252|3221|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche A.S.|Klónazepam||1252||1252|3221||2|0|G|2|100|töflur|0 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7927|4147|lyfalmen|V0694|4119|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||1925||1925|4147||2|0|G|0|||0 593555|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|70|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1556|3474|lyfalmen|V0686|2542|2|70|0|17,5000|Acare ehf|Medical Valley Invest AB|Pregabalín||1436||1436|3474||2|0|E|0|||0 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|G|0|MEA|0|0|1|100|DKK|17970|26232|lyfalmen|||1|12|0|32,0000|Icepharma hf|Meda AB|Tríamcínólón||17970||17970|26232|31.8.2020|2|0|G|||| 594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|0|G|0|RTH|0|0|0|100|IKR|3504|6321|lyfalmen|V0945|6262|2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||3504||3504|6321||2|0|G|1|30|dagar|0 594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|EVO|0|0|0|100|IKR|10293|13734|lyfalmen|V0969|12927|2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||8890||8890|13734||2|0|E|0|||0 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|16854|24696|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16854||16854|24696||1|0|G|0|||0 595364|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4858|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E|1|30|dagar|0 595455|A10BA0205|Metformin EQL|filmhtfl|500|mg|330|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|2000|4251|lyfalmen|||2|330|0|82,5000|LYFIS ehf|EQL Pharma AB|Metformín||2000||2000|4251||2|0|G|0|||0 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|21030|29872|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||21030||21030|29872||1|0|L|0|||0 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|53274|70655|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||53274|70655||1|0|S|0|||0 596223|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|40|skammtar|1|glas||N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|40|0|1,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|BAN|0|0|0|100|DKK|1359|2342|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|Febantel, Pyrantelembonat,Prazikvantel||1359||1359|2342||2|0||0|||0 597167|J01DD0206|Ceftazidima Normon|sts|2|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|1|LNA|0|0|1|100|XEU|100026|112296|lyfsjukr|||2|50|0|25,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||86197||86197|112296||2|0|0|0|||0 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1813|3993|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1813||1813|3993||1|0|E|0|||0 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|1|BMS|0|1|0|100|DKK|583050|731662|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||583050||583050|731662||1|H|L|0|||0 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|106601|139093|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||106601||106601|139093||2|0|S|0|||0 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|G|0|ADI|0|0|0|100|SEK|2431|4844|lyfalmen|||1|100|0|33,3333|Abcur AB|Amdipharm Limited|Acetazólamíð||2431||2431|4844||2|0|G|0|||0 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|SNP|0|0|1|100|XEU|383|2025|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||383||383|2025||1|0||0|||0 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0 598843|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|tfílát||A07EC03|01.04.2018||R|1|0|0|G|0|ATN|0|0|0|100|DKK|4390|7540|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4390||4390|7540||2|0|G|0|||0 598859|M05BA0306|Pamidronatdinatrium Pfizer|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|1|PLS|0|0|0|100|DKK|5627|9243|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5627||5627|9243||1|H|S|0|||0 598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|EKI|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Íbúprófen|||||2285||1|0||0|||0 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|1|0|1|PEU|0|1|0|100|DKK|544078|683192|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||544078||544078|683192||1|0|L|0|||0 599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|1|ATE|0|0|0|100|XEU|8159|12728|lyfsjukr|||2|20|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxalíplatín||8159||8159|12728||1|H|S|0|||0 599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3711|7211|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||3711||3711|7211||1|0||0|||0 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|4638|8970|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4638||4638|8970||2|0||0|||0 599460|S01XA2024|Oculac án rotvarnar|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2606||1|0|G|0|||0 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|29516|40605|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||29516|40605||1|0|G|0|||0 599531|H05BX0105|Cinacalcet Accord|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|AEE|0|0|0|100|XEU|20130|7357|lyfalmen|V0720|6829|2|28|0|14,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||4257||4257|7357||1|0||0|||0 599632|B01AA0303|Warfarin Teva|töflur|1|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1357|3366|lyfalmen|||2|100|0|13,3333|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1357||1357|3366||1|0|G|0|||0 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|3753|3849|lyfalmen|V0334|2601|2|100|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1708||1708|3849||1|0|G|0|||0 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|1|EAG|0|0|0|100|NOK|113464|147629|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare B.V.|Lofendýlat||113464||113464|147629||2|H|S|0|||0 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22309|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22309||2|0||0|||0 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3296|6035|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||3296||3296|6035||2|0||0|||0 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|1918|4138|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1918||1918|4138||2|0||0|||0 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27471|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27471||2|0||0|||0 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|1|0|0|PAR|0|0|0|100|IKR|7280|11518|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7280||7280|11518||2|0||0|||0 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5529|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5529||2|0||0|||0 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6522|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6522||2|0||0|||0 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|PAR|0|0|1|100|IKR|4187|7261|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||4187||4187|7261||2|0||0|||0 970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23513|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23513||2|0||0|||0 970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2095|4381|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||2095||2095|4381||2|0|E|0|||0 974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6143|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6143||2|0||0|||0 974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|33082|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|33082||2|0||0|||0 974809|A01AC0002|Fluticasone propionate - forskriftarlyf|munnskol|0,1|mg/ml|300|ml|1|fl||A01AC|01.12.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3962|6951|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3962|6951||2|0||0|||0 974825|D07XA0103|HTH krem - forskriftarlyf|krem|||30|g|1|túpa|4%/0,025%/1%|D07XA01|01.06.2019||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3475|6281|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Hydrocortisone||3475||3475|6281||2|0|0|0|||0 974841|D10AD0104|Tretinoin - forskriftarlyf|krem|0,05|%|30|g|1|túpa||D10AD01|01.01.2020||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2979|5598|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||2979||2979|5598||2|0|0|0|||0 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|5245|8717|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||5245||5245|8717||2|0||0|||0 980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|PAR|0|0|1|100|IKR|16998|24894|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24894||2|0||0|||0